US20010049517A1 - Method for containing and removing occlusions in the carotid arteries - Google Patents

Method for containing and removing occlusions in the carotid arteries Download PDF

Info

Publication number
US20010049517A1
US20010049517A1 US09/270,150 US27015099A US2001049517A1 US 20010049517 A1 US20010049517 A1 US 20010049517A1 US 27015099 A US27015099 A US 27015099A US 2001049517 A1 US2001049517 A1 US 2001049517A1
Authority
US
United States
Prior art keywords
catheter
occlusion
fluid
branch
vessel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/270,150
Inventor
Gholam-Reza Zadno-Azizi
Mukund R. Patel
Ketan P. Muni
Celso J. Bagaoisan
Hung V. Ha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Vascular Inc
Original Assignee
Medtronic Percusurge Inc
Percusurge Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Percusurge Inc, Percusurge Inc filed Critical Medtronic Percusurge Inc
Priority to US09/270,150 priority Critical patent/US20010049517A1/en
Assigned to PERCUSURGE, INC. reassignment PERCUSURGE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAGAOISAN, CELSO J., HA, HUNG V., MUNI, KETAN P., PATEL, MUKUND R., ZADNO-AZIZI, GHOLAM-REZA
Priority to DE60039594T priority patent/DE60039594D1/en
Priority to PCT/US2000/006906 priority patent/WO2000054673A1/en
Priority to AU37512/00A priority patent/AU3751200A/en
Priority to EP00916404A priority patent/EP1164944B1/en
Publication of US20010049517A1 publication Critical patent/US20010049517A1/en
Priority to US10/035,389 priority patent/US6958059B2/en
Assigned to MEDTRONIC PERCUSURGE, INC. reassignment MEDTRONIC PERCUSURGE, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: BAGAOISAN, CELSO J., HA, HUNG V., MUNI, KETAN P., PATEL, MUKUND R., ZADNO-AZIZI, GHOLAM-REZA
Priority to US10/246,077 priority patent/US6605074B2/en
Priority to US10/419,912 priority patent/US6790204B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/008Strength or flexibility characteristics of the catheter tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/0071Multiple separate lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1011Multiple balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22065Functions of balloons
    • A61B2017/22067Blocking; Occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • A61B2017/22084Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2217/00General characteristics of surgical instruments
    • A61B2217/002Auxiliary appliance
    • A61B2217/005Auxiliary appliance with suction drainage system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/008Strength or flexibility characteristics of the catheter tip
    • A61M2025/0081Soft tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M2025/0183Rapid exchange or monorail catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1052Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0693Brain, cerebrum

Definitions

  • the present invention relates to containment and removal of substances including emboli (such as from thrombi, plaque, and other types of material and debris) from blood vessels.
  • emboli such as from thrombi, plaque, and other types of material and debris
  • the preferred embodiments are particularly advantages for use in the carotid arteries and other arteries above the aortic arch during diagnostic and therapeutic procedures.
  • the carotid arteries are the main vessels which supply blood to the brain and face.
  • the common carotid artery leads upwards from the aortic arch, branching into the internal carotid artery which feeds the brain, and the external carotid artery which feeds the head and face.
  • the carotid arteries are first narrowed and may eventually be almost completely blocked by plaque, and may further be complicated by the formation of thrombi (blood clots) on the roughened surfaces of the plaques. Narrowing or blockage of the carotid arteries is often untreatable and can result in devastating physical and cognitive debilitation, and even death.
  • Various types of intervention techniques have been developed which facilitate the reduction or removal of the blockage in the blood vessel, allowing increased blood flow through the vessel.
  • One technique for treating stenosis or occlusion of a blood vessel is percutaneous balloon angioplasty.
  • a balloon catheter is threaded through the patient's arterial system and inserted into the narrowed or blocked area, and the balloon is inflated to expand the constricted area.
  • the fear of dislodging an embolus from an ulcerative plaque and the severe resulting consequences has prevented the widespread use of angioplasty in the carotid arteries. Because of the potential complications, the options for minimally invasive treatment of the carotid arteries are severely limited.
  • Carotid endarterectomy is another type of intervention for removal of blockages from the carotid arteries.
  • endarterectomy the carotid bifurcation is exposed through an incision in the neck of the patient. Clamps are placed on either side of the occlusion to isolate it, and an incision made to open the artery. The occlusion is removed, the isolated area irrigated and aspirated, and the artery sutured closed. The clamps are removed to reestablish blood flow through the artery.
  • the emboli and debris are contained and directed by activating and deactivating the clamps.
  • the particles are contained between the two clamps.
  • the clamp on the common carotid artery is opened, allowing blood to flow into the previously isolated area toward the clamp on the internal carotid.
  • This blood flow is then aspirated through an external aspiration tube.
  • the common carotid artery is then reclamped, and the clamp on the internal carotid opened. This causes blood to flow into the previously isolated area toward the clamp on the common carotid artery.
  • the flow is then aspirated.
  • the clamp on the internal carotid artery is closed, and the artery is sutured closed. This method allows for the flushing of debris into the area where aspiration occurs.
  • this method of clamping and unclamping the carotid arteries can be done after the incision in the artery is sutured closed. Using this method, it is hoped that any particles in the internal carotid artery will be forced back to the common carotid artery, then into the external carotid area, where serious complications are unlikely to arise from emboli.
  • Carotid endarterectomy is not without the serious risk of embolization and stroke caused by particles of the blocking material and other debris moving downstream to the brain, however. There is therefore a need for improved methods of treatment for occluded carotid arteries which decrease the risks to the patient.
  • the present invention provides a novel method for containing and removing substances such as emboli from blood vessels.
  • the method is particularly useful in bifurcated vessels, such as the carotid arteries and in other blood vessels above the aortic arch.
  • at least one occlusive device such as a balloon or filter, a therapy catheter to treat the occlusion, and a source of aspiration to remove the debris created by the therapy.
  • this method can eliminate the need for a separate irrigation catheter and irrigation fluid.
  • irrigation fluid may be provided to flush the area.
  • the minimally invasive treatment allows occlusions to be treated more rapidly and less invasively than known methods, with reduced cost and risk to the patient.
  • a method for the treatment of an occlusion in a carotid artery A main catheter having a first occlusive device on its distal end is inserted into the artery, until the occlusive device is proximal to the occlusion. The first occlusive device is activated to occlude the artery proximal to the occlusion. An inner catheter having a second occlusive device on its distal end is inserted into the artery across the occlusion, until the occlusive device is distal to the occlusion.
  • occlusive device is then activated to occlude the artery distal to the occlusion and create a working area surrounding the occlusion.
  • occlusive device is meant any device which is capable of preventing at least some particles or other debris from migrating downstream. Examples of occlusive devices include inflatable balloons, filters or braids, or other mechanical devices.
  • a therapy catheter is then inserted into the working area and used to treat the occlusion.
  • Appropriate treatment can include direct drug delivery to the site of the occlusion, angioplasty, cutting, scraping or pulverizing the occlusion, ablating the occlusion using ultrasound or a laser, deploying a stent within the artery, use of a thrombectomy or rheolitic device, or other treatments.
  • the therapy catheter is removed.
  • An aspiration catheter is then delivered to the working area, and the first occlusive device is deactivated to allow blood flow into the working area.
  • Blood flow from collateral vessels prevent the movement of particles and debris downstream where they could cause serious complications.
  • the blood flow also acts as irrigation fluid to create turbulence within the area.
  • Aspiration of the working area is then performed to removed particles and debris. Aspiration can occur simultaneously with the deactivating of the first occlusive device, if desired. Alternatively, either step can be performed first.
  • the occlusive devices are activated and deactivated more than once. After the first occlusive device is deactivated to allow blood flow into the area, the occlusive device is reactivated. The second occlusive device is then deactivated, to allow blood flow in from the distal end of the working area. The second occlusive device is reactivated, and these steps can be repeated any number of times until sufficient irrigation and aspiration of the working area occurs.
  • the first inner catheter with its occlusive device is delivered into one branch of a bifurcated vessel (such as the carotid artery), while a second inner catheter having a third occlusive device on its distal end is delivered into the other branch of the bifurcated vessel to occlude it. Aspiration then occurs in both branches of the artery to remove particles and debris.
  • a bifurcated vessel such as the carotid artery
  • aspiration occurs through the main catheter, and a separate aspiration catheter is not required. Following removal of the therapy catheter, and deactivation of the first occlusive device to allow blood flow into the working area, aspiration occurs through the distal end of the main catheter. This eliminates the need to deliver a separate aspiration catheter, thus saving time which is critical in these types of procedures.
  • an irrigation catheter can be delivered into the working area following the removal of the therapy catheter.
  • the irrigation catheter is used to deliver irrigation fluid to the working area. Aspiration then occurs through the distal end of the main catheter.
  • anatomical irrigation the use of the patient's own blood flow for irrigation as described above, is not used.
  • Yet another aspect of the method may be performed with a single occlusive device.
  • a main catheter or guide catheter is first delivered into the carotid artery, with the distal end positioned just proximal to the occlusion.
  • An inner catheter having an occlusive device on its distal end is then positioned with the occlusive device distal to the occlusion.
  • the occlusive device is activated to occlude the artery distal to the occlusion.
  • a therapy catheter is delivered into the artery until it reaches the occlusion and therapy is performed to reduce or eliminate the occlusion.
  • the therapy catheter is removed, and an intermediate catheter is delivered to a position proximal to the occlusive device.
  • the distance between the proximal end of the occlusive device and the distal end of the intermediate catheter is narrowed at one point during aspiration to a distance of about 2 centimeters or less.
  • the area just proximal to the occlusive device is aspirated, using the intermediate catheter, and then irrigated.
  • the aspirating and irrigating steps can be repeated as often as necessary to facilitate the removal of particles and debris.
  • the intermediate catheter has two or more lumens, such that aspiration and irrigation occur through different lumens within the same catheter. This prevents the possibility that aspirated particles will be flushed back into the patient when irrigation is begun.
  • two and even three occlusive devices are employed.
  • a main or guide catheter with an occlusive device on its distal end is delivered to the common carotid artery and the occlusive device is activated.
  • an inner catheter with an occlusive device is delivered distal to the occlusion in the internal carotid artery and activated, thus isolating the occlusion between the two occlusive devices.
  • Therapy is performed on the occlusion, followed by aspiration, and irrigation if desired.
  • an occlusive device is activated in the common carotid artery.
  • An inner catheter with an occlusive device is then delivered to the external carotid artery and the occlusive device activated.
  • a second inner catheter is delivered to the internal carotid artery past the site of the occlusion and the occlusive device activated to occlude the internal carotid artery.
  • the first inner catheter and occlusive device is delivered to the internal carotid artery and activated, followed by delivery and activation of the second inner catheter and occlusive device in the external carotid artery.
  • the occlusion is completely isolated between the three occlusive devices. This is followed by therapy on the occlusion and sequential aspiration and irrigation as desired.
  • a carotid artery can be treated quickly and efficiently.
  • the patient's own blood can serve as irrigation fluid, thereby eliminating the need for a separate irrigation catheter and supply of irrigation fluid.
  • the working area may be cleaned in an efficient manner by performing repeated activation and deactivation of the occlusive devices surrounding the working area.
  • the catheter-based approach reduces the amount of time required to complete the procedure, and allows normal blood flow in the vessel to be restored in a very short period of time. Use of a minimally invasive procedure reduces risks and trauma to the patient, decreases costs, and improves recovery time.
  • Another aspect of the invention comprises a method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), and positioning the occlusive device in said branch distal of the occlusion.
  • the method further comprises sliding a therapy catheter on the elongate member, occluding said branch only on the distal side of the occlusion by actuating the occlusive device, treating the occlusion with the therapy catheter, and providing a second catheter having a fluid flow lumen in fluid communication with a fluid flow opening at a distal end portion of the second catheter.
  • the method additionally comprises using the occlusive device to occlude said branch of the vessel while: (a) positioning the fluid flow opening of the second catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion; and (b) applying fluid pressure to the fluid flow lumen to cause fluid flow along said branch, between (i) an intersection of said branch with the common portion and (ii) said location, whereby fluid flows across the treated occlusion; and then deactuating the occlusive device.
  • Still another aspect of the invention comprises a method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), positioning the occlusive device in said branch distal of the occlusion, sliding a therapy catheter on the elongate member, and occluding said branch on the distal side of the occlusion by actuating the occlusive device.
  • the method further comprises treating the occlusion with the therapy catheter, removing the therapy catheter from said branch of the vessel, providing a second catheter having a fluid flow lumen in fluid communication with a fluid flow opening at a distal end portion of the second catheter, and sliding the second catheter on the elongate member after the removal of the therapy catheter.
  • the method additionally comprises using the occlusive device to occlude said branch of the vessel while (a) positioning the fluid flow opening of the second catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion; (b) applying fluid pressure to the fluid flow lumen to cause fluid flow along said branch, between (i) an intersection of said branch with the common portion and (ii) said location, whereby fluid flows across the treated occlusion; and then deactuating the occlusive device.
  • Yet another aspect of the invention comprises a method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), positioning the occlusive device in said branch distal of the occlusion, sliding a therapy catheter on the elongate member, occluding said branch only on the distal side of the occlusion by actuating the occlusive device, and treating the occlusion with the therapy catheter.
  • the method further comprises using the occlusive device to occlude the branch of the vessel while: (a) delivering irrigation fluid to a distal end portion of the therapy catheter through an annulus between the therapy catheter and the elongate member; (b) passing the irrigation fluid out of a fluid flow opening in the distal end portion of the therapy catheter; and (c) positioning the fluid flow opening of the therapy catheter in said branch of the vessel at a location near the occlusive device between the occlusive device and the treated occlusion, such that fluid flows across the treated occlusion; and then deactuating the occlusive device.
  • Still another aspect of the invention comprises a method for the treatment of an occlusion in a branch of bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), positioning the occlusive device in said branch distal of the occlusion, positioning an outer catheter so that a portion of the outer catheter is in the common portion of the vessel, sliding a therapy catheter within the outer catheter and on the elongate member, actuating the occlusive device such that it occludes said branch of the vessel, and treating the occlusion with the therapy catheter.
  • the method further comprises using the occlusive device to occlude the branch of the vessel while (a) delivering irrigation fluid to a distal end portion of the outer catheter; (b) passing the irrigation fluid out of a fluid flow opening in the distal end portion of the outer catheter; (c) positioning the fluid flow opening of the outer catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion, such that fluid flows across the treated occlusion; and then deactuating the occlusive device.
  • Still another aspect of the invention comprises a method for treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, comprising positioning an occlusive device distal of the occlusion to occlude said branch of the vessel, treating the occlusion using a therapy device, delivering irrigation fluid between the occlusion and the occlusive device such that irrigation fluid flows across the treated occlusion towards an intersection of said branch and the common portion, wherein emboli in said branch are carried to the intersection, and allowing anatomical blood flow in the common portion to carry the emboli through another of the branches.
  • Yet another aspect of the invention comprises a method for the treatment of an occlusion in a blood vessel, such as the carotid artery, comprising providing an inner catheter comprising an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the vessel, positioning the occlusive device distal of the occlusion, sliding a therapy catheter on the elongate member, actuating the occlusive device such that it occludes the vessel, and treating the occlusion with the therapy catheter.
  • the method further comprises uses the occlusive device to occlude the vessel while: (a) delivering irrigation fluid through the elongate member; (b) passing the irrigation fluid out of a fluid flow opening in the occlusive device such that fluid flows across the treated occlusion; and then deactuating the occlusive device.
  • Still another aspect of the invention comprises a method of performing a medical procedure in a blood vessel using an expandable member which seals against walls of the blood vessel in response to application of an expansion force through a range of vessel diameters up to a maximum diameter beyond which sealing will not occur in the vessel, in which the method comprises positioning the expandable member in a selected blood vessel distal to an occlusion to be treated at a location where the vessel diameter is at least 20% less than said maximum diameter, applying an expansion force to cause the expandable member to expand into sealing contact with walls of the selected vessel at said location, and treating the occlusion while the expandable member is expanded, whereby the expandable member seals against walls of the selected vessel even if the diameter of the selected vessel at said location increases to said maximum diameter as a result of the treatment.
  • Another aspect of the invention comprises a method of treating an occlusion in a blood vessel, comprising positioning an expandable member distal to the occlusion to be treated, performing therapy on the occlusion, and using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow from one side to another side of the expandable member in a proximal to distal direction.
  • the method further comprises positioning a fluid port of a catheter between the treated occlusion and the expandable member, and applying suction to the fluid port to aspirate fluid into the catheter while the fluid port is positioned between the treated occlusion and the expandable member.
  • Still another aspect of the invention comprises a method of treating an occlusion in a blood vessel, comprising positioning an expandable member distal to the occlusion to be treated, performing therapy on the occlusion, and using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow past the expandable member in a proximal to distal direction.
  • the method further comprises positioning a fluid port of a catheter between the treated occlusion and the expandable member, delivering irrigation fluid through the fluid port, and using the irrigation fluid to provide fluid flow across the treated occlusion in a distal to proximal direction.
  • Yet another aspect of the invention comprises a method of treating an occlusion in a blood vessel, comprising positioning an expandable member distal to the occlusion to be treated, using a therapy balloon to perform therapy on the occlusion, using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow from one side to another side of the expandable member in a proximal to distal direction.
  • the method further comprises using the therapy balloon to occlude the blood vessel at a location distal to the treated occlusion, positioning a fluid port of a catheter between the treated occlusion and said location, and providing fluid flow through the fluid port such that said fluid flows across the treated occlusion.
  • FIG. 1 is a perspective drawing of the carotid arteries.
  • FIG. 2 is a side view of an embodiment of a main catheter.
  • FIG. 3 is a cross-sectional view of the main catheter taken along line 3 - 3 of FIG. 2.
  • FIG. 4 is a cross-sectional view of the main catheter taken along line 4 - 4 of FIG. 2.
  • FIG. 5 is a side view of the distal end of an embodiment of an inner catheter.
  • FIG. 6 is a partial cross-sectional view of the inner catheter taken along line 6 - 6 of FIG. 5.
  • FIG. 7 is a side view of an embodiment of an over-the-wire aspiration catheter.
  • FIG. 8 is a cross-sectional view of the over-the-wire aspiration catheter taken along line 8 - 8 in FIG. 7.
  • FIG. 9 is a cross-sectional view of the over-the-wire aspiration catheter taken along line 8 - 8 in FIG. 7, showing an elongate member (e.g., a guidewire) inserted therethrough.
  • an elongate member e.g., a guidewire
  • FIG. 10 is a side view of an embodiment of a single operator aspiration catheter.
  • FIG. 11 is a cross-sectional view of the single operator aspiration catheter taken along line 11 - 11 in FIG. 10.
  • FIG. 12 is a side view of an embodiment of an over-the-wire irrigation or aspiration catheter.
  • FIG. 13 is a side view of an embodiment of a single operator irrigation catheter.
  • FIGS. 14 through 16A are cross-sectional views of the single operator irrigation catheter taken along lines 14 - 14 , 15 - 15 and 16 A- 16 A of FIG. 13.
  • FIG. 17 is a perspective view of one example of an emboli containment and removal method within a carotid artery.
  • FIG. 18 is a perspective view of another example of an emboli containment and removal method.
  • FIG. 19 is a perspective view of yet another example of an emboli containment and removal method which employs a single occlusive device.
  • FIG. 20 is a perspective view of the emboli containment and removal method illustrated in FIG. 19, showing the use of an intermediate catheter.
  • FIG. 21 is a perspective view of still another example of an emboli containment and removal method which employs two occlusive devices.
  • FIG. 22 is a perspective view showing a preferred location for the intermediate catheter when the intermediate catheter is used to flush away emboli from the treated occlusion.
  • FIG. 23 is a perspective view of an embodiment in which the intermediate catheter is used for aspiration of emboli.
  • FIG. 24 is a perspective view of an embodiment in which the intermediate catheter is used for irrigation of emboli.
  • FIG. 24A is a perspective view of an embodiment in which a therapy catheter is used for irrigation of emboli.
  • FIG. 25 is a perspective view of an embodiment in which the main catheter is used for aspiration of emboli.
  • FIG. 26 is a perspective view of an embodiment in which the main catheter is used for irrigation of emboli.
  • FIG. 27 is a perspective view of an embodiment in which a distal occlusion device has a plurality of holes therein for passing irrigation fluid across the treated occlusion.
  • FIG. 28 is a perspective view of an embodiment in which an elongate member (e.g., a guidewire) has a plurality of holes therein for passing irrigation fluid across the treated occlusion.
  • an elongate member e.g., a guidewire
  • FIGS. 29A and 29B are perspective views of an embodiment in which a perfusion-filter located distal to the lesion to be treated permits the perfusion of blood while entraining emboli produced as a result of therapy.
  • FIGS. 30A is a perspective view of an alternative embodiment in which emboli are captured in a perfusion-filter.
  • FIG. 30B is a cross sectional view of the main catheter of the embodiment of FIG. 30A, illustrating lumens used for inflation of the occlusive device, for delivering irrigation fluid, and for passing an elongate member (e.g., a guidewire).
  • an elongate member e.g., a guidewire
  • FIG. 31 is a perspective view of an embodiment in which passive perfusion is performed with a hypotube having holes therein.
  • FIGS. 32A and 32B are perspective views of a perfusion-filter embodiment in which the occlusion of the vessel is performed with the therapy catheter.
  • FIG. 33 shows a preferred embodiment of a syringe assembly having features in accordance with the present invention and operably coupled to an illustrative inflation adapter at a proximal portion of a balloon guidewire catheter.
  • FIGS. 34A and 34B show open and closed positions, respectively, of the sealing member, which is used with the balloon guidewire catheter of FIGS. 33 and 35.
  • FIG. 35 shows a perspective view of the balloon guidewire catheter of FIG. 33 placed within an open inflation adapter.
  • the preferred embodiments of the present invention provide improved methods for containing and removing emboli resulting from plaque, thrombi or other occlusions.
  • the preferred methods are particularly advantageous for use in the carotid artery and other arteries above the aortic arch.
  • the preferred methods may be used, for example, in the treatment of a stenosis or an occlusion which has a length and a width or thickness resulting in at least partial occlusion of the vessel's lumen.
  • the preferred methods are effective in treating both partial and substantially complete occlusions of arteries.
  • occlusion includes both complete and partial occlusions, stenoses, emboli, thrombi, plaque, and any other substance which at least partially occludes the lumen of the artery.
  • the common carotid artery 10 is located in the neck and branches off into the internal carotid 12 , and the external carotid 14 arteries.
  • the internal carotid artery 12 supplies blood to the brain, while the external carotid artery 14 supplies blood to the head and face.
  • the preferred methods of the present invention will be described for the treatment of an occlusion within the internal carotid artery. It is to be understood that this method can be used on other arteries as well.
  • the preferred methods are adapted for the percutaneous treatment, containment and removal of occlusions within the carotid arteries or other arteries above the aortic arch.
  • a main catheter having an occlusive device on its distal end is first delivered to the common carotid artery, proximal to the site of the occlusion.
  • proximal refers to the portion of the apparatus closest to the end which remains outside the patient's body
  • distal refers to the portion closest to the end inserted into the patient's body.
  • the occlusive device is activated to stop the downstream flow of blood.
  • a main catheter without an occlusive device on its distal end, or a main catheter having an occlusive device which is not deployed is delivered to the common carotid artery, proximal to the site of the occlusion.
  • an inner catheter having an occlusive device on its distal end is delivered through the main catheter and across the site of the occlusion.
  • a detachable occlusive device can also be used. In either case, the occlusive device is activated at a site distal to the occlusion.
  • a second inner catheter is used to provide a third occlusive device.
  • One inner catheter is delivered to the internal carotid artery, while the other inner catheter is delivered to the external carotid artery.
  • the three occlusive devices When activated, the three occlusive devices completely isolate the area surrounding the occlusion to be treated.
  • a therapy catheter is then delivered to the site of the occlusion to treat the occlusion.
  • Such treatment includes, but is not limited to, balloon angioplasty, thermal balloon angioplasty, delivery of an intravascular stent, atherectomy, or radiation treatment.
  • an irrigation catheter is delivered into the working area to provide irrigation fluid.
  • anatomical irrigation can be used, as explained below.
  • Aspiration of the area surrounding the treated occlusion is begun using either the main catheter or a separate aspiration catheter. Blood flow is allowed into the working area to be aspirated by deactivating the occlusive devices on the main and/or inner catheters. This helps to irrigate the area and ensure the removal of particles and debris from the artery.
  • the need for a separate irrigation catheter and irrigation fluid are eliminated.
  • separate irrigation fluid is generally provided through an irrigation catheter to the site of treatment. It has been discovered that the patient's own blood can be used as irrigation fluid, without the need for delivery of a separate irrigation catheter and irrigation fluid.
  • a separate catheter is introduced into the patient after the therapy catheter is removed and is delivered within close proximity to the occlusive device. Once the catheter is delivered proximal to the occlusive device, the area is first aspirated through the catheter. By delivering the catheter close to the occlusive device a turbulence is created freeing debris from the edge of the occlusive device and other areas where it may be trapped. The debris is then aspirated from the patient. Following aspiration, irrigation fluid is provided if desired to flush any remaining particles and debris from the internal carotid.
  • a main or guide catheter is first introduced into the patient's vasculature. This catheter is used to guide the insertion of other catheters and devices to the desired site.
  • a guide catheter e.g., 9F
  • a long sheath e.g., 7F
  • an angiography catheter may be positioned inside the guide catheter, and both the guide catheter and the angiography catheter can be delivered on a guidewire.
  • guidewire is used broadly herein to include elongate members (such as hollow or tubular members) made of metal as well as other materials, such as plastic.)
  • the main catheter has an occlusive device on its distal end.
  • the occlusive device can be an inflatable balloon, filter, expandable braid or other mechanical occlusive device.
  • the occlusive device should be capable of preventing the migration of particles and debris from the working area, either through total or partial occlusion of the vessel. Note that the occlusion of the vessel need not be complete, and that substantial occlusion of the vessel may be sufficient.
  • the catheter should be sized so as to slidably receive the inner, therapy and intermediate (irrigation and/or aspiration) catheters inserted therethrough.
  • FIG. 2 illustrates a side view of a catheter which can be used as the outer or main catheter of the present system.
  • Catheter 110 generally comprises an elongate flexible tubular body 116 extending between a proximal control end 112 and a distal functional end 114 .
  • the tubular body 116 has a main lumen 130 which extends between the ends 112 and 114 .
  • the main lumen 130 terminates in a proximal opening 123 and a distal opening 127 .
  • a smaller inflation lumen 132 configured in a side-by-side relationship with the main lumen 130 , extends along the length of the tubular body 116 , and terminates within an occlusive device such as an occlusion balloon 126 mounted on the distal end 114 of the catheter 110 , as described below.
  • the inflation lumen 132 illustrated in FIGS. 3 and 4, is in fluid communication with the occlusion balloon 126 , such that fluid passing through the inflation lumen 132 may be used to inflate or deflate the balloon 126 .
  • the proximal end of the inflation lumen can terminate at one of the ports 122 , 124 on the proximal end of the catheter 110 .
  • a control manifold 119 is provided at the proximal end 112 of the catheter 110 .
  • the control manifold 119 is generally provided with a number of ports to provide access to the catheter lumen 130 .
  • the control manifold 119 is provided with a catheter end-access port 122 and a catheter side-access port 124 , to provide an introduction point for the insertion of other catheters into the lumen 130 .
  • Ports 122 and 124 are preferably provided with standard Touhy Borst connectors, although other types of connectors may be used.
  • An inflation port 118 in fluid communication with the small inflation lumen 132 , is further provided on the manifold 119 for attachment of devices to inflate or deflate the occlusion balloon 126 .
  • the manifold 119 is also provided with an irrigation/aspiration port 120 which is in fluid communication with the lumen 130 , for attachment of devices to provide irrigation fluid or aspiration pressure.
  • Other embodiments of the main catheter 110 may feature more or less ports, depending upon the number of lumens in the catheter and the desired functionalities of the catheter.
  • the manifold 119 is preferably formed out of hard polymers or metals, which possess the requisite structural integrity to provide a functional access port to the catheter lumen, such as for balloon inflation or delivery of irrigation fluid and/or aspiration pressure.
  • the manifold 119 is integrally formed out of polycarbonate.
  • any suitable material may be used to form the manifold 119 , including acrylonitrile butadiene styrene (ABS).
  • an inflatable balloon 126 is mounted on the distal end 114 of the catheter 110 .
  • the inflatable balloon 126 will function as an occlusion balloon, to prevent blood and debris from passing through the blood vessel distal to the balloon 126 .
  • the inflatable balloon 126 is preferably able to expand to fit a variety of different blood vessel diameters. Accordingly, it is preferred that the inflatable balloon 126 have a compliant expansion profile, tending to increase in radial diameter with increasing inflation pressure.
  • the balloon 126 may be made out of materials which impart such expansion characteristics, including elastomeric materials such as latex or irradiated polyethylene.
  • the inflatable balloon 126 is formed out of a material comprising a block copolymer of styrene-ethylene-butylene-styrene, sold under the trade name C-FLEX.
  • Non-compliant balloons such as those made from PET can also be used. Further details as to balloons of this type are disclosed in our copending application entitled “Pre-Stretched Catheter Balloon”, Ser. No. 08/812,140, filed Mar. 6, 1997, the entirety of which is incorporated by reference.
  • the main catheter 406 does not include a distal occlusive device, or the distal occlusive device on the main catheter is not used.
  • An inner catheter or guidewire having an occlusive device on its distal end is preferably made of metals such as stainless steel or nitinol, or plastics or composites.
  • the preferred methods can be effectively carried out using any of a number of guidewires or catheters that perform the function of occluding the vessel and allowing for the slidable insertion of various other catheters and devices.
  • the term “catheter” as used herein is therefore intended to include both guidewires and catheters with these desired characteristics.
  • the catheter apparatus 310 is generally comprised of four communicating members including an elongated tubular member 314 , an inflatable balloon member 316 , a core-wire member 320 and a coil member 322 .
  • the catheter apparatus 310 is preferably provided with an outer coating of a lubricous material, such as TEFLON.
  • the body member 314 of the catheter apparatus 310 is in the form of hypotubing and is provided with proximal and distal ends 314 A and 314 B as well as an inner lumen 315 extending along the tubular member 314 .
  • the balloon member 316 is coaxially mounted on the distal end 314 B of the tubular member 314 by suitable adhesives 319 at a proximal end 316 A and a distal end 316 B of the balloon member 316 as in the manner shown in FIG. 6.
  • the core-wire member 320 of the catheter 310 may be comprised of a flexible wire 320 .
  • the flexible wire 320 is joined by adhesives, soldering, brazing or crimping at a proximal end 320 A of the flexible wire 320 to the distal end 314 B of the tubular member 314 as in the manner show in FIG. 6.
  • the proximal end 320 A of the flexible wire 320 has a transverse cross sectional area substantially less than the smallest transverse cross-sectional area of the inner lumen 315 of the tubular member 314 .
  • the flexible wire 320 tapers in the distal end 320 B to smaller diameters to provide greater flexibility to the flexible wire 320 .
  • the flexible wire may be in the form of a solid rod or a ribbon or combinations thereof.
  • the distal end 320 B of the flexible wire 320 is secured to a rounded plug 318 of solder or braze at the distal end 322 B of the coil member 322 .
  • the coil member 322 of the catheter 310 may be comprised of a helical coil 322 .
  • the coil member 322 is coaxially disposed about the flexible wire 320 , and is secured to the flexible wire 320 by soldering, brazing or adhesives at about the proximal end 320 A of the flexible wire 320 as in the manner shown in FIG. 6.
  • the balloon member 316 is preferably a compliant balloon formed of a suitable elastic material such as a latex or the like, but can be made of non-compliant materials as well.
  • the flexible coil 322 is preferably formed of a wire of platinum based alloys or gold.
  • the flexible core-wire 320 and the tubular member 314 are preferably formed of a nickel-titanium alloy or stainless steel.
  • the occlusive device at the distal end of the inner catheter is actuated to occlude the vessel distal to the existing occlusion to create a working area.
  • the occlusive device is positioned at a point distal to the occlusion to be treated, and activated to occlude the artery.
  • the stenosis or occlusion could be in a discrete location or diffused within the artery. Therefore, although placement of the occlusive device is said to be distal to the stenosis or occlusion to be treated, portions of the diffused stenosis or occlusion may remain distal to the occlusive device.
  • a therapy catheter then is delivered to the site of the occlusion.
  • the term “therapy catheter” is meant to include any of a number of known devices used to treat an occluded vessel.
  • a catheter carrying an inflatable balloon for use in balloon angioplasty can be delivered to dilate the occlusion.
  • Thermal balloon angioplasty includes the use of heat to “mold” the vessel to the size and shape of the angioplasty balloon.
  • an intravascular stent can be delivered via a balloon catheter and deployed at the site of the occlusion to keep the vessel open.
  • Cutting, shaving, scraping or pulverizing devices can be delivered to excise the occlusion in a procedure known as atherectomy.
  • a laser or ultrasound device can also be delivered and used to ablate plaque in the vessel.
  • Thrombectomy devices can be used, as can rheolitic devices, and devices which create a venturi effect within the artery.
  • Various thrombolytic or other types of drugs can be delivered locally in high concentrations to the site of the occlusion. It is also possible to deliver various chemical substances or enzymes via a catheter to the site of the stenosis to dissolve the obstruction.
  • the term “therapy catheter” encompasses these and similar devices.
  • the working area may be aspirated to remove fluid and debris.
  • Aspiration can be provided through the main catheter if desired.
  • a source of negative pressure is attached at the proximal end of the main catheter, and fluid and debris are aspirated through the main catheter's main lumen.
  • an aspiration catheter or similar debris removing device can be delivered to the working area to remove particles and any other debris.
  • the term “aspiration catheter” includes any device which creates an area of fluid turbulence and uses negative pressure to aspirate fluid and debris, and includes thrombectomy catheters, rheolitic devices and those devices which create a venturi effect within the vessel. Thus, it is possible that a single catheter is used as both the therapy catheter and the aspiration catheter.
  • the catheter 260 includes an adapter 262 and a seal at its proximal end.
  • the catheter 260 further includes an aspiration port 264 to which a source of negative pressure is attached.
  • the aspiration catheter further comprises a long hollow shaft 266 having a distal end 268 .
  • the distal tip 268 can/include a radiopaque marker to aid in locating the tip 268 during insertion into the patient, and is preferably soft to prevent damage to the patient's vasculature.
  • the aspiration catheter illustrated in FIG. 7 is an over-the-wire catheter. As seen in FIG. 8, the catheter shaft 266 is hollow. During insertion of the aspiration catheter 260 , the proximal end of a guidewire 270 is inserted into the distal end of the aspiration catheter 268 , and the aspiration catheter 260 is slidably advanced over the guidewire 270 , which is positioned inside the hollow lumen 272 of the aspiration catheter 260 . The position of the guidewire 270 relative to the shaft 260 of the aspiration catheter 260 is illustrated in FIG. 9, but of course, can vary. For this type of aspiration catheter 260 , a very long guidewire 270 , generally around 300 centimeters in length, is used to facilitate the insertion of the aspiration catheter 260 over the guidewire 270 .
  • the aspiration catheter 280 can be of a single operator design, as illustrated in FIGS. 10 - 11 .
  • the catheter 280 has an adapter and an aspiration port at its proximal end.
  • the single operator aspiration catheter 280 further comprises a long hollow shaft 282 having a distal end 288 .
  • the distal tip 288 can include a radiopaque marker to aid in locating the tip 288 during insertion into the patient, and is preferably soft to prevent damage to the patient's vasculature.
  • a guidewire lumen 286 is attached at the distal end of the shaft 288 .
  • This lumen 286 provides a separate lumen, apart from the main aspiration lumen 284 of the catheter 280 , for the insertion of the guidewire.
  • This guidewire lumen 286 can be as short as 5 centimeters or longer. As illustrated in FIG. 11, during delivery of the aspiration catheter 280 , the proximal end of the guidewire is inserted into the distal end of the guidewire lumen 286 , and the guidewire lumen 286 is slidably advanced over the guidewire.
  • the single operator aspiration catheter 280 rides over the guidewire, and the guidewire remains in the guidewire lumen 286 and does not enter the aspiration lumen 284 of the aspiration catheter 280 .
  • the long guidewire used with the over-the-wire catheter 260 and the extra operator needed to handle it, are not required.
  • the guidewire lumen 286 is shown in FIG. 10 as being located only on the distal end 288 of the shaft of the aspiration catheter 280 , the lumen 286 can also be made to extend the entire length of the shaft 280 if desired. In both embodiments, the aspiration lumen 284 is advantageously left completely unobstructed to provide more efficient aspiration.
  • the guidewire lumen 286 can also include a slit in the outside wall of the lumen to facilitate faster and easier insertion and removal of the guidewire through the side wall of the lumen.
  • the aspiration catheter can be configured such that the therapy catheter can be inserted through the lumen of the aspiration catheter.
  • the lumen is made large enough to accommodate the desired therapy catheter. This allows the aspiration catheter and the therapy catheter to be delivered into the patient at the same time. When therapy is complete, the therapy catheter is removed while the aspiration catheter remains in place. This eliminates the need to separately deliver the aspiration catheter after removal of the therapy catheter, saving valuable time.
  • the therapy catheter can be built over the aspiration catheter.
  • a dual or triple lumen catheter having a dilatation balloon at its distal end can be used.
  • One lumen is used to inflate the dilatation balloon to be used for angioplasty, while the second lumen is used for aspiration.
  • the third lumen is used as a guidewire lumen.
  • the aspiration catheter can be designed to deploy a stent within the occluded artery, or could include an atherectomy device on its distal end. These designs allows a single combined aspiration catheter and therapy catheter to be delivered into the patient. When therapy is complete, aspiration is carried out without the need to first remove the therapy catheter or separately deliver an aspiration catheter.
  • FIG. 12 is a side view of an irrigation catheter 140 or aspiration catheter which may be utilized in the preferred methods. It should be understood that when an irrigation catheter is used, aspiration occurs through the outer pathway between the irrigation and main catheters, while irrigation occurs through the irrigation pathway. Similarly, when an aspiration catheter is used, aspiration occurs through the aspiration catheter while irrigation occurs through the pathway between the aspiration and main catheters. Irrigation fluid is supplied under pressure at the proximal end of the catheter 142 and delivered through the side holes 146 and through the distal end of the catheter 144 .
  • aspiration can be provided at the proximal end of the catheter 142 and fluid and debris aspirated through the side holes 146 and through the distal end of the catheter 144 .
  • the catheter 140 can be about 125 centimeters in length and constructed from a plastic material such as HYTREL tubing or high density polyethylene (HDPE) or PEBAX (Atochem, France).
  • HDPE high density polyethylene
  • PEBAX PEBAX
  • the durometer of the tube 148 material is reduced in the distal section to about 55 whereas that of the proximal section 142 is higher, such as about 80.
  • Proximal valves and fittings which are well known in the art can be mounted on the catheter 140 of FIG. 12.
  • FIGS. 13 - 16 illustrate another type of irrigation or aspiration catheter 230 , a single operator catheter, which can be used in the present system.
  • irrigation is through the inner pathway and aspiration is through the outer pathway. If the catheter is used for aspiration, aspiration is through the inner pathway and irrigation is through the outer pathway.
  • the catheter 230 has an adaptor 232 on its proximal end.
  • This single operator catheter 230 further comprises a long tubular body 236 having a distal end 238 .
  • the distal tip 238 can include a radiopaque marker to aid in locating the tip 238 during insertion into the patient, and is preferably soft to prevent damage to the patient's vasculature.
  • an inner catheter lumen 240 is attached. This lumen 240 provides a separate lumen, apart from the main irrigation or aspiration lumen 242 of the catheter 230 , for the insertion of the inner catheter, and has an inner diameter sized to received the inner catheter.
  • the inner diameter of the lumen is about 0.016′′ to about 0.020′′, and more preferably is about 0.019′′.
  • This inner catheter or guidewire lumen can be as short as 5 centimeters, but can extend 30 centimeters or longer in a proximal direction.
  • the proximal end of the inner catheter is inserted into the distal end of the inner catheter lumen 240 , and the lumen 240 is slidably advanced over the inner catheter. Only a short segment of the single operator catheter 230 rides over the inner catheter, and the inner catheter remains in the lumen 240 and does not enter the main lumen 242 of the catheter 230 .
  • the inner catheter lumen 240 is shown in FIG. 13 as being located only on the distal end 238 of the shaft of the catheter 236 , the lumen 240 can also be made to extend the entire length of the shaft 236 if desired. In both embodiments, the main lumen 242 is advantageously left completely unobstructed to provide more efficient irrigation or aspiration. As seen in FIG. 16, the inner catheter lumen 240 can also include a slit 241 or weakened area in the outside wall of the lumen 240 along the entire length of the lumen 240 to facilitate faster and easier insertion and removal of the inner catheter through the side wall of the lumen 240 .
  • this slit 241 or weakened area through which the inner catheter can be inserted and removed can exist on the intermediate catheter regardless of whether the catheter is used for irrigation, aspiration, therapy or some other purpose.
  • the irrigation and aspiration are conducted through a multi lumen catheter.
  • a single catheter is used.
  • the catheter includes at least two separate lumens; one lumen is used for aspiration and has a source of negative pressure attached at the proximal end, while a second lumen is used to provide irrigation and has a source of irrigation fluid attached at the proximal end.
  • FIG. 17 illustrates the removal of plaque and any associated thrombi from the internal carotid artery 400 . It should be noted that this method is merely exemplary, and that occlusions in other locations, such as within the external carotid 402 , common carotid 404 artery, or other arteries above the aortic arch, may be treated.
  • a main catheter or guide catheter 406 is introduced into the patient's vasculature through an incision in the femoral artery in the groin of the patient, or through direct access to the arteries in the neck (e.g., jugular access, in which case the catheters do not need to be as long as in the case of femoral access).
  • the main catheter 406 has a lumen sized to receive other catheters and devices, and can be used to guide the insertion of these other catheters and devices.
  • the main catheter 406 is guided through the vasculature until it reaches the common carotid artery 404 , where it can remain in place throughout the procedure. Fluoroscopy is typically used to guide the main catheter 406 and other devices to the desired location within the patient.
  • the devices are frequently marked with radiopaque markings to facilitate visualization of the insertion and positioning of the devices within the patient's vasculature.
  • the occlusive device 408 is activated. Downstream blood flow is effectively stopped, and blood flow coming from collateral blood vessels distal to the occlusive device prevents the downstream migration of any free particles.
  • the occlusive device 408 is an inflatable balloon. The balloon is inflated to occlude the common carotid artery 404 .
  • an inner catheter or guidewire 420 having an occlusive device 422 at its distal end is delivered through the main catheter 406 into the internal carotid artery 400 and past the site of the occlusion 410 .
  • a detachable occlusive device can be deployed at the site distal to the occlusion, and the delivery device removed.
  • the occlusive device 422 is also an inflatable balloon. The balloon is inflated to occlude the internal carotid artery at a site distal to the occlusion 410 . It should be understood that the occlusion within the artery can be in a discrete location or diffused within the vessel. Therefore, although placement of the distal occlusive device is said to be distal to the occlusion to be treated, portions of the diffuse occlusion may remain distal to the occlusive device.
  • a working area is therefore created between the two occlusive devices 408 , 422 surrounding the occlusion 410 .
  • a therapy catheter (not shown) is then delivered.
  • the therapy catheter can be any of a number of devices, including a balloon catheter used to perform angioplasty, a catheter which delivers a stent, a catheter for delivering enzymes, chemicals, or drugs to dissolve and treat the occlusion, an atherectomy device, a thrombectomy device, a rheolitic device, a device which creates a venturi effect within the artery, or a laser or ultrasound device used to ablate the occlusion.
  • the therapy catheter is withdrawn from the patient's body and an aspiration catheter 424 is delivered through the main catheter 406 , preferably over the inner catheter or guidewire 420 .
  • the aspiration catheter 424 rides over the guidewire 420 with the guidewire 420 inserted through the aspiration lumen of the catheter 424 .
  • a single operator type aspiration catheter can be used, in which only a portion of the aspiration catheter rides over the guidewire, which is inserted into a separate guidewire lumen.
  • FIG. 17 illustrates the treatment site after the over-the-wire aspiration catheter 424 is inserted into the internal carotid artery 400 .
  • a source of negative pressure is connected to the aspiration catheter 424 at its proximal end.
  • a preferred source of negative pressure is any container containing a fixed vacuum, such as a syringe, attached to the proximal end of the aspiration catheter 424 at the aspiration port.
  • a mechanical pump or bulb or any other appropriate source of negative pressure can also be used, including the creation of a venturi effect within the blood vessel.
  • the difference between the existing pressure within the vessel and the aspiration or negative pressure within the vessel should not exceed about 50 psi. If too much aspiration is applied, the change in pressure in the vessel will be too great and damage may occur to the vessel itself.
  • the proximal occlusive device 408 Prior to aspiration, simultaneous with aspiration, or after aspiration is begun, the proximal occlusive device 408 is deactivated to allow blood flow into the area.
  • the blood flow into the area provides irrigation fluid which creates turbulence and facilitates the removal of particles and debris.
  • the anatomical irrigation pressure provided is approximately 1-1.5 psi, and the blood flow into the area is at least 10 cubic centimeters/min and more preferably about 60-80 cubic centimeters/min.
  • the proximal occlusive device is then reactivated, and the distal occlusive device is deactivated. This allows blood flow into the working area from the distal end.
  • the distal occlusive device is reactivated.
  • This method of alternately deactivating and reactivating the occlusive devices acts to contain and direct the emboli to an area within the working area where they will be aspirated. Particles are initially contained between the two occlusive devices.
  • the proximal occlusion device When the proximal occlusion device is deactivated, blood flow forces particles and debris toward the distal end of the working area. The working area is aspirated, and the occlusive device reactivated.
  • the distal occlusive device is deactivated, blood flow forces particles and debris back toward the proximal end of the working area, where they are then aspirated.
  • the steps of deactivating and reactivating the occlusive devices and aspirating the working area can be repeated as often as desired, until the working area is substantially free of particles and debris.
  • the aspiration catheter is removed, and the occlusive devices are deactivated.
  • the main and inner catheters are also removed from the patient.
  • the aspiration catheter can be sized such that it can receive the therapy catheter within its lumen.
  • the aspiration catheter and the therapy catheter are delivered into the artery together.
  • the therapy catheter is removed while the aspiration catheter remains in place.
  • the aspiration catheter, inner catheter and main catheter are removed from the patient's body. Delivering the aspiration catheter and therapy catheter together saves time, which is critical during these types of procedures.
  • aspiration takes place through the lumen of the inner catheter or guidewire.
  • the occlusive device on the inner catheter is positioned distal to the occlusion, and the occlusive device is activated to at least partially occlude the vessel.
  • the therapy catheter is delivered and therapy performed.
  • a source of negative pressure is provided at the proximal end of the inner catheter, and aspiration occurs through openings located at the distal end of the catheter just proximal to the occlusive device. This eliminates the need for a separate aspiration catheter, and the need to remove the therapy catheter prior to aspiration. Again, this saves time, which is critical during these types of procedures.
  • a third occlusive device 430 is used to occlude the external carotid artery 402 .
  • inner catheters 420 , 432 are delivered to both the internal 400 and external 402 carotid artery branches and occluded.
  • the aspiration catheter is moved in a proximal direction, and delivered over the inner catheter 420 into the external carotid artery branch 402 . Aspiration is then performed in that branch to remove any particles or debris that may have been moved into the external carotid artery 402 .
  • the three occlusive devices can be alternately deactivated and reactivated as described above, to ensure the desired clearance of the working area.
  • the occlusive devices are deactivated, and the main 406 , aspiration, and inner catheters 420 , 432 are removed from the patient.
  • an irrigation catheter can be delivered to the site of the occlusion following therapy and removal of the therapy catheter.
  • the irrigation catheter is delivered through the main catheter and over the inner catheter. Irrigation fluid is provided through the irrigation catheter, while aspiration is provided through the main catheter.
  • a main catheter 406 with or without a distal occlusive device, is introduced into the patient's vasculature through an incision in the femoral artery in the groin of the patient or through direct access to the arteries in the neck.
  • the main catheter 406 is guided through the vasculature until it reaches the common carotid artery 404 , where it can remain in place throughout the procedure.
  • an inner catheter or guidewire 420 having an occlusive device 422 at its distal end is delivered through the main catheter 406 into the internal carotid artery 400 and past the site of the occlusion 410 .
  • a detachable occlusive device can be deployed at the site distal to the occlusion, and the delivery device removed.
  • the occlusive device 422 is an inflatable balloon. The balloon is inflated to occlude the internal carotid artery 400 at a site distal to the occlusion 410 .
  • the occlusion within the artery can be in a discrete location or diffused within the vessel. Therefore, although placement of the distal occlusive device is said to be distal to the occlusion to be treated, portions of the diffuse occlusion may remain distal to the occlusive device.
  • a therapy catheter is then delivered.
  • the therapy catheter can be any of a number of devices, including a balloon catheter used to perform angioplasty, a catheter which delivers a stent, a catheter for delivering enzymes, radiation, chemicals, or drugs to dissolve and treat the occlusion, an atherectomy device, a thrombectomy device, a rheolitic device, a device which creates a venturi effect within the artery, or a laser or ultrasound device used to ablate the occlusion.
  • the therapy catheter is withdrawn from the patient's body and an intermediate catheter 426 is delivered through the main catheter 406 .
  • a single operator type catheter may be used in which only a portion of the catheter rides over the guidewire, which is inserted into a separate guidewire lumen (as illustrated in FIG. 20).
  • an over-the-wire type catheter can be used.
  • the intermediate catheter 426 is delivered into the internal carotid artery 400 to a location just proximal to the occlusive device 422 .
  • the catheter 426 is positioned less than two centimeters from the proximal end of the occlusive device 422 at some point during aspiration.
  • Delivering the intermediate catheter 426 in such close proximity to the occlusion device 422 will allow the creation of a turbulent effect near the occlusive device during aspiration and irrigation thus aiding in the removal of the particles and debris.
  • the intermediate catheter 426 can be moved in a proximal direction, to ensure more effective aspiration of the area.
  • a preferred embodiment of this invention comprises delivering a soft-tipped intermediate catheter 426 made of a compound of a durometer 55 or less.
  • the area is first aspirated. As noted above, the intermediate catheter 426 can be moved backward in a proximal direction during aspiration. This forward and backward movement of the intermediate catheter 426 can be repeated as often as desired to provide effective aspiration. At some point during aspiration, the distal end of the aspiration catheter should be positioned about 2 cm or less from the proximal end of the occlusive device to ensure effective aspiration. Following aspiration, the area is irrigated by supplying a fluid, such as saline, through the intermediate catheter 426 .
  • a fluid such as saline
  • the irrigation fluid acts to flush any remaining particles or debris from the internal carotid 400 , to the external carotid 402 , as indicated by the arrows in FIG. 21.
  • the steps of sequential aspiration and irrigation or flushing, can be repeated as many times as necessary to remove all of the particles and debris from the vessel.
  • the intermediate catheter 426 has a single lumen for delivery of aspiration pressure and irrigation fluid, such as the aspiration or irrigation catheters shown in FIGS. 7 through 16.
  • the proximal end of the intermediate catheter 426 is connected to a source of negative pressure (as described above) and is used to aspirate the debris and particles around the occlusive device 422 .
  • the proximal end of the intermediate catheter 426 is connected to a source of irrigation fluid, such as saline, in order to irrigate the area near the occlusive device 422 .
  • a source of irrigation fluid such as saline
  • the volume of fluid used to irrigate the area near the occlusive device 422 is equal to or greater than the volume of the area between the proximal end of the distal occlusive device and the start of the internal carotid artery at the bifurcation of the common carotid artery.
  • at least 10 cubic centimeters of fluid is delivered to the area that is between the distal occlusive device and the start of the internal carotid branch, which is approximately 1-5 cubic centimeters.
  • the intermediate catheter 426 has two lumens, one for aspiration and another for irrigation.
  • the lumen providing aspiration is attached at its proximal end to a negative pressure source.
  • a second lumen is attached at its proximal end to source of irrigation fluid.
  • the distal end of the intermediate catheter 426 may be advantageously placed distal to the treated occlusion, i.e., between the treated occlusion 410 ′ and the occlusive device 422 . This facilitates more thorough flushing of the region between the occlusive device 422 and the treated occlusion 410 ′, and around the treated occlusion generally, so that any particles and debris remaining after therapy can be more effectively removed as the aspiration fluid (i.e., blood from the common carotid) passes across the treated occlusion 410 ′.
  • the aspiration fluid i.e., blood from the common carotid
  • Flushing of the region in and around the treated occlusion 410 ′ may be accomplished in a number of ways.
  • the intermediate catheter 426 may be used as an aspiration catheter.
  • the intermediate catheter 426 may be used as an irrigation catheter, in which particles and debris are flushed towards the point where the common carotid 404 intersects the internal carotid 400 , and towards the external carotid 402 .
  • particles, debris, and emboli are flushed down the external carotid with anatomical blood flow.
  • the therapy catheter 448 advantageously comprises a therapy device (such as a balloon for balloon angioplasty, a stent, an atherectomy device for cutting away plaque, or a rheolitic catheter) for use after the occlusive device 422 is deployed.
  • a therapy device such as a balloon for balloon angioplasty, a stent, an atherectomy device for cutting away plaque, or a rheolitic catheter
  • the steps illustrated by FIGS. 23 and 24 may be performed sequentially, i.e., the intermediate catheter 426 may first be used as an aspiration catheter and then as an irrigation catheter.
  • the distal end of the catheter 426 (or therapy catheter 448 ) is preferably positioned beyond the treated occlusion 410 ′ to more efficiently remove emboli from the treated region.
  • aspiration is performed as close to the occlusive device 422 as possible.
  • the intermediate catheter 426 (like the therapy catheter 448 ) is advantageously separate from the guidewire 420 and slidable on it, so that the catheter 426 may be properly positioned by the user.
  • the main (outer) catheter 406 itself may be used for aspiration and irrigation of the region in and around the treated occlusion 410 ′, as illustrated in FIGS. 25 and 26, respectively.
  • the main catheter 406 has a radial extent that permits the therapy catheter 448 and the intermediate catheter 426 to pass through the main catheter 406 .
  • the distal end of the main catheter 406 is positioned distal to the treated occlusion 410 ′, and blood containing emboli or other particles is aspirated away into the main catheter and removed from the patient.
  • FIG. 25 the distal end of the main catheter 406 is positioned distal to the treated occlusion 410 ′, and blood containing emboli or other particles is aspirated away into the main catheter and removed from the patient.
  • the main catheter 406 is used to flush the region in and around the treated occlusion 410 ′ by ejecting, for example, saline solution which then transports particles and debris away from the internal carotid 400 and down the external carotid 402 .
  • Either of the treatment methods illustrated by FIGS. 25 and 26 may be used to flush away particles, or both may be used sequentially, e.g., the main catheter 406 may be used for aspiration and then for flushing. (However, the presently preferred methods utilize the main catheter 406 only for irrigation.)
  • FIGS. 23 - 26 Other combinations of the methods illustrated by FIGS. 23 - 26 can be utilized.
  • the intermediate catheter 426 of FIG. 23 may be used for aspiration, followed by flushing with the main catheter 406 (as illustrated in FIG. 26).
  • the main catheter 406 may be used for aspiration (as illustrated in FIG. 25), followed by flushing with the intermediate catheter 426 (as illustrated in FIG. 24).
  • the best results are obtained by first aspirating (thereby removing particles from the patient) and then flushing, and the aspirating and flushing steps may be repeated as necessary.
  • the same catheter can be used for aspiration and then irrigation, but in this case, this catheter should be removed from the patient and cleaned after aspiration to remove emboli from it.
  • Irrigation then removes any emboli remaining in the patient. (However, if the main catheter 406 is used for both aspiration and irrigation, this cleaning step should be foregone since the main catheter 406 should be the last catheter to be removed from the patient.) It is preferred, however, to use a separate aspiration catheter and irrigate through the main catheter 406 .
  • Aspiration and irrigation may be performed simultaneously by having two catheters deployed at the same time and irrigating through one (e.g., the therapy catheter 448 or the intermediate catheter 426 ) and aspirating through another (e.g., the main catheter 406 ).
  • the main catheter 406 may be deployed to a location near the intersection of the internal carotid 400 and the external carotid 402 .
  • aspiration may be performed through the intermediate catheter 426 while irrigating through the main catheter 406 , in which the distal ends of the intermediate catheter 426 and the main catheter 406 are preferably positioned distal and proximal, respectively, to the treated lesion 410 ′.
  • flushing may also be performed in a blood vessel (not necessarily a bifurcated vessel as illustrated herein), using an occlusive device 422 ′ that passes saline solution (or another suitable flushing solution).
  • the saline solution may be advantageously passed through a lumen in the guidewire 420 and into the occlusive device 422 ′.
  • the occlusive device 422 ′ has at least one fluid flow opening and is preferably microporous on its proximal end, having a plurality of holes 450 (e.g., 10-50) that are preferably less than 1000 microns in diameter and more preferably between 50 and 100 microns in diameter.
  • the holes may be formed in the occlusive device 422 ′ by laser drilling, for example.
  • emboli, particulates, and other debris are flushed past the treated occlusion 410 ′ and down the external carotid 402 .
  • the fluid flow may be maintained with a pressurized syringe located outside the patient.
  • the fluid flow may be advantageously reduced to avoid overpressurizing that segment of the internal carotid artery 400 between the occlusion device 422 ′ and the occlusion 410 (pressures should be kept less than 50 psi).
  • the saline solution is used for inflating the occlusive device 422 ′ as well as for irrigating emboli from the internal carotid 400 down the external carotid 402 .
  • the irrigation method of FIG. 27 may be augmented by aspirating the region in and around the treated occlusion 410 ′ through a catheter, e.g., through the intermediate catheter 426 (as in FIG. 23) or the main catheter 406 (as in FIG. 25).
  • FIG. 28 Another irrigation device and method is disclosed in FIG. 28, in which one or more holes 460 in the guidewire 420 are located distal to the treated lesion 410 ′ and proximal to the occlusive device 422 .
  • Irrigation fluid is pumped through the guidewire 420 and out of the holes 460 (which may advantageously be 50-300 microns in diameter) to flush away emboli from the treated lesion 410 ′ and down the external carotid 402 .
  • the guidewire 420 may have a single lumen (not shown) that is in fluid communication with both the internal carotid artery 400 (via the holes 460 ) and the occlusive device 422 , in which case the irrigation fluid and the fluid used to inflate the occlusive device 422 are the same.
  • the guidewire 420 may have dedicated lumens (not shown) for irrigation and inflation.
  • the irrigation method of FIG. 28 may be augmented by aspirating the region in and around the treated occlusion 410 ′ through a catheter, e.g., through the intermediate catheter 426 (as in FIG. 23) or the main catheter 406 (as in FIG. 25).
  • a larger slot (not shown) of dimensions 0.005′′ ⁇ 0.100-0.200′′ may be cut into the guidewire 420 and then covered with a braid (not shown) that extends 0.010-0.030′′ beyond the edges of the slot.
  • this slot may alternatively be covered with a plastic sheath (not shown) having a plurality of slits or pores (not shown) which are in fluid communication with the slot. Ten pores having a diameter of 50-100 microns may advantageously be used.
  • Irrigation rates for the methods disclosed herein are preferably between 0.1 cc/sec and 3 cc/sec, more preferably between 0.5 and 1.5 cc/sec, and still more preferably about 1 cc/sec.
  • Aspiration rates are preferably between 0.5 and 5 cc/sec, and more preferably between 0.5 and 1.1 cc/sec.
  • the fluid pressure used to generate the irrigation and aspiration rates may be pulsed on and off to better flush away emboli. For example, fluid pressure may be alternately applied for 5 seconds (in the form a pulse) and then turned off for 2-3 seconds.
  • fluid is irrigated (or aspirated) through a lumen in a catheter, with the lumen being in fluid communication with a fluid flow opening at a distal end portion of the catheter.
  • the single balloon methods disclosed herein may additionally comprise inflating a balloon on the main catheter 406 within the common portion of the vessel to occlude the common portion.
  • FIG. 21 Under certain circumstances, use of a second occlusive device is desired, as illustrated in FIG. 21.
  • the second occlusive device 432 is positioned on the distal end of the main catheter 406 and acts to occlude the main carotid artery 404 .
  • a second occlusive device 432 may be desired where the physician is concerned about crossing the occlusion 410 in the internal carotid artery 400 with the inner catheter 420 or where there is another occlusion 428 in the external carotid artery 402 resulting in decreased flow through the external carotid 402 .
  • the occlusive device 432 is activated.
  • the activation of the occlusive device 432 will have the effect of occluding the common carotid artery 404 thereby cutting off the blood flow to both the internal carotid 400 and the external carotid 402 arteries.
  • an inner catheter 420 with an occlusive device 422 is delivered distal to the occlusion 410 in the internal carotid artery 400 and activated, thus isolating the occlusion 410 between the two occlusive devices 432 , 422 .
  • This is followed by therapy on the occlusion 410 as described above. Sequential aspiration and irrigation are then performed as described above.
  • the main advantage of using two occlusive devices is that when the internal carotid artery 400 is irrigated, a back pressure is created in the chamber defined by the proximal occlusive device 432 and the distal occlusive device 422 . This back pressure will force the fluid, particles and debris from the internal 400 and common 404 carotid arteries through the external carotid artery 402 .
  • a triple balloon system is used. This system is especially advantageous in those patients where occlusion of the common carotid artery results in blood from collateral vessels flowing from the external carotid artery to the internal carotid artery.
  • the direction of blood flow in a particular patient can be determined through angiography.
  • a first inner catheter with an occlusive device is delivered to the external carotid artery and the occlusive device activated. This prevents flow from collateral blood vessels moving from the external to the internal carotid artery.
  • a second inner catheter is delivered to the internal carotid artery past the site of the occlusion and the occlusive device activated to occlude the internal carotid artery.
  • the first inner catheter can be positioned within the internal carotid artery and the occlusive device activated, followed by delivery of the second inner catheter to the external carotid artery and activation of the occlusive device.
  • the occlusion is completely isolated between the three occlusive devices. This is followed by therapy on the occlusion, aspiration, and irrigation if desired, as described above.
  • FIGS. 29A and 29B show a guidewire 420 to which an expandable member 470 is attached. In its undeployed state, the expandable member 470 has a relatively narrow profile so that the member 470 may be delivered through a blood vessel.
  • the expandable member 470 may be, for example, a mesh- or filter-like device which, when deployed, permits the perfusion of blood but is capable of entraining emboli. After positioning the (undeployed) expandable member 470 distal to the lesion 410 within the internal carotid artery 400 to be treated, the member 470 may be deployed so that it expands to fill the internal carotid artery.
  • the expandable member 470 may be deployed by any one of a number of techniques, for example, the distal end of the member 470 may be attached to a pull wire (not shown) that passes through the guidewire 420 such that when the pull wire is retracted, the member 470 expands to fill the internal carotid artery 400 .
  • the member 470 may be returned to its undeployed position when the pull wire moves in the distal direction.
  • the member 470 may be self-expanding and deployed by retracting a low profile sheath (not shown) that surrounds the expandable member.
  • a therapy catheter (not shown in FIGS. 29A and 29B) may be deployed over the guidewire 420 , and any one of a number of therapy operations performed, such as balloon angioplasty, deploying a stent, or the application of drug therapy.
  • the therapy catheter may then be withdrawn from the patient.
  • Emboli that are created as a result of the therapy are blocked by the expandable member 470 when these emboli are flushed distally by anatomical blood flow, so that the emboli are prevented from traveling downstream towards the brain, for example.
  • the expandable member 470 still permits the perfusion of blood, so that the health of tissue supported by the internal carotid artery 400 is not jeopardized.
  • an intermediate catheter 474 to which an occlusive device 478 (such as an occlusion balloon) is attached, is directed through the common carotid 404 (by passing the catheter 474 over the guidewire 420 and through a guide or main catheter 406 ) and positioned such that the occlusive device 478 is distal to the treated lesion 410 ′ and proximal to (and preferably adjacent proximal to) the expandable member 470 .
  • the occlusive device 478 may then be deployed to occlude the internal carotid artery 400 , thereby preventing anatomical blood flow.
  • Emboli that have been entrained within the expandable member 470 may then be advantageously aspirated away by applying suction through the intermediate catheter 474 , such that blood distal to the expandable member 470 passes through the expandable member, entraining emboli in the process.
  • the aspirated emboli and blood pass through the intermediate catheter 474 and are directed out of the patient. If the expandable member 470 is clogged, aspiration will nevertheless draw emboli from the expandable member by drawing blood from the proximal side of the expandable member.
  • the main catheter 406 may be brought distal to the treated lesion, as illustrated in FIG. 29B. With the occlusive device 478 still deployed, irrigation fluid is ejected from an opening near the distal end of the main catheter 406 , such that emboli are carried towards the intersection of the internal carotid 400 and the external carotid 402 , whereupon the emboli are flushed down the external carotid 402 by anatomical blood flow.
  • the expandable member 470 may be retracted, preferably while aspirating through the intermediate catheter 474 , so that any emboli that are dislodged during the retraction of the expandable member are removed from the patient.
  • the expandable member 470 , the intermediate catheter 474 , and the main catheter 404 may then be removed from the patient.
  • FIGS. 30A and 30B Another embodiment in which an occlusive device is combined with perfusion is illustrated in FIGS. 30A and 30B, in which the expandable member 470 is positioned and deployed distal to the lesion 410 as in the embodiment of FIG. 29A.
  • a catheter such as an outer catheter or main catheter 490 is brought distal to the treated lesion 410 ′.
  • An occlusive device 482 such as a balloon, located on the main catheter is then deployed, occluding the vessel 400 .
  • Aspiration is then performed through the main catheter 490 , so that blood flows through the expandable member 470 and into the main catheter, thereby removing emboli trapped in the expandable member, which may have been produced as a result of therapy.
  • Irrigation fluid may be advantageously ejected from one or more openings 486 in the main catheter 490 distal to the treated lesion 410 ′, so that emboli remaining in and around the treated lesion are flushed towards the intersection of the internal carotid 400 and the external carotid 402 , whereupon they are flushed down the external carotid by anatomical blood flow.
  • the aspiration and irrigation steps may be performed sequentially or simultaneously. While the expandable member 470 is retracted, aspiration is preferably performed to remove any emboli that are dislodged during the process of retracting the member 470 .
  • FIG. 30B shows the cross section of the main catheter 490 , illustrating that the main catheter 490 of FIG. 30A has at least three lumens—a lumen 492 for passing the guidewire 420 and the therapy catheter (not shown in FIG. 30A), a lumen 494 for inflating the occlusive device 482 , and a lumen 496 for delivering irrigation fluid to one or more openings 486 distal of the treated lesion 410 ′.
  • a lumen 492 for passing the guidewire 420 and the therapy catheter (not shown in FIG. 30A)
  • a lumen 494 for inflating the occlusive device 482
  • a lumen 496 for delivering irrigation fluid to one or more openings 486 distal of the treated lesion 410 ′.
  • FIG. 31 Yet another embodiment in which an occlusive device is combined with perfusion is illustrated in FIG. 31, in which a hypotube 502 having a plurality of holes 506 is passed through an outer or main catheter 510 .
  • an occlusive device such as an occlusion balloon 514 is used rather than the expandable member 470 , and the hypotube 502 extends beyond the occlusion balloon 514 in the distal direction to provide perfusion while therapy is performed on a lesion 410 .
  • the occlusion balloon is inflated so that the occlusion balloon occludes the vessel 400 while contacting the hypotube 502 .
  • the holes 506 in the hypotube 502 are preferably located at least 1-2 mm proximal of the lesion to reduce the risk of emboli entering the holes and traveling distal of the occlusion balloon 514 .
  • Therapy is then performed on the lesion 410 , while the inflated balloon 514 blocks emboli (produced as a result of the therapy) from traveling downstream.
  • a fluid port of the catheter 510 may be advantageously positioned distal to the treated occlusion 410 ′ (and proximal to the balloon 514 ) and irrigation fluid delivered distal to the treated lesion 410 ′, so that fluid flows across the treated occlusion in a distal to proximal direction.
  • the irrigation fluid carries away emboli towards the junction of the internal carotid 400 and the external carotid 402 , whereupon the emboli are flushed down the external carotid by anatomical blood flow.
  • holes may be introduced into the guidewire, with the guidewire having a lumen that extends through the occlusion balloon leading to an opening distal of the balloon.
  • the holes 506 in the hypotube 502 or in the guidewire 420 may advantageously have diameters of 0.005′′ or larger, or slits of dimensions 0.005′′ ⁇ 0.005′′. Several such hole (or slits) are preferably used to create a flow of blood of between 8 and 50 cc/min.
  • the perfusion illustrated in FIG. 31 is passive, since the blood passes through the hypotube 502 on its own.
  • a pump such as a syringe pump (not shown) may be attached to the proximal end of a hypotube that does not have holes.
  • a guidewire such as guidewire 420 may be used in which the guidewire passes through the occlusive device 422 —such a guidewire has a lumen therein having an opening which is distal to the balloon 514 .
  • the lumen could have a diameter between 0.010′′ and 0.025′′, and more preferably a diameter of about 0.018′′.
  • a preferred pump rate is between 8 and 40 cc/min.
  • FIGS. 32A and 32B Another embodiment that combines features of occlusion with perfusion is illustrated in FIGS. 32A and 32B.
  • the guidewire 420 is brought through the vessel 400 until the expandable member 470 is located distal to the lesion 410 to be treated.
  • therapy is performed on the lesion 410 , e.g., using a therapy catheter 550 to which an angioplasty balloon 560 is attached.
  • the expandable member 470 collects emboli that may be produced as a result of the therapy, as blood travels from one side of the expandable member to the other in a proximal to distal direction.
  • the angioplasty balloon 560 After performing therapy (e.g., after deploying the angioplasty balloon 560 ), the angioplasty balloon 560 is deflated and the therapy catheter 550 is moved over the guidewire 420 in the distal direction such that the angioplasty balloon 560 is distal of the treated lesion 410 ′. The angioplasty balloon 560 is then reinflated so that the vessel 400 is occluded. With the vessel 400 occluded, a catheter 580 such as an outer or main catheter is then positioned such that a fluid port of the catheter 580 is distal of the treated lesion 410 ′. As illustrated in FIG. 32B, irrigation fluid is ejected from the catheter 580 to flush away any emboli that may remain in and around the treated lesion 410 ′.
  • irrigation fluid is ejected from the catheter 580 to flush away any emboli that may remain in and around the treated lesion 410 ′.
  • the irrigation fluid and any emboli entrained within it travel in a distal to proximal direction towards the intersection of the internal carotid 400 and the external carotid 402 , whereupon the irrigation fluid and emboli are carried down the external carotid artery 402 by anatomical blood flow.
  • the catheter 580 may be used to aspirate the region in and around the treated lesion 410 ′ to create a flow of fluid in the proximal to distal direction.
  • the expandable member 470 , the therapy catheter 550 , and the catheter 580 can then be removed from the patient. When removing the expandable member 470 from the vessel 400 , however, care should be taken to avoid introducing any emboli into the bloodstream.
  • the diameter of the vessel or vessels being occluded may increase.
  • the diameter of the internal carotid artery may increase substantially as a result of the treatment. If the occlusive device in the internal carotid does not accommodate this increase in diameter, resulting in a break in the seal between the occlusive device and the walls of the internal carotid, the risks to the patient may be significant.
  • a method for avoiding this possibility involves applying an expansion force to the occlusive device beyond that which is required to seal the occlusive device to the walls of the vessel.
  • the balloon may be advantageously inflated to a pressure beyond that which is required to maintain a seal in the internal carotid.
  • the balloon begins to be inflated, it will expand both axially and radially.
  • the balloon continues to expand radially until it mates with the walls of the vessel, at which point further expansion of the balloon in the radial direction is hindered by the tendency of the vessel to resist enlargement.
  • inflate the balloon at this point results in the balloon expanding preferentially in the axial direction, rather than in the radial direction.
  • potential energy continues to be stored up in the balloon.
  • the vessel expands (e.g., as a result of therapy being performed on it), then the potential energy stored in the balloon is harnessed in that the balloon expands in the radial direction (while correspondingly contracting somewhat in the axial direction), such that the balloon continues to make contact with the vessel during and following treatment, thereby preventing a break in the seal which could result in injury to the patient.
  • the seal is self-accommodating with respect to changes in vessel diameter.
  • the occlusive device may also comprise a self-expanding material such as nitinol, for which it is possible to obtain a nearly constant level of stress over a relatively wide range of strain.
  • a self-expanding material such as nitinol
  • an occlusive device comprising a nitinol filter-like mesh is capable of sealing a 6 mm diameter vessel
  • such an occlusive device may be used to occlude a vessel that is initially 5 mm in diameter, so that if the vessel expands, the perfusion-filter will also expand to maintain occlusion within the vessel.
  • the diameter of the internal carotid artery may increase substantially as a result of therapy performed on it.
  • a vessel that has a 4 mm diameter at the point where the occlusion balloon is located may increase to 5 mm or more as a result of therapy.
  • the balloon may be advantageously positioned in a blood vessel such that the vessel diameter is at least 20% less than the maximum useful sealing diameter of the balloon. As the lesion is treated, the balloon will continue to seal against the walls of the vessel, even if the diameter of the vessel should expand in response to the treatment.
  • This method can be used with a variety of expandable members other than balloons, such as braids, coils, ribs, ribbon-like structures, slotted tubes, and filter-like meshes, which may be partially or completely covered with a membrane or another covering to provide a seal with the vessel.
  • expandable members other than balloons, such as braids, coils, ribs, ribbon-like structures, slotted tubes, and filter-like meshes, which may be partially or completely covered with a membrane or another covering to provide a seal with the vessel.
  • FIG. 33 A preferred embodiment of a low volume or inflation syringe 60 in a syringe assembly 100 for inflating an occlusion balloon in accordance with the present invention is shown in FIG. 33. Also shown in FIG. 33 is an illustrative connection of the assembly 100 to an occlusion balloon guidewire catheter 62 (such as guidewire 420 ) utilizing an inflation adapter 30 .
  • the syringe assembly 100 comprising the inflation syringe 60 and a larger capacity or reservoir syringe 64 , is attached via tubing 216 to the inflation adapter 30 within which a sealing member 930 (see FIGS. 34A and 34B) and the balloon catheter 62 are engaged during use.
  • a sealing member 930 see FIGS. 34A and 34B
  • other devices that control the flow of inflation fluid such as flow controllers, may be used.
  • the sealing member 930 is inserted into an open proximal end of the catheter 62 .
  • the syringe 60 is used to inject inflation fluid through the adapter 30 and inflation port 17 into a lumen of the catheter 62 , and into a balloon 66 (such as balloon 422 ).
  • the inflation adapter 30 described in more detail below in connection with FIG. 35, is used to open and close the sealing member 930 to permit the inflation or deflation of the balloon 66 mounted on the distal end of the catheter 62 .
  • the syringe 60 and/or syringe assembly 100 is preferably connected at the proximal end of the catheter 62 .
  • the distal end of the catheter 62 and the balloon 66 are first “primed” or evacuated.
  • the reservoir syringe 64 of the assembly 100 may be used for the evacuation.
  • Access to the vascular site is through a port in the patient obtained, for example, using an introducer (not shown).
  • a preferred system and method for accomplishing the occlusion balloon inflation is described below.
  • the inflation syringe 60 may be provided with a stop mechanism 20 for limiting both the intake of fluid into the syringe and the delivery of fluid from the syringe.
  • the syringe 60 has an elongate cylinder 44 and plunger arrangement 50 which provide for greater displacement or travel by the plunger along the cylinder length than is necessary to expel a relatively small amount of inflation fluid.
  • the clinician is provided with an enhanced sense of whether the fluid in the syringe 60 has been delivered to the balloon, which helps compensate for lack of precision by the clinician.
  • the stop mechanism 20 may be mounted on the syringe 60 during production, or as separate components that can be retro-fit onto an existing supply of syringes.
  • the catheter 62 has the sealing member 930 inserted into its proximal end and has a side-access inflation port 17 , shown in greater detail in FIGS. 34A and 34B.
  • the inflation port 17 , proximal end of the catheter 62 and distal end of the sealing member 930 are positioned within the inflation adapter 30 (see FIG. 35) to which a syringe assembly 100 in accordance with the present invention has been operably coupled.
  • the inflation syringe 60 is coupled via an injection cap 22 at its distal end to a valve 68 that also connects the large capacity syringe 64 and a short tube segment 216 .
  • the tube segment 216 is adapted to connect to a fitting or male luer member 24 of the inflation adapter 30 .
  • the sealing member 930 is engaged by the adapter 30 to allow use of the low volume syringe 60 of the syringe assembly 100 to inflate the balloon 66 at the end of the catheter 62 .
  • the catheter 62 (depicted in FIGS. 34A and 34B) has a proximal end 912 , and a distal end (not shown in FIGS. 34A and 34B) to which is mounted the inflatable balloon 66 .
  • a central lumen 940 extends within a tubular body 918 between the proximal and distal ends.
  • An opening 923 to lumen 940 is present at the proximal end 912 of catheter 62 .
  • the inflation port 17 in fluid communication with lumen 940 is provided on tubular body 918 .
  • the sealing member 930 is inserted into lumen 940 through central lumen opening 923 .
  • Sealing member 930 has a first region 935 which has an outer diameter substantially the same as the outer diameter of the proximal end 912 of the catheter tubular body.
  • Region 935 has a taper 934 , reducing in diameter to a second region 933 which has an outer diameter less than the inner diameter of lumen 940 .
  • region 933 tapers over length 931 to form a plug mandrel wire 932 .
  • region 933 and plug mandrel wire 932 are slidably insertable into the proximal opening 923 of catheter 62 and may move within lumen 940 .
  • region 935 has an outer diameter of about 0.013 inches
  • region 933 has an outer diameter of about 0.008 inches
  • plug mandrel wire 932 has a diameter of about 0.006 inches, with region 933 and plug mandrel wire 932 being inserted into a catheter having a central lumen 940 with an inner diameter of about 0.009 inches.
  • the length of sealing member region 935 extending proximally of catheter 62 may vary in length depending upon the intended use environment. For example, where catheter 62 is to be used as a guide for other catheters in an “over-the-wire” embodiment, it is preferred that the total length of catheter 62 and sealing member region 935 be about 300 centimeters. Alternately, where catheter 62 is to be used in a single operator or rapid exchange embodiment, it is preferred that the total length of catheter 62 and region 935 be about 190 centimeters. Accordingly, with a known catheter length and use environment, an appropriate length for region 935 may be chosen.
  • Regions 935 and 933 and plug mandrel wire 932 may all be made out of metals such as stainless steel. Alternatively, combinations of materials may be used as well. For example, in some applications it may be desirable to manufacture regions 935 and 933 out of stainless steel, while manufacturing plug mandrel wire 932 out of nitinol. Furthermore, the various sealing member regions may be made from a single metal wire strand coined at various points to achieve the desired dimensional tolerances, or multiple segments may be joined together to form sealing member 930 .
  • region 935 , region 933 , and plug mandrel wire 932 are attached to one another by any suitable means of bonding metal to metal, such as crimping, soldering, brazing, adhesives and the like.
  • cyanoacrylate adhesives are used to adhere these various parts of sealing member 930 to one another.
  • the outer diameter of sealing member region 933 is less than the inner diameter of lumen 940 , such that region 933 is slidably insertable into lumen 940 .
  • the outer diameters of the tapered portions 931 and wire 932 are also small enough such that they too are slidably insertable in lumen 940 .
  • the outer diameter of region 935 is greater than the inner diameter 940 , and thus only a small portion of tapered portion 934 of sealing member 930 between region 935 and region 933 is insertable into lumen 940 through opening 923 .
  • this provides for a snug interference fit when sealing member 930 is fully inserted into catheter 62 .
  • This interference fit provides a frictional force which counteracts the tendency of the pressurized fluids and internal wire flexing in the catheter to push sealing member 930 out of opening 923 .
  • sealing member 930 has movement-force increasing structure which increases the force required to move sealing member 930 within lumen 940 .
  • the movement-force increasing structure consists of waves 938 a and 938 b formed in wire 932 near its distal end. Waves 938 a and 938 b contact the inner surface of lumen 940 , thereby increasing the frictional force which must be overcome to move wire 932 within lumen 940 .
  • wire 932 is made of nitinol and has an outer diameter of about 0.006 inches, and is inserted into a nitinol catheter which has an inner lumen 940 with a diameter of about 0.009 inches.
  • waves are formed on wire 932 for 3 cycles with an amplitude of about 0.019 inches to increase the valve-opening movement force.
  • the frictional forces may be increased.
  • a lumen sealer portion 936 is coaxially and fixedly mounted on wire 932 .
  • Sealer portion 936 forms a fluid tight seal with the outer diameter of wire 932 and the inner diameter of lumen 940 , such that fluid introduced into lumen 940 through the inflation port 17 is prevented from flowing past sealer portion 936 when sealer portion 936 is inserted into lumen 940 distally of the inflation port 17 .
  • Sealer portion 936 forms the fluid tight seal by firmly contacting the entire inner circumference of a section of lumen 940 along a substantial portion of the length of sealer portion 936 .
  • sealer portion 936 is positioned proximally of the inflation port 17 , so that an unrestricted fluid passageway exists between inflation port 17 and the inflatable balloon at the distal end of catheter 62 , which is like a valve “open” position. In this position, region 933 is shown partially withdrawn from opening 923 .
  • sealer portion 936 is positioned distally of inflation port 17 , so that fluid flow between inflation port 17 and the inflatable balloon 66 at the distal end of catheter 62 are substantially blocked, which is like a valve “closed” position.
  • Catheter 62 is changed from the valve open position to the valve closed position by the movement of sealing member 930 and its various components.
  • the exact length of movement needed to change catheter 62 from the valve closed to the valve open position is built into the movement function of the adaptor used to manipulate sealing member 930 thereby opening and closing the catheter valve.
  • catheter 62 be used with an adaptor such as adaptor 30 , which provides for such controlled precise movement.
  • sealing member 930 required to open or close the valve may be varied depending upon the catheter requirements. When relying upon the inflation adaptor to control movement, however, it is important that the movement of the controlling elements of the adaptor be coordinated with those of sealing member 930 .
  • the inflation adapter 30 comprises a housing having two halves 34 , 36 preferably formed of metal, medical grade polycarbonate, or the like.
  • the halves 34 , 36 are attached by hinges 205 to be separated or joined in a clam shell manner.
  • a locking clip 38 secures the halves while the adapter 30 is in use.
  • a groove within the housing has a width to accept the proximal end of the catheter 62 having the sealing member 930 .
  • the male luer member 24 (FIG. 33), or other suitable connector, extrudes from a top of the housing to provide an inflation passageway. Seals 70 are provided within the housing and around the internal segment 285 of the inflation pathway to conduct the pressurized fluid provided by the syringe 60 attached to the male luer member 24 .
  • An actuator 40 shown in FIG. 33 at the top of the adapter housing, controls a cam which operates sliding panels 291 (FIG. 35) contained in the housing.
  • the catheter 62 is positioned within the housing with the sealing member 930 in the closed position (FIG. 34B), such that the side inflation port 17 is located in the sealed inflation area 285 of the housing.
  • An adjacent proximal portion of the catheter 62 extends outside the housing (and into the patient), and a proximal portion of the sealing member 930 extends out of the other side of the housing.
  • the locking clip 38 is then secured and then the syringe 60 may be attached.
  • the actuator 40 is moved from a first position to a second position, such that the sliding panels 291 within the housing cause the sealing member 930 to be in an open position to allow fluid flow through the inflation port 17 (FIG. 34A). “Closing” the sealing member 930 is accomplished by moving the actuator 40 from the second position back to the first position (FIG. 34B), such that the balloon inflation is maintained.

Abstract

A method for the treatment of a stenosis or an occlusion in a blood vessel is disclosed in which a main catheter is first delivered to a site proximal to the occlusion. The main catheter may include an occlusive device at its distal end. An inner catheter or elongate member (e.g., a guidewire) having an occlusive device at its distal end is delivered to the site of the occlusion, and the occlusive device is activated at a site distal to the occlusion. A therapy catheter is then introduced to treat the occlusion. Next, a catheter is delivered just proximal to the occlusive device, and this catheter is used to aspirate and/or irrigate the area removing particles and debris. The aspiration and irrigation steps are preferably repeated until the particles and debris are removed. Perfusion may be performed by using a perfusion-filter distal of the lesion to be treated or a hypotube which extends beyond the occlusive device attached to the guidewire. The present invention provides for a minimally invasive procedure which can be performed quickly and efficiently, with reduced risks to the patient.

Description

    REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part of U.S. patent application Ser. No. 08/933,816 filed Sep. 19, 1997, which is a continuation-in-part of U.S. patent application Ser. No. 08/813,810, filed Mar. 6, 1997.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • The present invention relates to containment and removal of substances including emboli (such as from thrombi, plaque, and other types of material and debris) from blood vessels. The preferred embodiments are particularly advantages for use in the carotid arteries and other arteries above the aortic arch during diagnostic and therapeutic procedures. [0003]
  • 2. Description of the Related Art [0004]
  • Human blood vessels often become occluded or completely blocked by plaque, thrombi, deposits, or other substances, which reduce the blood carrying capacity of the vessel. Should the blockage occur at a critical place in the circulatory system, serious and permanent injury, or even death, can occur. To prevent this, some form of medical intervention is usually performed when significant occlusion is detected. [0005]
  • The carotid arteries are the main vessels which supply blood to the brain and face. The common carotid artery leads upwards from the aortic arch, branching into the internal carotid artery which feeds the brain, and the external carotid artery which feeds the head and face. The carotid arteries are first narrowed and may eventually be almost completely blocked by plaque, and may further be complicated by the formation of thrombi (blood clots) on the roughened surfaces of the plaques. Narrowing or blockage of the carotid arteries is often untreatable and can result in devastating physical and cognitive debilitation, and even death. [0006]
  • Various types of intervention techniques have been developed which facilitate the reduction or removal of the blockage in the blood vessel, allowing increased blood flow through the vessel. One technique for treating stenosis or occlusion of a blood vessel is percutaneous balloon angioplasty. A balloon catheter is threaded through the patient's arterial system and inserted into the narrowed or blocked area, and the balloon is inflated to expand the constricted area. The fear of dislodging an embolus from an ulcerative plaque and the severe resulting consequences, however, has prevented the widespread use of angioplasty in the carotid arteries. Because of the potential complications, the options for minimally invasive treatment of the carotid arteries are severely limited. [0007]
  • Carotid endarterectomy is another type of intervention for removal of blockages from the carotid arteries. In endarterectomy, the carotid bifurcation is exposed through an incision in the neck of the patient. Clamps are placed on either side of the occlusion to isolate it, and an incision made to open the artery. The occlusion is removed, the isolated area irrigated and aspirated, and the artery sutured closed. The clamps are removed to reestablish blood flow through the artery. In carotid endarterectomy, the emboli and debris are contained and directed by activating and deactivating the clamps. For example, after the clamps are in place, one on the common carotid artery and one on the internal carotid artery, the particles are contained between the two clamps. After the occlusion is removed, the clamp on the common carotid artery is opened, allowing blood to flow into the previously isolated area toward the clamp on the internal carotid. This blood flow is then aspirated through an external aspiration tube. The common carotid artery is then reclamped, and the clamp on the internal carotid opened. This causes blood to flow into the previously isolated area toward the clamp on the common carotid artery. The flow is then aspirated. The clamp on the internal carotid artery is closed, and the artery is sutured closed. This method allows for the flushing of debris into the area where aspiration occurs. [0008]
  • Alternatively, this method of clamping and unclamping the carotid arteries can be done after the incision in the artery is sutured closed. Using this method, it is hoped that any particles in the internal carotid artery will be forced back to the common carotid artery, then into the external carotid area, where serious complications are unlikely to arise from emboli. [0009]
  • Carotid endarterectomy is not without the serious risk of embolization and stroke caused by particles of the blocking material and other debris moving downstream to the brain, however. There is therefore a need for improved methods of treatment for occluded carotid arteries which decrease the risks to the patient. [0010]
  • SUMMARY OF THE INVENTION
  • The present invention provides a novel method for containing and removing substances such as emboli from blood vessels. The method is particularly useful in bifurcated vessels, such as the carotid arteries and in other blood vessels above the aortic arch. In one embodiment of the method, there is provided at least one occlusive device such as a balloon or filter, a therapy catheter to treat the occlusion, and a source of aspiration to remove the debris created by the therapy. By utilizing the fluid pressure and flow within the blood vessel, this method can eliminate the need for a separate irrigation catheter and irrigation fluid. Alternatively, irrigation fluid may be provided to flush the area. The minimally invasive treatment allows occlusions to be treated more rapidly and less invasively than known methods, with reduced cost and risk to the patient. [0011]
  • In accordance with one aspect of the present invention, there is provided a method for the treatment of an occlusion in a carotid artery. A main catheter having a first occlusive device on its distal end is inserted into the artery, until the occlusive device is proximal to the occlusion. The first occlusive device is activated to occlude the artery proximal to the occlusion. An inner catheter having a second occlusive device on its distal end is inserted into the artery across the occlusion, until the occlusive device is distal to the occlusion. The second occlusive device is then activated to occlude the artery distal to the occlusion and create a working area surrounding the occlusion. By occlusive device is meant any device which is capable of preventing at least some particles or other debris from migrating downstream. Examples of occlusive devices include inflatable balloons, filters or braids, or other mechanical devices. [0012]
  • According to the foregoing aspect of the invention, a therapy catheter is then inserted into the working area and used to treat the occlusion. Appropriate treatment can include direct drug delivery to the site of the occlusion, angioplasty, cutting, scraping or pulverizing the occlusion, ablating the occlusion using ultrasound or a laser, deploying a stent within the artery, use of a thrombectomy or rheolitic device, or other treatments. Following treatment of the occlusion, the therapy catheter is removed. An aspiration catheter is then delivered to the working area, and the first occlusive device is deactivated to allow blood flow into the working area. Blood flow from collateral vessels prevent the movement of particles and debris downstream where they could cause serious complications. The blood flow also acts as irrigation fluid to create turbulence within the area. Aspiration of the working area is then performed to removed particles and debris. Aspiration can occur simultaneously with the deactivating of the first occlusive device, if desired. Alternatively, either step can be performed first. [0013]
  • In another aspect of the method of the present invention, the occlusive devices are activated and deactivated more than once. After the first occlusive device is deactivated to allow blood flow into the area, the occlusive device is reactivated. The second occlusive device is then deactivated, to allow blood flow in from the distal end of the working area. The second occlusive device is reactivated, and these steps can be repeated any number of times until sufficient irrigation and aspiration of the working area occurs. [0014]
  • In yet another aspect of the method, the first inner catheter with its occlusive device is delivered into one branch of a bifurcated vessel (such as the carotid artery), while a second inner catheter having a third occlusive device on its distal end is delivered into the other branch of the bifurcated vessel to occlude it. Aspiration then occurs in both branches of the artery to remove particles and debris. [0015]
  • In a further aspect of the method, aspiration occurs through the main catheter, and a separate aspiration catheter is not required. Following removal of the therapy catheter, and deactivation of the first occlusive device to allow blood flow into the working area, aspiration occurs through the distal end of the main catheter. This eliminates the need to deliver a separate aspiration catheter, thus saving time which is critical in these types of procedures. [0016]
  • If desired, an irrigation catheter can be delivered into the working area following the removal of the therapy catheter. The irrigation catheter is used to deliver irrigation fluid to the working area. Aspiration then occurs through the distal end of the main catheter. In this case, anatomical irrigation (the use of the patient's own blood flow for irrigation) as described above, is not used. [0017]
  • Yet another aspect of the method may be performed with a single occlusive device. A main catheter or guide catheter is first delivered into the carotid artery, with the distal end positioned just proximal to the occlusion. An inner catheter having an occlusive device on its distal end is then positioned with the occlusive device distal to the occlusion. The occlusive device is activated to occlude the artery distal to the occlusion. A therapy catheter is delivered into the artery until it reaches the occlusion and therapy is performed to reduce or eliminate the occlusion. The therapy catheter is removed, and an intermediate catheter is delivered to a position proximal to the occlusive device. Preferably, the distance between the proximal end of the occlusive device and the distal end of the intermediate catheter is narrowed at one point during aspiration to a distance of about 2 centimeters or less. The area just proximal to the occlusive device is aspirated, using the intermediate catheter, and then irrigated. The aspirating and irrigating steps can be repeated as often as necessary to facilitate the removal of particles and debris. [0018]
  • In another embodiment, the intermediate catheter has two or more lumens, such that aspiration and irrigation occur through different lumens within the same catheter. This prevents the possibility that aspirated particles will be flushed back into the patient when irrigation is begun. [0019]
  • In further aspects of the present invention, two and even three occlusive devices are employed. In the case of two occlusive devices, a main or guide catheter with an occlusive device on its distal end is delivered to the common carotid artery and the occlusive device is activated. Next, an inner catheter with an occlusive device is delivered distal to the occlusion in the internal carotid artery and activated, thus isolating the occlusion between the two occlusive devices. Therapy is performed on the occlusion, followed by aspiration, and irrigation if desired. [0020]
  • When three occlusive devices are used, an occlusive device is activated in the common carotid artery. An inner catheter with an occlusive device is then delivered to the external carotid artery and the occlusive device activated. Next, a second inner catheter is delivered to the internal carotid artery past the site of the occlusion and the occlusive device activated to occlude the internal carotid artery. Alternatively, the first inner catheter and occlusive device is delivered to the internal carotid artery and activated, followed by delivery and activation of the second inner catheter and occlusive device in the external carotid artery. In either case, the occlusion is completely isolated between the three occlusive devices. This is followed by therapy on the occlusion and sequential aspiration and irrigation as desired. [0021]
  • Accordingly, a carotid artery can be treated quickly and efficiently. The patient's own blood can serve as irrigation fluid, thereby eliminating the need for a separate irrigation catheter and supply of irrigation fluid. The working area may be cleaned in an efficient manner by performing repeated activation and deactivation of the occlusive devices surrounding the working area. The catheter-based approach reduces the amount of time required to complete the procedure, and allows normal blood flow in the vessel to be restored in a very short period of time. Use of a minimally invasive procedure reduces risks and trauma to the patient, decreases costs, and improves recovery time. [0022]
  • Another aspect of the invention comprises a method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), and positioning the occlusive device in said branch distal of the occlusion. The method further comprises sliding a therapy catheter on the elongate member, occluding said branch only on the distal side of the occlusion by actuating the occlusive device, treating the occlusion with the therapy catheter, and providing a second catheter having a fluid flow lumen in fluid communication with a fluid flow opening at a distal end portion of the second catheter. The method additionally comprises using the occlusive device to occlude said branch of the vessel while: (a) positioning the fluid flow opening of the second catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion; and (b) applying fluid pressure to the fluid flow lumen to cause fluid flow along said branch, between (i) an intersection of said branch with the common portion and (ii) said location, whereby fluid flows across the treated occlusion; and then deactuating the occlusive device. [0023]
  • Still another aspect of the invention comprises a method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), positioning the occlusive device in said branch distal of the occlusion, sliding a therapy catheter on the elongate member, and occluding said branch on the distal side of the occlusion by actuating the occlusive device. The method further comprises treating the occlusion with the therapy catheter, removing the therapy catheter from said branch of the vessel, providing a second catheter having a fluid flow lumen in fluid communication with a fluid flow opening at a distal end portion of the second catheter, and sliding the second catheter on the elongate member after the removal of the therapy catheter. The method additionally comprises using the occlusive device to occlude said branch of the vessel while (a) positioning the fluid flow opening of the second catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion; (b) applying fluid pressure to the fluid flow lumen to cause fluid flow along said branch, between (i) an intersection of said branch with the common portion and (ii) said location, whereby fluid flows across the treated occlusion; and then deactuating the occlusive device. [0024]
  • Yet another aspect of the invention comprises a method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), positioning the occlusive device in said branch distal of the occlusion, sliding a therapy catheter on the elongate member, occluding said branch only on the distal side of the occlusion by actuating the occlusive device, and treating the occlusion with the therapy catheter. The method further comprises using the occlusive device to occlude the branch of the vessel while: (a) delivering irrigation fluid to a distal end portion of the therapy catheter through an annulus between the therapy catheter and the elongate member; (b) passing the irrigation fluid out of a fluid flow opening in the distal end portion of the therapy catheter; and (c) positioning the fluid flow opening of the therapy catheter in said branch of the vessel at a location near the occlusive device between the occlusive device and the treated occlusion, such that fluid flows across the treated occlusion; and then deactuating the occlusive device. [0025]
  • Still another aspect of the invention comprises a method for the treatment of an occlusion in a branch of bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising providing an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel (such as the internal carotid artery), positioning the occlusive device in said branch distal of the occlusion, positioning an outer catheter so that a portion of the outer catheter is in the common portion of the vessel, sliding a therapy catheter within the outer catheter and on the elongate member, actuating the occlusive device such that it occludes said branch of the vessel, and treating the occlusion with the therapy catheter. The method further comprises using the occlusive device to occlude the branch of the vessel while (a) delivering irrigation fluid to a distal end portion of the outer catheter; (b) passing the irrigation fluid out of a fluid flow opening in the distal end portion of the outer catheter; (c) positioning the fluid flow opening of the outer catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion, such that fluid flows across the treated occlusion; and then deactuating the occlusive device. [0026]
  • Still another aspect of the invention comprises a method for treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, comprising positioning an occlusive device distal of the occlusion to occlude said branch of the vessel, treating the occlusion using a therapy device, delivering irrigation fluid between the occlusion and the occlusive device such that irrigation fluid flows across the treated occlusion towards an intersection of said branch and the common portion, wherein emboli in said branch are carried to the intersection, and allowing anatomical blood flow in the common portion to carry the emboli through another of the branches. [0027]
  • Yet another aspect of the invention comprises a method for the treatment of an occlusion in a blood vessel, such as the carotid artery, comprising providing an inner catheter comprising an elongate member having an occlusive device at a distal end portion thereof, delivering the elongate member through the vessel, positioning the occlusive device distal of the occlusion, sliding a therapy catheter on the elongate member, actuating the occlusive device such that it occludes the vessel, and treating the occlusion with the therapy catheter. The method further comprises uses the occlusive device to occlude the vessel while: (a) delivering irrigation fluid through the elongate member; (b) passing the irrigation fluid out of a fluid flow opening in the occlusive device such that fluid flows across the treated occlusion; and then deactuating the occlusive device. Still another aspect of the invention comprises a method of performing a medical procedure in a blood vessel using an expandable member which seals against walls of the blood vessel in response to application of an expansion force through a range of vessel diameters up to a maximum diameter beyond which sealing will not occur in the vessel, in which the method comprises positioning the expandable member in a selected blood vessel distal to an occlusion to be treated at a location where the vessel diameter is at least 20% less than said maximum diameter, applying an expansion force to cause the expandable member to expand into sealing contact with walls of the selected vessel at said location, and treating the occlusion while the expandable member is expanded, whereby the expandable member seals against walls of the selected vessel even if the diameter of the selected vessel at said location increases to said maximum diameter as a result of the treatment. [0028]
  • Another aspect of the invention comprises a method of treating an occlusion in a blood vessel, comprising positioning an expandable member distal to the occlusion to be treated, performing therapy on the occlusion, and using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow from one side to another side of the expandable member in a proximal to distal direction. The method further comprises positioning a fluid port of a catheter between the treated occlusion and the expandable member, and applying suction to the fluid port to aspirate fluid into the catheter while the fluid port is positioned between the treated occlusion and the expandable member. [0029]
  • Still another aspect of the invention comprises a method of treating an occlusion in a blood vessel, comprising positioning an expandable member distal to the occlusion to be treated, performing therapy on the occlusion, and using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow past the expandable member in a proximal to distal direction. The method further comprises positioning a fluid port of a catheter between the treated occlusion and the expandable member, delivering irrigation fluid through the fluid port, and using the irrigation fluid to provide fluid flow across the treated occlusion in a distal to proximal direction. [0030]
  • Yet another aspect of the invention comprises a method of treating an occlusion in a blood vessel, comprising positioning an expandable member distal to the occlusion to be treated, using a therapy balloon to perform therapy on the occlusion, using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow from one side to another side of the expandable member in a proximal to distal direction. The method further comprises using the therapy balloon to occlude the blood vessel at a location distal to the treated occlusion, positioning a fluid port of a catheter between the treated occlusion and said location, and providing fluid flow through the fluid port such that said fluid flows across the treated occlusion.[0031]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective drawing of the carotid arteries. [0032]
  • FIG. 2 is a side view of an embodiment of a main catheter. [0033]
  • FIG. 3 is a cross-sectional view of the main catheter taken along line [0034] 3-3 of FIG. 2.
  • FIG. 4 is a cross-sectional view of the main catheter taken along line [0035] 4-4 of FIG. 2.
  • FIG. 5 is a side view of the distal end of an embodiment of an inner catheter. [0036]
  • FIG. 6 is a partial cross-sectional view of the inner catheter taken along line [0037] 6-6 of FIG. 5.
  • FIG. 7 is a side view of an embodiment of an over-the-wire aspiration catheter. [0038]
  • FIG. 8 is a cross-sectional view of the over-the-wire aspiration catheter taken along line [0039] 8-8 in FIG. 7.
  • FIG. 9 is a cross-sectional view of the over-the-wire aspiration catheter taken along line [0040] 8-8 in FIG. 7, showing an elongate member (e.g., a guidewire) inserted therethrough.
  • FIG. 10 is a side view of an embodiment of a single operator aspiration catheter. [0041]
  • FIG. 11 is a cross-sectional view of the single operator aspiration catheter taken along line [0042] 11-11 in FIG. 10.
  • FIG. 12 is a side view of an embodiment of an over-the-wire irrigation or aspiration catheter. [0043]
  • FIG. 13 is a side view of an embodiment of a single operator irrigation catheter. [0044]
  • FIGS. 14 through 16A are cross-sectional views of the single operator irrigation catheter taken along lines [0045] 14-14, 15-15 and 16A-16A of FIG. 13.
  • FIG. 17 is a perspective view of one example of an emboli containment and removal method within a carotid artery. [0046]
  • FIG. 18 is a perspective view of another example of an emboli containment and removal method. [0047]
  • FIG. 19 is a perspective view of yet another example of an emboli containment and removal method which employs a single occlusive device. [0048]
  • FIG. 20 is a perspective view of the emboli containment and removal method illustrated in FIG. 19, showing the use of an intermediate catheter. [0049]
  • FIG. 21 is a perspective view of still another example of an emboli containment and removal method which employs two occlusive devices. [0050]
  • FIG. 22 is a perspective view showing a preferred location for the intermediate catheter when the intermediate catheter is used to flush away emboli from the treated occlusion. [0051]
  • FIG. 23 is a perspective view of an embodiment in which the intermediate catheter is used for aspiration of emboli. [0052]
  • FIG. 24 is a perspective view of an embodiment in which the intermediate catheter is used for irrigation of emboli. [0053]
  • FIG. 24A is a perspective view of an embodiment in which a therapy catheter is used for irrigation of emboli. [0054]
  • FIG. 25 is a perspective view of an embodiment in which the main catheter is used for aspiration of emboli. [0055]
  • FIG. 26 is a perspective view of an embodiment in which the main catheter is used for irrigation of emboli. [0056]
  • FIG. 27 is a perspective view of an embodiment in which a distal occlusion device has a plurality of holes therein for passing irrigation fluid across the treated occlusion. [0057]
  • FIG. 28 is a perspective view of an embodiment in which an elongate member (e.g., a guidewire) has a plurality of holes therein for passing irrigation fluid across the treated occlusion. [0058]
  • FIGS. 29A and 29B are perspective views of an embodiment in which a perfusion-filter located distal to the lesion to be treated permits the perfusion of blood while entraining emboli produced as a result of therapy. [0059]
  • FIGS. 30A is a perspective view of an alternative embodiment in which emboli are captured in a perfusion-filter. [0060]
  • FIG. 30B is a cross sectional view of the main catheter of the embodiment of FIG. 30A, illustrating lumens used for inflation of the occlusive device, for delivering irrigation fluid, and for passing an elongate member (e.g., a guidewire). [0061]
  • FIG. 31 is a perspective view of an embodiment in which passive perfusion is performed with a hypotube having holes therein. [0062]
  • FIGS. 32A and 32B are perspective views of a perfusion-filter embodiment in which the occlusion of the vessel is performed with the therapy catheter. [0063]
  • FIG. 33 shows a preferred embodiment of a syringe assembly having features in accordance with the present invention and operably coupled to an illustrative inflation adapter at a proximal portion of a balloon guidewire catheter. [0064]
  • FIGS. 34A and 34B show open and closed positions, respectively, of the sealing member, which is used with the balloon guidewire catheter of FIGS. 33 and 35. [0065]
  • FIG. 35 shows a perspective view of the balloon guidewire catheter of FIG. 33 placed within an open inflation adapter. [0066]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The preferred embodiments of the present invention provide improved methods for containing and removing emboli resulting from plaque, thrombi or other occlusions. The preferred methods are particularly advantageous for use in the carotid artery and other arteries above the aortic arch. The preferred methods may be used, for example, in the treatment of a stenosis or an occlusion which has a length and a width or thickness resulting in at least partial occlusion of the vessel's lumen. Thus, the preferred methods are effective in treating both partial and substantially complete occlusions of arteries. It is to be understood that “occlusion” as used herein, includes both complete and partial occlusions, stenoses, emboli, thrombi, plaque, and any other substance which at least partially occludes the lumen of the artery. Although the methods disclosed herein are described with specific reference to the carotid arteries, they can be applied to other vessels as well, particularly bifurcated vessels. [0067]
  • As illustrated in FIG. 1, the common [0068] carotid artery 10 is located in the neck and branches off into the internal carotid 12, and the external carotid 14 arteries. The internal carotid artery 12 supplies blood to the brain, while the external carotid artery 14 supplies blood to the head and face. The preferred methods of the present invention will be described for the treatment of an occlusion within the internal carotid artery. It is to be understood that this method can be used on other arteries as well.
  • Generally, the preferred methods are adapted for the percutaneous treatment, containment and removal of occlusions within the carotid arteries or other arteries above the aortic arch. In one of these methods, a main catheter having an occlusive device on its distal end is first delivered to the common carotid artery, proximal to the site of the occlusion. It should be noted that, as used herein, “proximal” refers to the portion of the apparatus closest to the end which remains outside the patient's body, and “distal” refers to the portion closest to the end inserted into the patient's body. The occlusive device is activated to stop the downstream flow of blood. Collateral pressures from the Circle of Willis and other vessels keep the blood flow in the direction of the main catheter, preventing any emboli from moving downstream. In another embodiment, a main catheter without an occlusive device on its distal end, or a main catheter having an occlusive device which is not deployed, is delivered to the common carotid artery, proximal to the site of the occlusion. [0069]
  • In either case, an inner catheter having an occlusive device on its distal end is delivered through the main catheter and across the site of the occlusion. Alternatively, a detachable occlusive device can also be used. In either case, the occlusive device is activated at a site distal to the occlusion. [0070]
  • In some cases, a second inner catheter is used to provide a third occlusive device. One inner catheter is delivered to the internal carotid artery, while the other inner catheter is delivered to the external carotid artery. When activated, the three occlusive devices completely isolate the area surrounding the occlusion to be treated. [0071]
  • A therapy catheter is then delivered to the site of the occlusion to treat the occlusion. Such treatment includes, but is not limited to, balloon angioplasty, thermal balloon angioplasty, delivery of an intravascular stent, atherectomy, or radiation treatment. [0072]
  • In one embodiment of the present invention, once therapy is complete, an irrigation catheter is delivered into the working area to provide irrigation fluid. Alternatively, anatomical irrigation can be used, as explained below. Aspiration of the area surrounding the treated occlusion is begun using either the main catheter or a separate aspiration catheter. Blood flow is allowed into the working area to be aspirated by deactivating the occlusive devices on the main and/or inner catheters. This helps to irrigate the area and ensure the removal of particles and debris from the artery. [0073]
  • In another embodiment of the present invention, the need for a separate irrigation catheter and irrigation fluid are eliminated. In the context of removing plaque, thrombi or other blockages from blood vessels, separate irrigation fluid is generally provided through an irrigation catheter to the site of treatment. It has been discovered that the patient's own blood can be used as irrigation fluid, without the need for delivery of a separate irrigation catheter and irrigation fluid. [0074]
  • Although the patient's own flow of blood can provide an irrigation source, situations sometime arise where providing separate irrigation fluid is desired. In such cases a separate catheter is introduced into the patient after the therapy catheter is removed and is delivered within close proximity to the occlusive device. Once the catheter is delivered proximal to the occlusive device, the area is first aspirated through the catheter. By delivering the catheter close to the occlusive device a turbulence is created freeing debris from the edge of the occlusive device and other areas where it may be trapped. The debris is then aspirated from the patient. Following aspiration, irrigation fluid is provided if desired to flush any remaining particles and debris from the internal carotid. [0075]
  • Main Catheter [0076]
  • In the preferred methods, a main or guide catheter is first introduced into the patient's vasculature. This catheter is used to guide the insertion of other catheters and devices to the desired site. A guide catheter (e.g., 9F) or a long sheath (e.g., 7F) may be used as the main catheter. If the guide catheter is not sufficiently stiff, then an angiography catheter may be positioned inside the guide catheter, and both the guide catheter and the angiography catheter can be delivered on a guidewire. (The term guidewire is used broadly herein to include elongate members (such as hollow or tubular members) made of metal as well as other materials, such as plastic.) Once the guide catheter is properly positioned, the angiography catheter can be removed. In some embodiments of the present invention, the main catheter has an occlusive device on its distal end. The occlusive device can be an inflatable balloon, filter, expandable braid or other mechanical occlusive device. The occlusive device should be capable of preventing the migration of particles and debris from the working area, either through total or partial occlusion of the vessel. Note that the occlusion of the vessel need not be complete, and that substantial occlusion of the vessel may be sufficient. The catheter should be sized so as to slidably receive the inner, therapy and intermediate (irrigation and/or aspiration) catheters inserted therethrough. [0077]
  • FIG. 2 illustrates a side view of a catheter which can be used as the outer or main catheter of the present system. [0078] Catheter 110 generally comprises an elongate flexible tubular body 116 extending between a proximal control end 112 and a distal functional end 114. The tubular body 116 has a main lumen 130 which extends between the ends 112 and 114. The main lumen 130 terminates in a proximal opening 123 and a distal opening 127. A smaller inflation lumen 132, configured in a side-by-side relationship with the main lumen 130, extends along the length of the tubular body 116, and terminates within an occlusive device such as an occlusion balloon 126 mounted on the distal end 114 of the catheter 110, as described below. The inflation lumen 132, illustrated in FIGS. 3 and 4, is in fluid communication with the occlusion balloon 126, such that fluid passing through the inflation lumen 132 may be used to inflate or deflate the balloon 126. The proximal end of the inflation lumen can terminate at one of the ports 122, 124 on the proximal end of the catheter 110.
  • A [0079] control manifold 119 is provided at the proximal end 112 of the catheter 110. The control manifold 119 is generally provided with a number of ports to provide access to the catheter lumen 130. For example, for the embodiment depicted in FIG. 2, the control manifold 119 is provided with a catheter end-access port 122 and a catheter side-access port 124, to provide an introduction point for the insertion of other catheters into the lumen 130. Ports 122 and 124 are preferably provided with standard Touhy Borst connectors, although other types of connectors may be used. An inflation port 118, in fluid communication with the small inflation lumen 132, is further provided on the manifold 119 for attachment of devices to inflate or deflate the occlusion balloon 126. The manifold 119 is also provided with an irrigation/aspiration port 120 which is in fluid communication with the lumen 130, for attachment of devices to provide irrigation fluid or aspiration pressure. Other embodiments of the main catheter 110 may feature more or less ports, depending upon the number of lumens in the catheter and the desired functionalities of the catheter.
  • The [0080] manifold 119 is preferably formed out of hard polymers or metals, which possess the requisite structural integrity to provide a functional access port to the catheter lumen, such as for balloon inflation or delivery of irrigation fluid and/or aspiration pressure. In one preferred embodiment, the manifold 119 is integrally formed out of polycarbonate. Of course, any suitable material may be used to form the manifold 119, including acrylonitrile butadiene styrene (ABS).
  • As illustrated in FIG. 2, an [0081] inflatable balloon 126 is mounted on the distal end 114 of the catheter 110. The inflatable balloon 126 will function as an occlusion balloon, to prevent blood and debris from passing through the blood vessel distal to the balloon 126. Thus, the inflatable balloon 126 is preferably able to expand to fit a variety of different blood vessel diameters. Accordingly, it is preferred that the inflatable balloon 126 have a compliant expansion profile, tending to increase in radial diameter with increasing inflation pressure. To achieve this, the balloon 126 may be made out of materials which impart such expansion characteristics, including elastomeric materials such as latex or irradiated polyethylene. In one preferred embodiment, the inflatable balloon 126 is formed out of a material comprising a block copolymer of styrene-ethylene-butylene-styrene, sold under the trade name C-FLEX. Non-compliant balloons, such as those made from PET can also be used. Further details as to balloons of this type are disclosed in our copending application entitled “Pre-Stretched Catheter Balloon”, Ser. No. 08/812,140, filed Mar. 6, 1997, the entirety of which is incorporated by reference.
  • Alternatively, as illustrated in FIGS. [0082] 19-20, the main catheter 406 does not include a distal occlusive device, or the distal occlusive device on the main catheter is not used.
  • Inner Catheter [0083]
  • An inner catheter or guidewire having an occlusive device on its distal end is preferably made of metals such as stainless steel or nitinol, or plastics or composites. The preferred methods can be effectively carried out using any of a number of guidewires or catheters that perform the function of occluding the vessel and allowing for the slidable insertion of various other catheters and devices. The term “catheter” as used herein is therefore intended to include both guidewires and catheters with these desired characteristics. [0084]
  • A preferred inner catheter is illustrated in FIGS. 5 and 6. The [0085] catheter apparatus 310 is generally comprised of four communicating members including an elongated tubular member 314, an inflatable balloon member 316, a core-wire member 320 and a coil member 322. The catheter apparatus 310 is preferably provided with an outer coating of a lubricous material, such as TEFLON.
  • The [0086] body member 314 of the catheter apparatus 310 is in the form of hypotubing and is provided with proximal and distal ends 314A and 314B as well as an inner lumen 315 extending along the tubular member 314. The balloon member 316 is coaxially mounted on the distal end 314B of the tubular member 314 by suitable adhesives 319 at a proximal end 316A and a distal end 316B of the balloon member 316 as in the manner shown in FIG. 6. The core-wire member 320 of the catheter 310 may be comprised of a flexible wire 320. The flexible wire 320 is joined by adhesives, soldering, brazing or crimping at a proximal end 320A of the flexible wire 320 to the distal end 314B of the tubular member 314 as in the manner show in FIG. 6.
  • Preferably, the proximal end [0087] 320A of the flexible wire 320 has a transverse cross sectional area substantially less than the smallest transverse cross-sectional area of the inner lumen 315 of the tubular member 314. In the preferred embodiment, the flexible wire 320 tapers in the distal end 320B to smaller diameters to provide greater flexibility to the flexible wire 320. However, the flexible wire may be in the form of a solid rod or a ribbon or combinations thereof.
  • As shown in FIG. 6, the [0088] distal end 320B of the flexible wire 320 is secured to a rounded plug 318 of solder or braze at the distal end 322B of the coil member 322. The coil member 322 of the catheter 310 may be comprised of a helical coil 322. The coil member 322 is coaxially disposed about the flexible wire 320, and is secured to the flexible wire 320 by soldering, brazing or adhesives at about the proximal end 320A of the flexible wire 320 as in the manner shown in FIG. 6.
  • The [0089] balloon member 316 is preferably a compliant balloon formed of a suitable elastic material such as a latex or the like, but can be made of non-compliant materials as well. The flexible coil 322 is preferably formed of a wire of platinum based alloys or gold. The flexible core-wire 320 and the tubular member 314 are preferably formed of a nickel-titanium alloy or stainless steel.
  • Once the inner catheter has been properly positioned inside the carotid artery at a point distal to the occlusion, the occlusive device at the distal end of the inner catheter is actuated to occlude the vessel distal to the existing occlusion to create a working area. When a detachable occlusive device is used, the occlusive device is positioned at a point distal to the occlusion to be treated, and activated to occlude the artery. It is to be understood that the stenosis or occlusion could be in a discrete location or diffused within the artery. Therefore, although placement of the occlusive device is said to be distal to the stenosis or occlusion to be treated, portions of the diffused stenosis or occlusion may remain distal to the occlusive device. [0090]
  • Therapy Catheter [0091]
  • After the area surrounding the occlusion has been isolated, a therapy catheter then is delivered to the site of the occlusion. The term “therapy catheter” is meant to include any of a number of known devices used to treat an occluded vessel. For example, a catheter carrying an inflatable balloon for use in balloon angioplasty can be delivered to dilate the occlusion. Thermal balloon angioplasty includes the use of heat to “mold” the vessel to the size and shape of the angioplasty balloon. Similarly, an intravascular stent can be delivered via a balloon catheter and deployed at the site of the occlusion to keep the vessel open. Cutting, shaving, scraping or pulverizing devices can be delivered to excise the occlusion in a procedure known as atherectomy. A laser or ultrasound device can also be delivered and used to ablate plaque in the vessel. Thrombectomy devices can be used, as can rheolitic devices, and devices which create a venturi effect within the artery. Various thrombolytic or other types of drugs can be delivered locally in high concentrations to the site of the occlusion. It is also possible to deliver various chemical substances or enzymes via a catheter to the site of the stenosis to dissolve the obstruction. The term “therapy catheter” encompasses these and similar devices. [0092]
  • Aspiration and Irrigation Catheters [0093]
  • After the therapy has been performed and the occlusion has been treated, the working area may be aspirated to remove fluid and debris. Aspiration can be provided through the main catheter if desired. A source of negative pressure is attached at the proximal end of the main catheter, and fluid and debris are aspirated through the main catheter's main lumen. Alternatively, an aspiration catheter or similar debris removing device can be delivered to the working area to remove particles and any other debris. The term “aspiration catheter” includes any device which creates an area of fluid turbulence and uses negative pressure to aspirate fluid and debris, and includes thrombectomy catheters, rheolitic devices and those devices which create a venturi effect within the vessel. Thus, it is possible that a single catheter is used as both the therapy catheter and the aspiration catheter. [0094]
  • An aspiration catheter particularly suited for use with the preferred methods is illustrated in FIG. 7. The [0095] catheter 260 includes an adapter 262 and a seal at its proximal end. The catheter 260 further includes an aspiration port 264 to which a source of negative pressure is attached. The aspiration catheter further comprises a long hollow shaft 266 having a distal end 268. The distal tip 268 can/include a radiopaque marker to aid in locating the tip 268 during insertion into the patient, and is preferably soft to prevent damage to the patient's vasculature.
  • The aspiration catheter illustrated in FIG. 7 is an over-the-wire catheter. As seen in FIG. 8, the [0096] catheter shaft 266 is hollow. During insertion of the aspiration catheter 260, the proximal end of a guidewire 270 is inserted into the distal end of the aspiration catheter 268, and the aspiration catheter 260 is slidably advanced over the guidewire 270, which is positioned inside the hollow lumen 272 of the aspiration catheter 260. The position of the guidewire 270 relative to the shaft 260 of the aspiration catheter 260 is illustrated in FIG. 9, but of course, can vary. For this type of aspiration catheter 260, a very long guidewire 270, generally around 300 centimeters in length, is used to facilitate the insertion of the aspiration catheter 260 over the guidewire 270.
  • Alternatively, the [0097] aspiration catheter 280 can be of a single operator design, as illustrated in FIGS. 10-11. The catheter 280 has an adapter and an aspiration port at its proximal end. Like the over-the-wire aspiration catheter 260 the single operator aspiration catheter 280 further comprises a long hollow shaft 282 having a distal end 288. The distal tip 288 can include a radiopaque marker to aid in locating the tip 288 during insertion into the patient, and is preferably soft to prevent damage to the patient's vasculature. At the distal end of the shaft 288, a guidewire lumen 286 is attached. This lumen 286 provides a separate lumen, apart from the main aspiration lumen 284 of the catheter 280, for the insertion of the guidewire. This guidewire lumen 286 can be as short as 5 centimeters or longer. As illustrated in FIG. 11, during delivery of the aspiration catheter 280, the proximal end of the guidewire is inserted into the distal end of the guidewire lumen 286, and the guidewire lumen 286 is slidably advanced over the guidewire. Unlike the over-the-wire catheter 260 described above, only a short segment of the single operator aspiration catheter 280 rides over the guidewire, and the guidewire remains in the guidewire lumen 286 and does not enter the aspiration lumen 284 of the aspiration catheter 280. With the single operator system 280, the long guidewire used with the over-the-wire catheter 260, and the extra operator needed to handle it, are not required.
  • Although the [0098] guidewire lumen 286 is shown in FIG. 10 as being located only on the distal end 288 of the shaft of the aspiration catheter 280, the lumen 286 can also be made to extend the entire length of the shaft 280 if desired. In both embodiments, the aspiration lumen 284 is advantageously left completely unobstructed to provide more efficient aspiration. The guidewire lumen 286 can also include a slit in the outside wall of the lumen to facilitate faster and easier insertion and removal of the guidewire through the side wall of the lumen.
  • In another embodiment not shown, the aspiration catheter can be configured such that the therapy catheter can be inserted through the lumen of the aspiration catheter. The lumen is made large enough to accommodate the desired therapy catheter. This allows the aspiration catheter and the therapy catheter to be delivered into the patient at the same time. When therapy is complete, the therapy catheter is removed while the aspiration catheter remains in place. This eliminates the need to separately deliver the aspiration catheter after removal of the therapy catheter, saving valuable time. [0099]
  • In yet another embodiment, also not shown, the therapy catheter can be built over the aspiration catheter. For example, a dual or triple lumen catheter having a dilatation balloon at its distal end can be used. One lumen is used to inflate the dilatation balloon to be used for angioplasty, while the second lumen is used for aspiration. The third lumen is used as a guidewire lumen. Alternatively, the aspiration catheter can be designed to deploy a stent within the occluded artery, or could include an atherectomy device on its distal end. These designs allows a single combined aspiration catheter and therapy catheter to be delivered into the patient. When therapy is complete, aspiration is carried out without the need to first remove the therapy catheter or separately deliver an aspiration catheter. [0100]
  • FIG. 12 is a side view of an [0101] irrigation catheter 140 or aspiration catheter which may be utilized in the preferred methods. It should be understood that when an irrigation catheter is used, aspiration occurs through the outer pathway between the irrigation and main catheters, while irrigation occurs through the irrigation pathway. Similarly, when an aspiration catheter is used, aspiration occurs through the aspiration catheter while irrigation occurs through the pathway between the aspiration and main catheters. Irrigation fluid is supplied under pressure at the proximal end of the catheter 142 and delivered through the side holes 146 and through the distal end of the catheter 144. Alternatively, aspiration can be provided at the proximal end of the catheter 142 and fluid and debris aspirated through the side holes 146 and through the distal end of the catheter 144. The catheter 140 can be about 125 centimeters in length and constructed from a plastic material such as HYTREL tubing or high density polyethylene (HDPE) or PEBAX (Atochem, France). In order to achieve a softer distal section, the durometer of the tube 148 material is reduced in the distal section to about 55 whereas that of the proximal section 142 is higher, such as about 80. Proximal valves and fittings which are well known in the art can be mounted on the catheter 140 of FIG. 12.
  • FIGS. [0102] 13-16 illustrate another type of irrigation or aspiration catheter 230, a single operator catheter, which can be used in the present system. In the case of the irrigation catheter, irrigation is through the inner pathway and aspiration is through the outer pathway. If the catheter is used for aspiration, aspiration is through the inner pathway and irrigation is through the outer pathway. As shown in FIGS. 13-16, the catheter 230 has an adaptor 232 on its proximal end. This single operator catheter 230 further comprises a long tubular body 236 having a distal end 238. The distal tip 238 can include a radiopaque marker to aid in locating the tip 238 during insertion into the patient, and is preferably soft to prevent damage to the patient's vasculature. At the distal end of the shaft 238, an inner catheter lumen 240 is attached. This lumen 240 provides a separate lumen, apart from the main irrigation or aspiration lumen 242 of the catheter 230, for the insertion of the inner catheter, and has an inner diameter sized to received the inner catheter. In a preferred embodiment, the inner diameter of the lumen is about 0.016″ to about 0.020″, and more preferably is about 0.019″. This inner catheter or guidewire lumen can be as short as 5 centimeters, but can extend 30 centimeters or longer in a proximal direction. During delivery of the catheter 230, the proximal end of the inner catheter is inserted into the distal end of the inner catheter lumen 240, and the lumen 240 is slidably advanced over the inner catheter. Only a short segment of the single operator catheter 230 rides over the inner catheter, and the inner catheter remains in the lumen 240 and does not enter the main lumen 242 of the catheter 230.
  • Although the [0103] inner catheter lumen 240 is shown in FIG. 13 as being located only on the distal end 238 of the shaft of the catheter 236, the lumen 240 can also be made to extend the entire length of the shaft 236 if desired. In both embodiments, the main lumen 242 is advantageously left completely unobstructed to provide more efficient irrigation or aspiration. As seen in FIG. 16, the inner catheter lumen 240 can also include a slit 241 or weakened area in the outside wall of the lumen 240 along the entire length of the lumen 240 to facilitate faster and easier insertion and removal of the inner catheter through the side wall of the lumen 240. By inserting and removing the inner catheter through the side wall of the lumen 240 on the catheter 236, the need to remove adapters and attachments from the proximal end prior to slidably advancing or removing the catheter 236 over the inner catheter is eliminated. It should be understood that this slit 241 or weakened area through which the inner catheter can be inserted and removed can exist on the intermediate catheter regardless of whether the catheter is used for irrigation, aspiration, therapy or some other purpose.
  • In another embodiment, not shown, the irrigation and aspiration are conducted through a multi lumen catheter. In this embodiment, a single catheter is used. The catheter includes at least two separate lumens; one lumen is used for aspiration and has a source of negative pressure attached at the proximal end, while a second lumen is used to provide irrigation and has a source of irrigation fluid attached at the proximal end. [0104]
  • Additional details relative to the catheters described above are found in copending applications Ser. Nos. 08/813,023, 08/812,140, 08/813,808 and 08/812,876, filed on Mar. 6, 1997, entitled “Catheter for Emboli Containment”, “Prestretched Catheter Balloon”, “Aspiration Catheter”, and “Hollow Medical Wires and Methods of Constructing Same”, all of which are hereby incorporated by reference. [0105]
  • Preferred Methods [0106]
  • A. Dual Balloon System [0107]
  • FIG. 17 illustrates the removal of plaque and any associated thrombi from the internal [0108] carotid artery 400. It should be noted that this method is merely exemplary, and that occlusions in other locations, such as within the external carotid 402, common carotid 404 artery, or other arteries above the aortic arch, may be treated.
  • A main catheter or guide [0109] catheter 406 is introduced into the patient's vasculature through an incision in the femoral artery in the groin of the patient, or through direct access to the arteries in the neck (e.g., jugular access, in which case the catheters do not need to be as long as in the case of femoral access). The main catheter 406 has a lumen sized to receive other catheters and devices, and can be used to guide the insertion of these other catheters and devices. The main catheter 406 is guided through the vasculature until it reaches the common carotid artery 404, where it can remain in place throughout the procedure. Fluoroscopy is typically used to guide the main catheter 406 and other devices to the desired location within the patient. The devices are frequently marked with radiopaque markings to facilitate visualization of the insertion and positioning of the devices within the patient's vasculature.
  • Once the [0110] main catheter 406 is in place, with its occlusive device 408 at a position proximal to the occlusion 410, the occlusive device 408 is activated. Downstream blood flow is effectively stopped, and blood flow coming from collateral blood vessels distal to the occlusive device prevents the downstream migration of any free particles. In this example, the occlusive device 408 is an inflatable balloon. The balloon is inflated to occlude the common carotid artery 404.
  • Next, an inner catheter or [0111] guidewire 420 having an occlusive device 422 at its distal end is delivered through the main catheter 406 into the internal carotid artery 400 and past the site of the occlusion 410. Alternatively, a detachable occlusive device can be deployed at the site distal to the occlusion, and the delivery device removed. In this example, the occlusive device 422 is also an inflatable balloon. The balloon is inflated to occlude the internal carotid artery at a site distal to the occlusion 410. It should be understood that the occlusion within the artery can be in a discrete location or diffused within the vessel. Therefore, although placement of the distal occlusive device is said to be distal to the occlusion to be treated, portions of the diffuse occlusion may remain distal to the occlusive device.
  • A working area is therefore created between the two [0112] occlusive devices 408, 422 surrounding the occlusion 410. A therapy catheter (not shown) is then delivered. The therapy catheter can be any of a number of devices, including a balloon catheter used to perform angioplasty, a catheter which delivers a stent, a catheter for delivering enzymes, chemicals, or drugs to dissolve and treat the occlusion, an atherectomy device, a thrombectomy device, a rheolitic device, a device which creates a venturi effect within the artery, or a laser or ultrasound device used to ablate the occlusion.
  • Once the desired therapy is performed, the therapy catheter is withdrawn from the patient's body and an [0113] aspiration catheter 424 is delivered through the main catheter 406, preferably over the inner catheter or guidewire 420. The aspiration catheter 424 rides over the guidewire 420 with the guidewire 420 inserted through the aspiration lumen of the catheter 424. Alternatively, a single operator type aspiration catheter can be used, in which only a portion of the aspiration catheter rides over the guidewire, which is inserted into a separate guidewire lumen. FIG. 17 illustrates the treatment site after the over-the-wire aspiration catheter 424 is inserted into the internal carotid artery 400.
  • After the [0114] aspiration catheter 424 is in place, aspiration is begun. A source of negative pressure is connected to the aspiration catheter 424 at its proximal end. A preferred source of negative pressure is any container containing a fixed vacuum, such as a syringe, attached to the proximal end of the aspiration catheter 424 at the aspiration port. A mechanical pump or bulb or any other appropriate source of negative pressure can also be used, including the creation of a venturi effect within the blood vessel. The difference between the existing pressure within the vessel and the aspiration or negative pressure within the vessel should not exceed about 50 psi. If too much aspiration is applied, the change in pressure in the vessel will be too great and damage may occur to the vessel itself.
  • Prior to aspiration, simultaneous with aspiration, or after aspiration is begun, the proximal [0115] occlusive device 408 is deactivated to allow blood flow into the area. The blood flow into the area provides irrigation fluid which creates turbulence and facilitates the removal of particles and debris. Preferably, the anatomical irrigation pressure provided is approximately 1-1.5 psi, and the blood flow into the area is at least 10 cubic centimeters/min and more preferably about 60-80 cubic centimeters/min. In a preferred embodiment, the proximal occlusive device is then reactivated, and the distal occlusive device is deactivated. This allows blood flow into the working area from the distal end. Following aspiration, the distal occlusive device is reactivated. This method of alternately deactivating and reactivating the occlusive devices acts to contain and direct the emboli to an area within the working area where they will be aspirated. Particles are initially contained between the two occlusive devices. When the proximal occlusion device is deactivated, blood flow forces particles and debris toward the distal end of the working area. The working area is aspirated, and the occlusive device reactivated. When the distal occlusive device is deactivated, blood flow forces particles and debris back toward the proximal end of the working area, where they are then aspirated. The steps of deactivating and reactivating the occlusive devices and aspirating the working area can be repeated as often as desired, until the working area is substantially free of particles and debris.
  • When the deactivating and reactivating of the occlusive devices and aspiration steps are complete, the aspiration catheter is removed, and the occlusive devices are deactivated. The main and inner catheters are also removed from the patient. [0116]
  • As described above, the aspiration catheter can be sized such that it can receive the therapy catheter within its lumen. In this case, the aspiration catheter and the therapy catheter are delivered into the artery together. When therapy is complete, the therapy catheter is removed while the aspiration catheter remains in place. When aspiration is complete, the aspiration catheter, inner catheter and main catheter are removed from the patient's body. Delivering the aspiration catheter and therapy catheter together saves time, which is critical during these types of procedures. [0117]
  • In yet another embodiment, aspiration takes place through the lumen of the inner catheter or guidewire. The occlusive device on the inner catheter is positioned distal to the occlusion, and the occlusive device is activated to at least partially occlude the vessel. The therapy catheter is delivered and therapy performed. A source of negative pressure is provided at the proximal end of the inner catheter, and aspiration occurs through openings located at the distal end of the catheter just proximal to the occlusive device. This eliminates the need for a separate aspiration catheter, and the need to remove the therapy catheter prior to aspiration. Again, this saves time, which is critical during these types of procedures. [0118]
  • B. Triple Balloon System [0119]
  • In another embodiment illustrated in FIG. 18, a third [0120] occlusive device 430 is used to occlude the external carotid artery 402. Once the main catheter 406 is in place and the common carotid artery 404 is occluded, inner catheters 420, 432 are delivered to both the internal 400 and external 402 carotid artery branches and occluded. Following therapy and aspiration of the internal carotid artery 400, the aspiration catheter is moved in a proximal direction, and delivered over the inner catheter 420 into the external carotid artery branch 402. Aspiration is then performed in that branch to remove any particles or debris that may have been moved into the external carotid artery 402. The three occlusive devices can be alternately deactivated and reactivated as described above, to ensure the desired clearance of the working area. When aspiration is complete, the occlusive devices are deactivated, and the main 406, aspiration, and inner catheters 420, 432 are removed from the patient.
  • Should it be desired that a separate irrigation catheter be used to provide irrigation fluid, an irrigation catheter can be delivered to the site of the occlusion following therapy and removal of the therapy catheter. The irrigation catheter is delivered through the main catheter and over the inner catheter. Irrigation fluid is provided through the irrigation catheter, while aspiration is provided through the main catheter. [0121]
  • C. Single Balloon System [0122]
  • In another embodiment illustrated in FIG. 19, only a single occlusive device is used. As described above, a [0123] main catheter 406, with or without a distal occlusive device, is introduced into the patient's vasculature through an incision in the femoral artery in the groin of the patient or through direct access to the arteries in the neck. The main catheter 406 is guided through the vasculature until it reaches the common carotid artery 404, where it can remain in place throughout the procedure.
  • Once the [0124] main catheter 406 is in place proximal to the occlusion 410, an inner catheter or guidewire 420 having an occlusive device 422 at its distal end is delivered through the main catheter 406 into the internal carotid artery 400 and past the site of the occlusion 410. Alternatively, a detachable occlusive device can be deployed at the site distal to the occlusion, and the delivery device removed. In this example, the occlusive device 422 is an inflatable balloon. The balloon is inflated to occlude the internal carotid artery 400 at a site distal to the occlusion 410. As noted before, it should be understood that the occlusion within the artery can be in a discrete location or diffused within the vessel. Therefore, although placement of the distal occlusive device is said to be distal to the occlusion to be treated, portions of the diffuse occlusion may remain distal to the occlusive device.
  • A therapy catheter, not shown, is then delivered. Again, the therapy catheter can be any of a number of devices, including a balloon catheter used to perform angioplasty, a catheter which delivers a stent, a catheter for delivering enzymes, radiation, chemicals, or drugs to dissolve and treat the occlusion, an atherectomy device, a thrombectomy device, a rheolitic device, a device which creates a venturi effect within the artery, or a laser or ultrasound device used to ablate the occlusion. [0125]
  • Once the desired therapy is performed, the therapy catheter is withdrawn from the patient's body and an [0126] intermediate catheter 426 is delivered through the main catheter 406. A single operator type catheter may be used in which only a portion of the catheter rides over the guidewire, which is inserted into a separate guidewire lumen (as illustrated in FIG. 20). Alternatively, an over-the-wire type catheter can be used. The intermediate catheter 426 is delivered into the internal carotid artery 400 to a location just proximal to the occlusive device 422. Preferably, in order to maximize the effectiveness of the aspiration or irrigation, the catheter 426 is positioned less than two centimeters from the proximal end of the occlusive device 422 at some point during aspiration. Delivering the intermediate catheter 426 in such close proximity to the occlusion device 422 will allow the creation of a turbulent effect near the occlusive device during aspiration and irrigation thus aiding in the removal of the particles and debris. During aspiration, the intermediate catheter 426 can be moved in a proximal direction, to ensure more effective aspiration of the area.
  • Delivery of the [0127] intermediate catheter 426 near the occlusive device 422 requires passing the intermediate catheter 426 across the previously occluded vessel. In order to minimize the risk to the patient the intermediate catheter 426 is preferably soft, small and flexible. A preferred embodiment of this invention comprises delivering a soft-tipped intermediate catheter 426 made of a compound of a durometer 55 or less.
  • Once the [0128] intermediate catheter 426 is delivered in close proximity to the occlusive device 422, the area is first aspirated. As noted above, the intermediate catheter 426 can be moved backward in a proximal direction during aspiration. This forward and backward movement of the intermediate catheter 426 can be repeated as often as desired to provide effective aspiration. At some point during aspiration, the distal end of the aspiration catheter should be positioned about 2 cm or less from the proximal end of the occlusive device to ensure effective aspiration. Following aspiration, the area is irrigated by supplying a fluid, such as saline, through the intermediate catheter 426. The irrigation fluid acts to flush any remaining particles or debris from the internal carotid 400, to the external carotid 402, as indicated by the arrows in FIG. 21. The steps of sequential aspiration and irrigation or flushing, can be repeated as many times as necessary to remove all of the particles and debris from the vessel.
  • In one embodiment, the [0129] intermediate catheter 426 has a single lumen for delivery of aspiration pressure and irrigation fluid, such as the aspiration or irrigation catheters shown in FIGS. 7 through 16. The proximal end of the intermediate catheter 426 is connected to a source of negative pressure (as described above) and is used to aspirate the debris and particles around the occlusive device 422.
  • Following aspiration of the area, the proximal end of the [0130] intermediate catheter 426 is connected to a source of irrigation fluid, such as saline, in order to irrigate the area near the occlusive device 422. Preferably, the volume of fluid used to irrigate the area near the occlusive device 422 is equal to or greater than the volume of the area between the proximal end of the distal occlusive device and the start of the internal carotid artery at the bifurcation of the common carotid artery. For example, at least 10 cubic centimeters of fluid is delivered to the area that is between the distal occlusive device and the start of the internal carotid branch, which is approximately 1-5 cubic centimeters. As a result of this irrigation, any particles or debris remaining in the internal carotid 400 will be flushed into the external carotid 402.
  • In yet another embodiment, the [0131] intermediate catheter 426 has two lumens, one for aspiration and another for irrigation. The lumen providing aspiration is attached at its proximal end to a negative pressure source. A second lumen is attached at its proximal end to source of irrigation fluid. An advantage of this embodiment is that the particles and debris removed are in a separate lumen, eliminating the possibility that they could be flushed back into the vessel when the irrigation fluid is delivered through the same lumen as the aspiration pressure. As with the single lumen embodiment, the steps of aspirating and irrigating can be repeated as many times as necessary. Once the emboli have been flushed away, the distal occlusive device may be deactivated and removed from the patient.
  • As illustrated in FIG. 22, after the [0132] occlusion 410 has been treated, the distal end of the intermediate catheter 426 may be advantageously placed distal to the treated occlusion, i.e., between the treated occlusion 410′ and the occlusive device 422. This facilitates more thorough flushing of the region between the occlusive device 422 and the treated occlusion 410′, and around the treated occlusion generally, so that any particles and debris remaining after therapy can be more effectively removed as the aspiration fluid (i.e., blood from the common carotid) passes across the treated occlusion 410′.
  • Flushing of the region in and around the treated [0133] occlusion 410′ may be accomplished in a number of ways. For example, as illustrated in FIG. 23, the intermediate catheter 426 may be used as an aspiration catheter. Alternatively, as illustrated in FIG. 24, the intermediate catheter 426 may be used as an irrigation catheter, in which particles and debris are flushed towards the point where the common carotid 404 intersects the internal carotid 400, and towards the external carotid 402. Upon reaching the external carotid 402, particles, debris, and emboli are flushed down the external carotid with anatomical blood flow. The therapy catheter 448 of FIG. 24A may also be used for irrigation following therapy, in which saline solution is pumped through the annulus between the therapy catheter 448 and the guidewire 420. The therapy catheter 448 advantageously comprises a therapy device (such as a balloon for balloon angioplasty, a stent, an atherectomy device for cutting away plaque, or a rheolitic catheter) for use after the occlusive device 422 is deployed.
  • The steps illustrated by FIGS. 23 and 24 may be performed sequentially, i.e., the [0134] intermediate catheter 426 may first be used as an aspiration catheter and then as an irrigation catheter. In FIGS. 23 and 24 (or 24A), the distal end of the catheter 426 (or therapy catheter 448) is preferably positioned beyond the treated occlusion 410′ to more efficiently remove emboli from the treated region. In general, aspiration is performed as close to the occlusive device 422 as possible. The intermediate catheter 426 (like the therapy catheter 448) is advantageously separate from the guidewire 420 and slidable on it, so that the catheter 426 may be properly positioned by the user.
  • The main (outer) [0135] catheter 406 itself may be used for aspiration and irrigation of the region in and around the treated occlusion 410′, as illustrated in FIGS. 25 and 26, respectively. The main catheter 406 has a radial extent that permits the therapy catheter 448 and the intermediate catheter 426 to pass through the main catheter 406. In FIG. 25, the distal end of the main catheter 406 is positioned distal to the treated occlusion 410′, and blood containing emboli or other particles is aspirated away into the main catheter and removed from the patient. In FIG. 26, the main catheter 406 is used to flush the region in and around the treated occlusion 410′ by ejecting, for example, saline solution which then transports particles and debris away from the internal carotid 400 and down the external carotid 402. Either of the treatment methods illustrated by FIGS. 25 and 26 may be used to flush away particles, or both may be used sequentially, e.g., the main catheter 406 may be used for aspiration and then for flushing. (However, the presently preferred methods utilize the main catheter 406 only for irrigation.)
  • Other combinations of the methods illustrated by FIGS. [0136] 23-26 can be utilized. For example, the intermediate catheter 426 of FIG. 23 may be used for aspiration, followed by flushing with the main catheter 406 (as illustrated in FIG. 26). Also, the main catheter 406 may be used for aspiration (as illustrated in FIG. 25), followed by flushing with the intermediate catheter 426 (as illustrated in FIG. 24). In general, the best results are obtained by first aspirating (thereby removing particles from the patient) and then flushing, and the aspirating and flushing steps may be repeated as necessary. The same catheter can be used for aspiration and then irrigation, but in this case, this catheter should be removed from the patient and cleaned after aspiration to remove emboli from it. Irrigation then removes any emboli remaining in the patient. (However, if the main catheter 406 is used for both aspiration and irrigation, this cleaning step should be foregone since the main catheter 406 should be the last catheter to be removed from the patient.) It is preferred, however, to use a separate aspiration catheter and irrigate through the main catheter 406.
  • Aspiration and irrigation may be performed simultaneously by having two catheters deployed at the same time and irrigating through one (e.g., the [0137] therapy catheter 448 or the intermediate catheter 426) and aspirating through another (e.g., the main catheter 406). In this case, the main catheter 406 may be deployed to a location near the intersection of the internal carotid 400 and the external carotid 402. Alternatively, aspiration may be performed through the intermediate catheter 426 while irrigating through the main catheter 406, in which the distal ends of the intermediate catheter 426 and the main catheter 406 are preferably positioned distal and proximal, respectively, to the treated lesion 410′.
  • As shown in FIG. 27, flushing may also be performed in a blood vessel (not necessarily a bifurcated vessel as illustrated herein), using an [0138] occlusive device 422′ that passes saline solution (or another suitable flushing solution). In this embodiment, the saline solution may be advantageously passed through a lumen in the guidewire 420 and into the occlusive device 422′. The occlusive device 422′ has at least one fluid flow opening and is preferably microporous on its proximal end, having a plurality of holes 450 (e.g., 10-50) that are preferably less than 1000 microns in diameter and more preferably between 50 and 100 microns in diameter. The holes may be formed in the occlusive device 422′ by laser drilling, for example. As saline solution passes through the occlusive device 422′ and into the internal carotid 400, emboli, particulates, and other debris are flushed past the treated occlusion 410′ and down the external carotid 402. During irrigation, the fluid flow may be maintained with a pressurized syringe located outside the patient. However, while therapy is being performed on the occlusion 410, the fluid flow may be advantageously reduced to avoid overpressurizing that segment of the internal carotid artery 400 between the occlusion device 422′ and the occlusion 410 (pressures should be kept less than 50 psi). Thus, the saline solution is used for inflating the occlusive device 422′ as well as for irrigating emboli from the internal carotid 400 down the external carotid 402. The irrigation method of FIG. 27 may be augmented by aspirating the region in and around the treated occlusion 410′ through a catheter, e.g., through the intermediate catheter 426 (as in FIG. 23) or the main catheter 406 (as in FIG. 25).
  • Another irrigation device and method is disclosed in FIG. 28, in which one or [0139] more holes 460 in the guidewire 420 are located distal to the treated lesion 410′ and proximal to the occlusive device 422. (For example, 1, 2, or 3 holes of dimensions 0.050″×0.002-0.003″ may be used, or 10 holes of dimensions 0.003″×0.003″, to provide a flow such that the pressure inside the vessel does not exceed 50 psi.) Irrigation fluid is pumped through the guidewire 420 and out of the holes 460 (which may advantageously be 50-300 microns in diameter) to flush away emboli from the treated lesion 410′ and down the external carotid 402. The guidewire 420 may have a single lumen (not shown) that is in fluid communication with both the internal carotid artery 400 (via the holes 460) and the occlusive device 422, in which case the irrigation fluid and the fluid used to inflate the occlusive device 422 are the same. Alternatively, the guidewire 420 may have dedicated lumens (not shown) for irrigation and inflation. The irrigation method of FIG. 28 may be augmented by aspirating the region in and around the treated occlusion 410′ through a catheter, e.g., through the intermediate catheter 426 (as in FIG. 23) or the main catheter 406 (as in FIG. 25).
  • Instead of pumping irrigation fluid through the [0140] holes 460 as shown in FIG. 28, a larger slot (not shown) of dimensions 0.005″×0.100-0.200″ may be cut into the guidewire 420 and then covered with a braid (not shown) that extends 0.010-0.030″ beyond the edges of the slot. As irrigation fluid is passed through the guidewire 420, the braid expands, permitting the irrigation fluid to pass out of the slot and into the internal carotid 400. Instead of using a braid, this slot may alternatively be covered with a plastic sheath (not shown) having a plurality of slits or pores (not shown) which are in fluid communication with the slot. Ten pores having a diameter of 50-100 microns may advantageously be used.
  • Irrigation rates for the methods disclosed herein are preferably between 0.1 cc/sec and 3 cc/sec, more preferably between 0.5 and 1.5 cc/sec, and still more preferably about 1 cc/sec. Aspiration rates are preferably between 0.5 and 5 cc/sec, and more preferably between 0.5 and 1.1 cc/sec. The fluid pressure used to generate the irrigation and aspiration rates may be pulsed on and off to better flush away emboli. For example, fluid pressure may be alternately applied for 5 seconds (in the form a pulse) and then turned off for 2-3 seconds. In general, fluid is irrigated (or aspirated) through a lumen in a catheter, with the lumen being in fluid communication with a fluid flow opening at a distal end portion of the catheter. [0141]
  • The single balloon methods disclosed herein may additionally comprise inflating a balloon on the [0142] main catheter 406 within the common portion of the vessel to occlude the common portion.
  • D. Alternate Dual Balloon System [0143]
  • Under certain circumstances, use of a second occlusive device is desired, as illustrated in FIG. 21. The second [0144] occlusive device 432 is positioned on the distal end of the main catheter 406 and acts to occlude the main carotid artery 404. A second occlusive device 432 may be desired where the physician is concerned about crossing the occlusion 410 in the internal carotid artery 400 with the inner catheter 420 or where there is another occlusion 428 in the external carotid artery 402 resulting in decreased flow through the external carotid 402.
  • Once the [0145] main catheter 406 is delivered to the common carotid artery 404, the occlusive device 432 is activated. The activation of the occlusive device 432 will have the effect of occluding the common carotid artery 404 thereby cutting off the blood flow to both the internal carotid 400 and the external carotid 402 arteries.
  • Next, an [0146] inner catheter 420 with an occlusive device 422 is delivered distal to the occlusion 410 in the internal carotid artery 400 and activated, thus isolating the occlusion 410 between the two occlusive devices 432, 422. This is followed by therapy on the occlusion 410 as described above. Sequential aspiration and irrigation are then performed as described above.
  • The main advantage of using two occlusive devices is that when the internal [0147] carotid artery 400 is irrigated, a back pressure is created in the chamber defined by the proximal occlusive device 432 and the distal occlusive device 422. This back pressure will force the fluid, particles and debris from the internal 400 and common 404 carotid arteries through the external carotid artery 402.
  • E. Alternate Triple Balloon System [0148]
  • In some cases, a triple balloon system is used. This system is especially advantageous in those patients where occlusion of the common carotid artery results in blood from collateral vessels flowing from the external carotid artery to the internal carotid artery. The direction of blood flow in a particular patient can be determined through angiography. [0149]
  • In this system (not shown), following activation of the occlusive device in the common carotid artery, but before crossing the occlusion with an inner catheter, a first inner catheter with an occlusive device is delivered to the external carotid artery and the occlusive device activated. This prevents flow from collateral blood vessels moving from the external to the internal carotid artery. Next, a second inner catheter is delivered to the internal carotid artery past the site of the occlusion and the occlusive device activated to occlude the internal carotid artery. Alternatively, the first inner catheter can be positioned within the internal carotid artery and the occlusive device activated, followed by delivery of the second inner catheter to the external carotid artery and activation of the occlusive device. In either case, the occlusion is completely isolated between the three occlusive devices. This is followed by therapy on the occlusion, aspiration, and irrigation if desired, as described above. [0150]
  • F. Use of Occlusive Devices in Combination with Perfusion [0151]
  • For some applications, it may be desirable to provide for the perfusion of blood while medical procedures are performed on a blood vessel such as the internal carotid artery. Several such embodiments are now discussed in connection with FIGS. [0152] 29-32. Perfusion may be necessary for those patients who can not tolerate an excessive reduction of blood flow to their brain. One exemplary method is illustrated in FIGS. 29A and 29B. FIG. 29A shows a guidewire 420 to which an expandable member 470 is attached. In its undeployed state, the expandable member 470 has a relatively narrow profile so that the member 470 may be delivered through a blood vessel. The expandable member 470 may be, for example, a mesh- or filter-like device which, when deployed, permits the perfusion of blood but is capable of entraining emboli. After positioning the (undeployed) expandable member 470 distal to the lesion 410 within the internal carotid artery 400 to be treated, the member 470 may be deployed so that it expands to fill the internal carotid artery. The expandable member 470 may be deployed by any one of a number of techniques, for example, the distal end of the member 470 may be attached to a pull wire (not shown) that passes through the guidewire 420 such that when the pull wire is retracted, the member 470 expands to fill the internal carotid artery 400. (Conversely, in this example, the member 470 may be returned to its undeployed position when the pull wire moves in the distal direction.) Alternatively, the member 470 may be self-expanding and deployed by retracting a low profile sheath (not shown) that surrounds the expandable member.
  • After the [0153] expandable member 470 is deployed, therapy may be performed on the lesion 410, resulting in a treated lesion 410′. To this end, a therapy catheter (not shown in FIGS. 29A and 29B) may be deployed over the guidewire 420, and any one of a number of therapy operations performed, such as balloon angioplasty, deploying a stent, or the application of drug therapy. The therapy catheter may then be withdrawn from the patient. Emboli that are created as a result of the therapy are blocked by the expandable member 470 when these emboli are flushed distally by anatomical blood flow, so that the emboli are prevented from traveling downstream towards the brain, for example. However, the expandable member 470 still permits the perfusion of blood, so that the health of tissue supported by the internal carotid artery 400 is not jeopardized.
  • Following removal of the therapy catheter, an [0154] intermediate catheter 474, to which an occlusive device 478 (such as an occlusion balloon) is attached, is directed through the common carotid 404 (by passing the catheter 474 over the guidewire 420 and through a guide or main catheter 406) and positioned such that the occlusive device 478 is distal to the treated lesion 410′ and proximal to (and preferably adjacent proximal to) the expandable member 470. The occlusive device 478 may then be deployed to occlude the internal carotid artery 400, thereby preventing anatomical blood flow. Emboli that have been entrained within the expandable member 470 may then be advantageously aspirated away by applying suction through the intermediate catheter 474, such that blood distal to the expandable member 470 passes through the expandable member, entraining emboli in the process. The aspirated emboli and blood pass through the intermediate catheter 474 and are directed out of the patient. If the expandable member 470 is clogged, aspiration will nevertheless draw emboli from the expandable member by drawing blood from the proximal side of the expandable member.
  • To remove any emboli that may be remaining in and around the treated [0155] lesion 410′, the main catheter 406 may be brought distal to the treated lesion, as illustrated in FIG. 29B. With the occlusive device 478 still deployed, irrigation fluid is ejected from an opening near the distal end of the main catheter 406, such that emboli are carried towards the intersection of the internal carotid 400 and the external carotid 402, whereupon the emboli are flushed down the external carotid 402 by anatomical blood flow. The expandable member 470 may be retracted, preferably while aspirating through the intermediate catheter 474, so that any emboli that are dislodged during the retraction of the expandable member are removed from the patient. The expandable member 470, the intermediate catheter 474, and the main catheter 404 may then be removed from the patient.
  • Another embodiment in which an occlusive device is combined with perfusion is illustrated in FIGS. 30A and 30B, in which the [0156] expandable member 470 is positioned and deployed distal to the lesion 410 as in the embodiment of FIG. 29A. After performing therapy on the lesion 410, a catheter such as an outer catheter or main catheter 490 is brought distal to the treated lesion 410′. An occlusive device 482, such as a balloon, located on the main catheter is then deployed, occluding the vessel 400. Aspiration is then performed through the main catheter 490, so that blood flows through the expandable member 470 and into the main catheter, thereby removing emboli trapped in the expandable member, which may have been produced as a result of therapy. If the expandable member 470 is clogged, aspiration will nevertheless draw emboli from the expandable member by drawing blood from the proximal side of the expandable member. Irrigation fluid may be advantageously ejected from one or more openings 486 in the main catheter 490 distal to the treated lesion 410′, so that emboli remaining in and around the treated lesion are flushed towards the intersection of the internal carotid 400 and the external carotid 402, whereupon they are flushed down the external carotid by anatomical blood flow. The aspiration and irrigation steps may be performed sequentially or simultaneously. While the expandable member 470 is retracted, aspiration is preferably performed to remove any emboli that are dislodged during the process of retracting the member 470.
  • FIG. 30B shows the cross section of the [0157] main catheter 490, illustrating that the main catheter 490 of FIG. 30A has at least three lumens—a lumen 492 for passing the guidewire 420 and the therapy catheter (not shown in FIG. 30A), a lumen 494 for inflating the occlusive device 482, and a lumen 496 for delivering irrigation fluid to one or more openings 486 distal of the treated lesion 410′.
  • Yet another embodiment in which an occlusive device is combined with perfusion is illustrated in FIG. 31, in which a [0158] hypotube 502 having a plurality of holes 506 is passed through an outer or main catheter 510. In the embodiment illustrated in FIG. 31, an occlusive device such as an occlusion balloon 514 is used rather than the expandable member 470, and the hypotube 502 extends beyond the occlusion balloon 514 in the distal direction to provide perfusion while therapy is performed on a lesion 410.
  • After positioning the (uninflated) [0159] occlusion balloon 514 distal of the lesion 410 and positioning an opening 518 of the hypotube 502 distal of the occlusion balloon 514, the occlusion balloon is inflated so that the occlusion balloon occludes the vessel 400 while contacting the hypotube 502. (The holes 506 in the hypotube 502 are preferably located at least 1-2 mm proximal of the lesion to reduce the risk of emboli entering the holes and traveling distal of the occlusion balloon 514.) Therapy is then performed on the lesion 410, while the inflated balloon 514 blocks emboli (produced as a result of the therapy) from traveling downstream. However, blood may still pass through the holes 506 in the hypotube 502 and exit the opening 518 in the hypotube, so that perfusion of blood is allowed. After the therapy is complete and the therapy catheter is removed, a fluid port of the catheter 510 may be advantageously positioned distal to the treated occlusion 410′ (and proximal to the balloon 514) and irrigation fluid delivered distal to the treated lesion 410′, so that fluid flows across the treated occlusion in a distal to proximal direction. The irrigation fluid carries away emboli towards the junction of the internal carotid 400 and the external carotid 402, whereupon the emboli are flushed down the external carotid by anatomical blood flow. As an alternative (not shown) to using a hypotube dedicated for perfusion, holes may be introduced into the guidewire, with the guidewire having a lumen that extends through the occlusion balloon leading to an opening distal of the balloon. The holes 506 in the hypotube 502 or in the guidewire 420 may advantageously have diameters of 0.005″ or larger, or slits of dimensions 0.005″×0.005″. Several such hole (or slits) are preferably used to create a flow of blood of between 8 and 50 cc/min.
  • The perfusion illustrated in FIG. 31 is passive, since the blood passes through the [0160] hypotube 502 on its own. In the case of active perfusion, a pump such as a syringe pump (not shown) may be attached to the proximal end of a hypotube that does not have holes. Alternatively, a guidewire such as guidewire 420 may be used in which the guidewire passes through the occlusive device 422—such a guidewire has a lumen therein having an opening which is distal to the balloon 514. The lumen could have a diameter between 0.010″ and 0.025″, and more preferably a diameter of about 0.018″. A preferred pump rate is between 8 and 40 cc/min.
  • Another embodiment that combines features of occlusion with perfusion is illustrated in FIGS. 32A and 32B. The [0161] guidewire 420 is brought through the vessel 400 until the expandable member 470 is located distal to the lesion 410 to be treated. After deploying the expandable member 470, therapy is performed on the lesion 410, e.g., using a therapy catheter 550 to which an angioplasty balloon 560 is attached. During and after performing therapy on the lesion 410, the expandable member 470 collects emboli that may be produced as a result of the therapy, as blood travels from one side of the expandable member to the other in a proximal to distal direction. After performing therapy (e.g., after deploying the angioplasty balloon 560), the angioplasty balloon 560 is deflated and the therapy catheter 550 is moved over the guidewire 420 in the distal direction such that the angioplasty balloon 560 is distal of the treated lesion 410′. The angioplasty balloon 560 is then reinflated so that the vessel 400 is occluded. With the vessel 400 occluded, a catheter 580 such as an outer or main catheter is then positioned such that a fluid port of the catheter 580 is distal of the treated lesion 410′. As illustrated in FIG. 32B, irrigation fluid is ejected from the catheter 580 to flush away any emboli that may remain in and around the treated lesion 410′. The irrigation fluid and any emboli entrained within it travel in a distal to proximal direction towards the intersection of the internal carotid 400 and the external carotid 402, whereupon the irrigation fluid and emboli are carried down the external carotid artery 402 by anatomical blood flow. (Alternatively, the catheter 580 may be used to aspirate the region in and around the treated lesion 410′ to create a flow of fluid in the proximal to distal direction.) The expandable member 470, the therapy catheter 550, and the catheter 580 can then be removed from the patient. When removing the expandable member 470 from the vessel 400, however, care should be taken to avoid introducing any emboli into the bloodstream.
  • G. Accommodating Changes in Vessel Diameter [0162]
  • As a result of therapy being performed on a lesion, the diameter of the vessel or vessels being occluded may increase. For example, if the internal carotid artery is occluded distal to a lesion within the carotid artery, and then treatment is performed on that lesion, the diameter of the internal carotid artery may increase substantially as a result of the treatment. If the occlusive device in the internal carotid does not accommodate this increase in diameter, resulting in a break in the seal between the occlusive device and the walls of the internal carotid, the risks to the patient may be significant. [0163]
  • A method for avoiding this possibility involves applying an expansion force to the occlusive device beyond that which is required to seal the occlusive device to the walls of the vessel. For example, if an occlusion balloon is used as the occlusive device in the internal carotid, then the balloon may be advantageously inflated to a pressure beyond that which is required to maintain a seal in the internal carotid. As the balloon begins to be inflated, it will expand both axially and radially. The balloon continues to expand radially until it mates with the walls of the vessel, at which point further expansion of the balloon in the radial direction is hindered by the tendency of the vessel to resist enlargement. Continuing to inflate the balloon at this point results in the balloon expanding preferentially in the axial direction, rather than in the radial direction. As the balloon expands in the axial direction, potential energy continues to be stored up in the balloon. [0164]
  • If the vessel expands (e.g., as a result of therapy being performed on it), then the potential energy stored in the balloon is harnessed in that the balloon expands in the radial direction (while correspondingly contracting somewhat in the axial direction), such that the balloon continues to make contact with the vessel during and following treatment, thereby preventing a break in the seal which could result in injury to the patient. Thus, with such a method, it is not necessary to actively adjust the pressure in the balloon as a result of treatment of a lesion, and in this sense, the seal is self-accommodating with respect to changes in vessel diameter. [0165]
  • The occlusive device may also comprise a self-expanding material such as nitinol, for which it is possible to obtain a nearly constant level of stress over a relatively wide range of strain. For example, if an occlusive device comprising a nitinol filter-like mesh is capable of sealing a 6 mm diameter vessel, such an occlusive device may be used to occlude a vessel that is initially 5 mm in diameter, so that if the vessel expands, the perfusion-filter will also expand to maintain occlusion within the vessel. [0166]
  • The diameter of the internal carotid artery may increase substantially as a result of therapy performed on it. For example, a vessel that has a 4 mm diameter at the point where the occlusion balloon is located may increase to 5 mm or more as a result of therapy. Thus, in this method, the balloon may be advantageously positioned in a blood vessel such that the vessel diameter is at least 20% less than the maximum useful sealing diameter of the balloon. As the lesion is treated, the balloon will continue to seal against the walls of the vessel, even if the diameter of the vessel should expand in response to the treatment. This method can be used with a variety of expandable members other than balloons, such as braids, coils, ribs, ribbon-like structures, slotted tubes, and filter-like meshes, which may be partially or completely covered with a membrane or another covering to provide a seal with the vessel. [0167]
  • H. Inflation Apparatus [0168]
  • A preferred embodiment of a low volume or [0169] inflation syringe 60 in a syringe assembly 100 for inflating an occlusion balloon in accordance with the present invention is shown in FIG. 33. Also shown in FIG. 33 is an illustrative connection of the assembly 100 to an occlusion balloon guidewire catheter 62 (such as guidewire 420) utilizing an inflation adapter 30. The syringe assembly 100, comprising the inflation syringe 60 and a larger capacity or reservoir syringe 64, is attached via tubing 216 to the inflation adapter 30 within which a sealing member 930 (see FIGS. 34A and 34B) and the balloon catheter 62 are engaged during use. Alternatively, other devices that control the flow of inflation fluid, such as flow controllers, may be used.
  • The sealing [0170] member 930, described in more detail below in connection with FIGS. 34A and 34B, is inserted into an open proximal end of the catheter 62. The syringe 60 is used to inject inflation fluid through the adapter 30 and inflation port 17 into a lumen of the catheter 62, and into a balloon 66 (such as balloon 422). The inflation adapter 30, described in more detail below in connection with FIG. 35, is used to open and close the sealing member 930 to permit the inflation or deflation of the balloon 66 mounted on the distal end of the catheter 62. However, it will be emphasized that other types of adapters, valves, and/or sealing members can be employed with the inflation syringe and/or syringe assembly of the present inflation, in order to achieve rapid and accurate inflation/deflation of medical balloons or other nonballoon medical devices. Therefore, although illustrated in connection with a low volume occlusion balloon 66, other types of balloons and nonballoon devices may be utilized.
  • If the [0171] balloon 66 is mounted on the distal end of the catheter 62, the syringe 60 and/or syringe assembly 100 is preferably connected at the proximal end of the catheter 62. Prior to use of the syringe 60 to inflate the balloon 66 to the proper size for the vascular segment to be treated, the distal end of the catheter 62 and the balloon 66 are first “primed” or evacuated. The reservoir syringe 64 of the assembly 100 may be used for the evacuation. Access to the vascular site is through a port in the patient obtained, for example, using an introducer (not shown). A preferred system and method for accomplishing the occlusion balloon inflation is described below.
  • The [0172] inflation syringe 60 may be provided with a stop mechanism 20 for limiting both the intake of fluid into the syringe and the delivery of fluid from the syringe. The syringe 60 has an elongate cylinder 44 and plunger arrangement 50 which provide for greater displacement or travel by the plunger along the cylinder length than is necessary to expel a relatively small amount of inflation fluid. Thus, with the stop mechanism 20, the clinician is provided with an enhanced sense of whether the fluid in the syringe 60 has been delivered to the balloon, which helps compensate for lack of precision by the clinician. The stop mechanism 20 may be mounted on the syringe 60 during production, or as separate components that can be retro-fit onto an existing supply of syringes.
  • Referring to FIGS. 33, 34A, [0173] 34B, and 35, the catheter 62 has the sealing member 930 inserted into its proximal end and has a side-access inflation port 17, shown in greater detail in FIGS. 34A and 34B. The inflation port 17, proximal end of the catheter 62 and distal end of the sealing member 930 are positioned within the inflation adapter 30 (see FIG. 35) to which a syringe assembly 100 in accordance with the present invention has been operably coupled. The inflation syringe 60 is coupled via an injection cap 22 at its distal end to a valve 68 that also connects the large capacity syringe 64 and a short tube segment 216. The tube segment 216 is adapted to connect to a fitting or male luer member 24 of the inflation adapter 30. Thus, the sealing member 930 is engaged by the adapter 30 to allow use of the low volume syringe 60 of the syringe assembly 100 to inflate the balloon 66 at the end of the catheter 62.
  • The catheter [0174] 62 (depicted in FIGS. 34A and 34B) has a proximal end 912, and a distal end (not shown in FIGS. 34A and 34B) to which is mounted the inflatable balloon 66. A central lumen 940 extends within a tubular body 918 between the proximal and distal ends. An opening 923 to lumen 940 is present at the proximal end 912 of catheter 62. The inflation port 17 in fluid communication with lumen 940 is provided on tubular body 918.
  • The sealing [0175] member 930 is inserted into lumen 940 through central lumen opening 923. Sealing member 930 has a first region 935 which has an outer diameter substantially the same as the outer diameter of the proximal end 912 of the catheter tubular body. Region 935 has a taper 934, reducing in diameter to a second region 933 which has an outer diameter less than the inner diameter of lumen 940. In one embodiment, region 933 tapers over length 931 to form a plug mandrel wire 932. As a consequence, region 933 and plug mandrel wire 932 are slidably insertable into the proximal opening 923 of catheter 62 and may move within lumen 940. In one preferred embodiment, region 935 has an outer diameter of about 0.013 inches, region 933 has an outer diameter of about 0.008 inches, and plug mandrel wire 932 has a diameter of about 0.006 inches, with region 933 and plug mandrel wire 932 being inserted into a catheter having a central lumen 940 with an inner diameter of about 0.009 inches.
  • The length of sealing [0176] member region 935 extending proximally of catheter 62 may vary in length depending upon the intended use environment. For example, where catheter 62 is to be used as a guide for other catheters in an “over-the-wire” embodiment, it is preferred that the total length of catheter 62 and sealing member region 935 be about 300 centimeters. Alternately, where catheter 62 is to be used in a single operator or rapid exchange embodiment, it is preferred that the total length of catheter 62 and region 935 be about 190 centimeters. Accordingly, with a known catheter length and use environment, an appropriate length for region 935 may be chosen.
  • [0177] Regions 935 and 933 and plug mandrel wire 932 may all be made out of metals such as stainless steel. Alternatively, combinations of materials may be used as well. For example, in some applications it may be desirable to manufacture regions 935 and 933 out of stainless steel, while manufacturing plug mandrel wire 932 out of nitinol. Furthermore, the various sealing member regions may be made from a single metal wire strand coined at various points to achieve the desired dimensional tolerances, or multiple segments may be joined together to form sealing member 930.
  • Where multiple segments are joined, [0178] region 935, region 933, and plug mandrel wire 932 are attached to one another by any suitable means of bonding metal to metal, such as crimping, soldering, brazing, adhesives and the like. In one preferred embodiment, cyanoacrylate adhesives are used to adhere these various parts of sealing member 930 to one another.
  • As illustrated in FIGS. 34A and 34B, the outer diameter of sealing [0179] member region 933 is less than the inner diameter of lumen 940, such that region 933 is slidably insertable into lumen 940. In addition, the outer diameters of the tapered portions 931 and wire 932 are also small enough such that they too are slidably insertable in lumen 940. However, the outer diameter of region 935 is greater than the inner diameter 940, and thus only a small portion of tapered portion 934 of sealing member 930 between region 935 and region 933 is insertable into lumen 940 through opening 923. Advantageously, this provides for a snug interference fit when sealing member 930 is fully inserted into catheter 62. This interference fit provides a frictional force which counteracts the tendency of the pressurized fluids and internal wire flexing in the catheter to push sealing member 930 out of opening 923.
  • As illustrated in FIGS. 34A and 34B, sealing [0180] member 930 has movement-force increasing structure which increases the force required to move sealing member 930 within lumen 940. The movement-force increasing structure consists of waves 938 a and 938 b formed in wire 932 near its distal end. Waves 938 a and 938 b contact the inner surface of lumen 940, thereby increasing the frictional force which must be overcome to move wire 932 within lumen 940. In one preferred embodiment, wire 932 is made of nitinol and has an outer diameter of about 0.006 inches, and is inserted into a nitinol catheter which has an inner lumen 940 with a diameter of about 0.009 inches. In one embodiment, waves are formed on wire 932 for 3 cycles with an amplitude of about 0.019 inches to increase the valve-opening movement force. Alternatively, by increasing the length over which wire 932 contacts the inner wall of the tubular body 918, the frictional forces may be increased.
  • A [0181] lumen sealer portion 936 is coaxially and fixedly mounted on wire 932. Sealer portion 936 forms a fluid tight seal with the outer diameter of wire 932 and the inner diameter of lumen 940, such that fluid introduced into lumen 940 through the inflation port 17 is prevented from flowing past sealer portion 936 when sealer portion 936 is inserted into lumen 940 distally of the inflation port 17. Sealer portion 936 forms the fluid tight seal by firmly contacting the entire inner circumference of a section of lumen 940 along a substantial portion of the length of sealer portion 936.
  • As shown in FIG. 34A, [0182] sealer portion 936 is positioned proximally of the inflation port 17, so that an unrestricted fluid passageway exists between inflation port 17 and the inflatable balloon at the distal end of catheter 62, which is like a valve “open” position. In this position, region 933 is shown partially withdrawn from opening 923. Referring to FIG. 34B, sealer portion 936 is positioned distally of inflation port 17, so that fluid flow between inflation port 17 and the inflatable balloon 66 at the distal end of catheter 62 are substantially blocked, which is like a valve “closed” position.
  • [0183] Catheter 62 is changed from the valve open position to the valve closed position by the movement of sealing member 930 and its various components. Preferably, the exact length of movement needed to change catheter 62 from the valve closed to the valve open position is built into the movement function of the adaptor used to manipulate sealing member 930 thereby opening and closing the catheter valve. In this regard, it is preferred that catheter 62 be used with an adaptor such as adaptor 30, which provides for such controlled precise movement.
  • The “stroke-length”, or overall movement in one dimension, of sealing [0184] member 930 required to open or close the valve may be varied depending upon the catheter requirements. When relying upon the inflation adaptor to control movement, however, it is important that the movement of the controlling elements of the adaptor be coordinated with those of sealing member 930.
  • Referring to FIGS. 33 and 35, the [0185] inflation adapter 30 comprises a housing having two halves 34, 36 preferably formed of metal, medical grade polycarbonate, or the like. In one embodiment, the halves 34, 36 are attached by hinges 205 to be separated or joined in a clam shell manner. A locking clip 38 secures the halves while the adapter 30 is in use. A groove within the housing has a width to accept the proximal end of the catheter 62 having the sealing member 930. The male luer member 24 (FIG. 33), or other suitable connector, extrudes from a top of the housing to provide an inflation passageway. Seals 70 are provided within the housing and around the internal segment 285 of the inflation pathway to conduct the pressurized fluid provided by the syringe 60 attached to the male luer member 24.
  • An [0186] actuator 40, shown in FIG. 33 at the top of the adapter housing, controls a cam which operates sliding panels 291 (FIG. 35) contained in the housing. Preferably, the catheter 62 is positioned within the housing with the sealing member 930 in the closed position (FIG. 34B), such that the side inflation port 17 is located in the sealed inflation area 285 of the housing. An adjacent proximal portion of the catheter 62 extends outside the housing (and into the patient), and a proximal portion of the sealing member 930 extends out of the other side of the housing. The locking clip 38 is then secured and then the syringe 60 may be attached. The actuator 40 is moved from a first position to a second position, such that the sliding panels 291 within the housing cause the sealing member 930 to be in an open position to allow fluid flow through the inflation port 17 (FIG. 34A). “Closing” the sealing member 930 is accomplished by moving the actuator 40 from the second position back to the first position (FIG. 34B), such that the balloon inflation is maintained.
  • Further details regarding catheter valves, catheter balloons, and inflation adaptors are found in copending applications Ser. No. 09/025,991 entitled “Syringe and Method for Inflating Low Volume Catheter Balloons” filed Feb. 19, 1998, and Ser. No. 08/975,723 entitled “Low Profile Catheter Valve and Inflation Adaptor” filed Nov. 20, 1997, both of which are hereby incorporated by reference herein. [0187]
  • While the foregoing detailed description has described several embodiments of the apparatus and methods of the present invention, it is to be understood that the above description is illustrative only and not limiting of the disclosed invention. It will be appreciated that the specific dimensions of the various catheters and guidewires can differ from those described above, and that the methods described can be used within any biological conduit within the body and remain within the scope of the present invention. Thus, the invention is to be limited only by the claims which follow. [0188]

Claims (94)

What is claimed is:
1. A method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising:
providing an elongate member having an occlusive device at a distal end portion thereof;
delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel, such as the internal carotid artery;
positioning the occlusive device in said branch distal of the occlusion;
sliding a therapy catheter on the elongate member;
occluding said branch only on the distal side of the occlusion by actuating the occlusive device;
treating the occlusion with the therapy catheter;
providing a second catheter having a fluid flow lumen in fluid communication with a fluid flow opening at a distal end portion of the second catheter;
using the occlusive device to occlude said branch of the vessel while:
(a) positioning the fluid flow opening of the second catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion;
(b) applying fluid pressure to the fluid flow lumen to cause fluid flow along said branch, between (i) an intersection of said branch with the common portion and (ii) said location, whereby fluid flows across the treated occlusion; and
deactuating the occlusive device.
2. The method of
claim 1
, comprising removing the therapy catheter from said branch of the vessel prior to applying the fluid pressure.
3. The method of
claim 1
, wherein the fluid flow across the treated occlusion flushes emboli in said branch away from the treated occlusion.
4. The method of
claim 1
, wherein said applying fluid pressure comprises aspirating fluid into the lumen to draw emboli away from the treated occlusion and into the lumen.
5. The method of
claim 4
, wherein fluid is aspirated at a rate between 0.5 and 5 cc/sec.
6. The method of
claim 4
, wherein fluid is aspirated at a rate of between 0.5 to 1.1 cc/sec.
7. The method of
claim 1
, wherein said applying fluid pressure comprises irrigating through the second catheter.
8. The method of
claim 7
, wherein said method further comprises ejecting sufficient irrigation fluid from the second catheter to transport emboli from the treated occlusion along said branch to the intersection, whereby the emboli are flushed down another branch of the bifurcated vessel.
9. The method of
claim 8
, wherein the irrigation fluid has a flow rate of between 0.1 and 5 cc/sec.
10. The method of
claim 8
, wherein the irrigation fluid has a flow rate of between 0.5 and 2 cc/sec.
11. The method of
claim 1
, wherein the second catheter is an intermediate catheter.
12. The method of
claim 1
, comprising allowing blood to flow from the common portion of the bifurcated vessel through another branch of the vessel during said using of the occlusive device to occlude said branch.
13. The method of
claim 1
, comprising applying the fluid pressure to the fluid flow lumen in the form of pulses.
14. The method of
claim 1
, wherein said providing the elongate member comprises providing a distal elongate member portion that is more flexible than a proximal elongate member portion.
15. The method of
claim 1
, wherein said applying fluid pressure comprises first aspirating and then irrigating.
16. The method of
claim 1
, comprising:
positioning an outer catheter such that a portion of the outer catheter is in the common portion of the vessel, the outer catheter having a radial extent that permits the therapy catheter and the second catheter to pass through the outer catheter; and
irrigating through the second catheter while simultaneously aspirating through the outer catheter.
17. The method of
claim 16
, wherein a fluid flow opening of the outer catheter is positioned proximal to the treated lesion.
18. The method of
claim 1
, wherein the blood vessel is the carotid artery.
19. The method of
claim 1
, wherein said treating the occlusion comprises balloon angioplasty or deploying a stent.
20. The method of
claim 1
, wherein said actuating the occlusive device comprises inflating an occlusion balloon.
21. The method of
claim 20
, wherein the balloon is of a compliant material.
22. The method of
claim 1
, wherein the elongate member is a tubular metallic guidewire.
23. A method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising:
providing an elongate member having an occlusive device at a distal end portion thereof;
delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel, such as the internal carotid artery;
positioning the occlusive device in said branch distal of the occlusion;
sliding a therapy catheter on the elongate member;
occluding said branch on the distal side of the occlusion by actuating the occlusive device;
treating the occlusion with the therapy catheter;
removing the therapy catheter from said branch of the vessel;
providing a second catheter having a fluid flow lumen in fluid communication with a fluid flow opening at a distal end portion of the second catheter;
sliding the second catheter on the elongate member after said removal of the therapy catheter;
using the occlusive device to occlude said branch of the vessel while:
(a) positioning the fluid flow opening of the second catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion;
(b) applying fluid pressure to the fluid flow lumen to cause fluid flow along said branch, between (i) an intersection of said branch with the common portion and (ii) said location, whereby fluid flows across the treated occlusion; and
deactuating the occlusive device.
24. The method of
claim 23
, wherein said applying fluid pressure comprises aspirating fluid into the lumen to draw emboli away from the treated occlusion and into the lumen.
25. The method of
claim 24
, wherein fluid is aspirated at a rate between 0.5 and 5 cc/sec.
26. The method of
claim 24
, wherein fluid is aspirated at a rate of between 0.5 to 1.1 cc/sec.
27. The method of
claim 23
, wherein said applying fluid pressure comprises irrigating through the second catheter.
28. The method of
claim 27
, wherein said method further comprises ejecting sufficient irrigation fluid from the second catheter to transport emboli from the treated occlusion along said branch to the intersection, whereby the emboli are flushed down another branch of the bifurcated vessel.
29. The method of
claim 28
, wherein the irrigation fluid has a flow rate of between 0.1 and 5 cc/sec.
30. The method of
claim 28
, wherein the irrigation fluid has a flow rate of between 0.5 and 2 cc/sec.
31. The method of
claim 23
, comprising applying the fluid pressure to the fluid flow lumen in the form of pulses.
32. The method of
claim 23
, further comprising inflating a balloon on an outer catheter within the common portion of the vessel to occlude the common portion.
33. The method of
claim 23
, wherein the elongate member is a tubular metallic guidewire.
34. A method for the treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising:
providing an elongate member having an occlusive device at a distal end portion thereof;
delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel, such as the internal carotid artery;
positioning the occlusive device in said branch distal of the occlusion;
sliding a therapy catheter on the elongate member;
occluding said branch only on the distal side of the occlusion by actuating the occlusive device;
treating the occlusion with the therapy catheter;
using the occlusive device to occlude the branch of the vessel while:
(a) delivering irrigation fluid to a distal end portion of the therapy catheter through an annulus between the therapy catheter and the elongate member;
(b) passing the irrigation fluid out of a fluid flow opening in the distal end portion of the therapy catheter;
(c) positioning the fluid flow opening of the therapy catheter in said branch of the vessel at a location near the occlusive device between the occlusive device and the treated occlusion, such that fluid flows across the treated occlusion; and
deactuating the occlusive device.
35. The method of
claim 34
, wherein the fluid flow across the treated occlusion flushes emboli in said branch away from the treated occlusion.
36. The method of
claim 35
, further comprising aspirating through an outer catheter, the outer catheter having a radial extent that permits the therapy catheter to pass through the outer catheter.
37. The method of
claim 34
, wherein the blood vessel is the carotid artery.
38. The method of
claim 34
, wherein said treating the occlusion comprises balloon angioplasty or deploying a stent.
39. The method of
claim 34
, wherein said treating the occlusion comprises breaking up the occlusion, such as atherectomy.
40. The method of
claim 34
, wherein said actuating the occlusive device comprises inflating an occlusion balloon.
41. The method of
claim 34
, wherein the elongate member is a tubular metallic guidewire.
42. A method for the treatment of an occlusion in a branch of bifurcated blood vessel having a common portion and two branches, such as the carotid artery, comprising:
providing an elongate member having an occlusive device at a distal end portion thereof;
delivering the elongate member through the common portion of the bifurcated vessel and into a branch of the bifurcated vessel, such as the internal carotid artery;
positioning the occlusive device in said branch distal of the occlusion;
positioning an outer catheter so that a portion of the outer catheter is in the common portion of the vessel;
sliding a therapy catheter within the outer catheter and on the elongate member;
actuating the occlusive device such that it occludes said branch of the vessel;
treating the occlusion with the therapy catheter;
using the occlusive device to occlude the branch of the vessel while:
(a) delivering irrigation fluid to a distal end portion of the outer catheter;
(b) passing the irrigation fluid out of a fluid flow opening in the distal end portion of the outer catheter;
(c) positioning the fluid flow opening of the outer catheter in said branch of the vessel at a location between the occlusive device and the treated occlusion, such that fluid flows across the treated occlusion; and
deactuating the occlusive device.
43. The method of
claim 42
, wherein the fluid flow across the treated occlusion flushes emboli in said branch away from the treated occlusion.
44. The method of
claim 43
, further comprising:
sliding an additional catheter on the elongate member, the additional catheter having a fluid flow opening;
positioning the fluid flow opening of the additional catheter between the occlusion and the occlusive device; and
aspirating through the fluid flow opening of the additional catheter.
45. The method of
claim 44
, wherein said aspirating is performed before said delivering irrigation fluid.
46. The method of
claim 43
, wherein the blood vessel is the carotid artery.
47. The method of
claim 42
, wherein said treating the occlusion comprises breaking up the occlusion, such as atherectomy.
48. The method of
claim 42
, wherein said treating the occlusion comprises balloon angioplasty.
49. The method of
claim 42
, wherein said actuating the occlusive device comprises inflating an occlusion balloon.
50. The method of
claim 42
, wherein the outer catheter is a main catheter.
51. The method of
claim 42
, wherein the elongate member comprises a tubular metallic guidewire.
52. A method for treatment of an occlusion in a branch of a bifurcated blood vessel having a common portion and two branches, comprising:
positioning an occlusive device distal of the occlusion to occlude said branch of the vessel;
treating the occlusion using a therapy device;
delivering irrigation fluid between the occlusion and the occlusive device such that irrigation fluid flows across the treated occlusion towards an intersection of said branch and the common portion, wherein emboli in said branch are carried to the intersection;
allowing anatomical blood flow in the common portion to carry the emboli through another of the branches.
53. The method of
claim 52
, additionally comprising using a catheter to aspirate at a location between the occlusion and the occlusive device to draw emboli away from the treated occlusion and into the catheter.
54. The method of
claim 52
, wherein aspiration is performed before irrigation.
55. The method of
claim 52
, wherein the blood vessel is the carotid artery.
56. The method of
claim 52
, wherein said treating the occlusion comprises balloon angioplasty.
57. The method of
claim 52
, wherein said treating the occlusion comprises breaking up the occlusion, such as atherectomy.
58. The method of
claim 52
, wherein said occluding of said branch comprises inflating an occlusion balloon.
59. A method for the treatment of an occlusion in a blood vessel, such as the carotid artery, comprising:
providing an inner catheter comprising an elongate member having an occlusive device at a distal end portion thereof;
delivering the elongate member through the vessel;
positioning the occlusive device distal of the occlusion;
sliding a therapy catheter on the elongate member;
actuating the occlusive device such that it occludes the vessel;
treating the occlusion with the therapy catheter;
using the occlusive device to occlude the vessel while:
(a) delivering irrigation fluid through the elongate member;
(b) passing the irrigation fluid out of a fluid flow opening in the occlusive device such that fluid flows across the treated occlusion; and
deactuating the occlusive device.
60. The method of
claim 59
, wherein emboli are flushed away from the treated occlusion.
61. The method of
claim 60
, wherein the occlusive device comprises a balloon and the fluid flow opening comprises at least one opening in the balloon.
62. The method of
claim 61
, wherein the at least one opening in the balloon comprises micropores in the balloon material.
63. The method of
claim 60
, wherein the blood vessel is the carotid artery.
64. The method of
claim 59
, wherein said treating the occlusion comprises balloon angioplasty.
65. The method of
claim 59
, wherein said treating the occlusion comprises breaking up the occlusion, such as atherectomy.
66. The method of
claim 59
, wherein said actuating the occlusive device comprises inflating an occlusion balloon of a compliant material.
67. The method of
claim 59
, wherein the elongate member is a tubular metallic guidewire.
68. A method of performing a medical procedure in a blood vessel using an expandable member which seals against walls of the blood vessel in response to application of an expansion force through a range of vessel diameters up to a maximum diameter beyond which sealing will not occur in the vessel, said method comprising:
positioning the expandable member in a selected blood vessel distal to an occlusion to be treated at a location where the vessel diameter is at least 20% less than said maximum diameter;
applying an expansion force to cause the expandable member to expand into sealing contact with walls of the selected vessel at said location; and
treating the occlusion while the expandable member is expanded, whereby the expandable member seals against walls of the selected vessel even if the diameter of the selected vessel at said location increases to said maximum diameter as a result of said treatment.
69. The method of
claim 68
, wherein said expandable member includes a balloon.
70. The method of
claim 69
, wherein the balloon expands axially as the expansion force is applied to store potential energy for expanding the balloon radially if the diameter of the selected vessel at said location increases.
71. The method of
claim 68
, in which the blood vessel is the internal carotid artery.
72. A method of treating an occlusion in a blood vessel, comprising:
positioning an expandable member distal to the occlusion to be treated;
performing therapy on the occlusion;
using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow from one side to another side of the expandable member in a proximal to distal direction;
positioning a fluid port of a catheter between the treated occlusion and the expandable member; and
applying suction to the fluid port to aspirate fluid into the catheter while the fluid port is positioned between the treated occlusion and the expandable member.
73. The method of
claim 72
, comprising injecting irrigation fluid distal to the treated occlusion to create a flow of fluid across the treated occlusion in a distal to proximal direction.
74. The method of
claim 73
, wherein the catheter comprises an aspiration catheter having an occlusive device near its distal end, said method comprising using the occlusive device to at least substantially block anatomical blood flow through the vessel during said aspiration.
75. The method of
claim 74
, wherein said injecting comprises advancing a distal opening in an outer catheter to a location adjacent a proximal side of the occlusive device and irrigating through the distal opening of the outer catheter while anatomical blood flow in the vessel is substantially blocked to cause fluid to flow across the treated occlusion in a distal to proximal direction.
76. The method of
claim 73
, wherein the catheter comprises an outer catheter having an occlusive device near its distal end, wherein said method comprises positioning the occlusive device at a location distal to the treated occlusion, wherein said aspiration is performed by aspirating through an opening in the outer catheter that is distal to said location, and wherein said injecting comprises irrigating through an opening in the outer catheter that is proximal to said location to cause a flow of fluid across the treated lesion in a distal to proximal direction.
77. The method of
claim 72
, wherein the treated occlusion is in a branch of a bifurcated vessel such as the carotid artery.
78. The method of
claim 77
, comprising injecting irrigation fluid into the branch at a location distal to the treated occlusion and creating a fluid flow across the treated occlusion and to a junction of the branch with a common portion of the bifurcated vessel, whereby the irrigation fluid from said branch is flushed down another branch by anatomical blood flow.
79. The method of
claim 72
, wherein the aspirated fluid contains emboli.
80. The method of
claim 72
, wherein the expandable member comprises a filter.
81. The method of
claim 72
, wherein blood flows through the expandable member.
82. The method of
claim 72
, wherein said providing fluid flow comprises providing fluid flow from said another side to said one side of the expandable member in a distal to proximal direction during the aspiration of said fluid.
83. The method of
claim 72
, comprising perfusing blood through a tube which carries blood from one side of the tube to the other.
84. A method of treating an occlusion in a blood vessel, comprising:
positioning an expandable member distal to the occlusion to be treated;
performing therapy on the occlusion;
using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow past the expandable member in a proximal to distal direction;
positioning a fluid port of a catheter between the treated occlusion and the expandable member;
delivering irrigation fluid through the fluid port; and
using the irrigation fluid to provide fluid flow across the treated occlusion in a distal to proximal direction.
85. The method of
claim 84
, wherein the expandable member comprises an occlusion balloon.
86. The method of
claim 85
, wherein the catheter comprises an outer catheter.
87. The method of
claim 86
, comprising perfusing blood through a tube which carries blood from one side of the balloon to the other.
88. The method of
claim 84
, wherein the treated occlusion is in a branch of a bifurcated vessel such as the carotid artery.
89. The method of
claim 88
, wherein said delivering comprises delivering irrigation fluid into the branch at a location distal to the treated occlusion and creating a fluid flow across the treated occlusion and to a junction of the branch with a common portion of the bifurcated vessel, whereby the irrigation fluid from said branch is flushed down another branch by anatomical blood flow.
90. A method of treating an occlusion in a blood vessel, comprising:
positioning an expandable member distal to the occlusion to be treated;
using a therapy balloon to perform therapy on the occlusion;
using the expandable member to block migration of emboli created as a result of the therapy, while allowing blood to flow from one side to another side of the expandable member in a proximal to distal direction;
using the therapy balloon to occlude the blood vessel at a location distal to the treated occlusion;
positioning a fluid port of a catheter between the treated occlusion and said location; and
providing fluid flow through the fluid port such that said fluid flows across the treated occlusion.
91. The method of
claim 90
, comprising injecting irrigation fluid through the fluid port to create a flow of fluid across the treated occlusion in a distal to proximal direction.
92. The method of
claim 90
, comprising aspirating through the fluid port to create a flow of fluid across the treated occlusion in a proximal to distal direction.
93. The method of
claim 90
, wherein the treated occlusion is in a branch of a bifurcated vessel such as the carotid artery.
94. The method of
claim 93
, comprising injecting irrigation fluid into the branch at a location distal to the treated occlusion and creating a fluid flow across the treated occlusion and to a junction of the branch with a common portion of the bifurcated vessel, whereby the irrigation fluid from said branch is flushed down another branch by anatomical blood flow.
US09/270,150 1996-05-20 1999-03-16 Method for containing and removing occlusions in the carotid arteries Abandoned US20010049517A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US09/270,150 US20010049517A1 (en) 1997-03-06 1999-03-16 Method for containing and removing occlusions in the carotid arteries
DE60039594T DE60039594D1 (en) 1999-03-16 2000-03-16 DEVICE FOR HOLDING AND REMOVING OCCULUSIONS FROM THE HEAD SHAFT
PCT/US2000/006906 WO2000054673A1 (en) 1999-03-16 2000-03-16 Apparatus for containing and removing occlusions in the carotid arteries
AU37512/00A AU3751200A (en) 1999-03-16 2000-03-16 Apparatus for containing and removing occlusions in the carotid arteries
EP00916404A EP1164944B1 (en) 1999-03-16 2000-03-16 Apparatus for containing and removing occlusions in the carotid arteries
US10/035,389 US6958059B2 (en) 1996-05-20 2001-12-28 Methods and apparatuses for drug delivery to an intravascular occlusion
US10/246,077 US6605074B2 (en) 1999-03-16 2002-09-16 Method for containing and removing occlusions in the carotid arteries
US10/419,912 US6790204B2 (en) 1999-03-16 2003-04-15 Method for containing and removing occlusions in the carotid arteries

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81381097A 1997-03-06 1997-03-06
US93381697A 1997-09-19 1997-09-19
US09/270,150 US20010049517A1 (en) 1997-03-06 1999-03-16 Method for containing and removing occlusions in the carotid arteries

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US93381697A Continuation-In-Part 1996-05-20 1997-09-19
US09/049,857 Continuation US6135991A (en) 1996-05-20 1998-03-27 Aspiration method

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US81213997A Continuation-In-Part 1996-05-20 1997-03-06
US09/314,054 Continuation-In-Part US20020016565A1 (en) 1996-05-20 1999-05-18 Catheter system for emboli containment
US10/246,077 Continuation US6605074B2 (en) 1999-03-16 2002-09-16 Method for containing and removing occlusions in the carotid arteries

Publications (1)

Publication Number Publication Date
US20010049517A1 true US20010049517A1 (en) 2001-12-06

Family

ID=23030123

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/270,150 Abandoned US20010049517A1 (en) 1996-05-20 1999-03-16 Method for containing and removing occlusions in the carotid arteries
US10/246,077 Expired - Fee Related US6605074B2 (en) 1999-03-16 2002-09-16 Method for containing and removing occlusions in the carotid arteries
US10/419,912 Expired - Fee Related US6790204B2 (en) 1999-03-16 2003-04-15 Method for containing and removing occlusions in the carotid arteries

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/246,077 Expired - Fee Related US6605074B2 (en) 1999-03-16 2002-09-16 Method for containing and removing occlusions in the carotid arteries
US10/419,912 Expired - Fee Related US6790204B2 (en) 1999-03-16 2003-04-15 Method for containing and removing occlusions in the carotid arteries

Country Status (5)

Country Link
US (3) US20010049517A1 (en)
EP (1) EP1164944B1 (en)
AU (1) AU3751200A (en)
DE (1) DE60039594D1 (en)
WO (1) WO2000054673A1 (en)

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620148B1 (en) * 1999-08-04 2003-09-16 Scimed Life Systems, Inc. Filter flush system and methods of use
US20030199802A1 (en) * 1999-01-15 2003-10-23 Denise Barbut Methods for flow augmentation in patients with occlusive cerebrovascular disease
US20050020973A1 (en) * 2001-07-17 2005-01-27 Macmahon John M. Fluid exchange system for controlled and localized irrigation and aspiration
WO2005051206A1 (en) * 2003-11-21 2005-06-09 Vnus Medical Technologies, Inc. Method and apparatus for treating a carotid artery
WO2006055967A2 (en) * 2004-11-19 2006-05-26 Lumen Biomedical, Inc. Extendable device on an aspiration catheter
US20060129223A1 (en) * 2004-07-27 2006-06-15 University Of Southern California Percutaneously retrievable stent assembly with fluid draining capability
US20060200168A1 (en) * 2005-03-03 2006-09-07 Azam Anwar System and method for providing access in divergent directions in a vascular environment
US7166120B2 (en) 2002-07-12 2007-01-23 Ev3 Inc. Catheter with occluding cuff
US20070088379A1 (en) * 2005-10-17 2007-04-19 Jacob Schneiderman Minimally invasive a AAPT extirpation
US7232452B2 (en) 2002-07-12 2007-06-19 Ev3 Inc. Device to create proximal stasis
US20070142819A1 (en) * 2005-12-20 2007-06-21 El-Nounou Fozan O Bifurcated catheter for agent delivery and method of agent delivery
US20080017202A1 (en) * 2006-07-24 2008-01-24 Advanced Cardiovascular Systems, Inc. Methods for inhibiting reperfusion injury
US20080172084A1 (en) * 2007-01-11 2008-07-17 Ev3 Inc. Convertible embolic protection devices and methods of use
US20090222035A1 (en) * 2006-03-27 2009-09-03 Tel Hashomer Medical Research Infrastructure And S Intraluminal Mass Collector
US20100082012A1 (en) * 2008-09-22 2010-04-01 Foxhollow Technologies, Inc. Double balloon catheter and methods for homogeneous drug delivery using the same
US7731683B2 (en) 1999-12-22 2010-06-08 Boston Scientific Scimed, Inc. Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use
US20100145356A1 (en) * 2006-02-08 2010-06-10 Vance Products, Inc., D/B/A Cook Urological Inc. Irrigating Catch and Removal Device
US20110112564A1 (en) * 2008-05-21 2011-05-12 Wolf Yehuda G Device And Method For Crossing Occlusions
US8157760B2 (en) 2007-07-18 2012-04-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US20120143099A1 (en) * 2009-06-01 2012-06-07 Mayo Foundation For Medical Education And Research Systems and methods for impairing smooth muscle tissue function
US8252016B2 (en) 2005-01-13 2012-08-28 Azam Anwar System and method for providing embolic protection
US8545432B2 (en) 2009-06-03 2013-10-01 Silk Road Medical, Inc. System and methods for controlling retrograde carotid arterial blood flow
US20140288587A1 (en) * 2012-01-12 2014-09-25 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9126018B1 (en) 2014-09-04 2015-09-08 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9669191B2 (en) 2008-02-05 2017-06-06 Silk Road Medical, Inc. Interventional catheter system and methods
US10226563B2 (en) 2008-12-23 2019-03-12 Silk Road Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10327790B2 (en) 2011-08-05 2019-06-25 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10471241B2 (en) 2013-08-26 2019-11-12 Merit Medical Systems, Inc. Sheathless guide, rapid exchange dilator and associated methods
CN111000616A (en) * 2018-10-04 2020-04-14 尼尔拉维有限公司 Reverse blood flow blocking flushing device
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11027104B2 (en) 2014-09-04 2021-06-08 Silk Road Medical, Inc. Methods and devices for transcarotid access
US20210170148A1 (en) * 2019-09-25 2021-06-10 Thrombolex, Inc Balloon Basket Catheter Device
US11129702B2 (en) 2018-05-09 2021-09-28 Boston Scientific Scimed, Inc. Pedal access embolic filtering sheath
US11160957B2 (en) * 2012-07-17 2021-11-02 Michael Zhadkevich Carotid artery occluding apparatus with first, second and third occluding balloons
US11229770B2 (en) 2018-05-17 2022-01-25 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US11311365B2 (en) 2012-07-06 2022-04-26 Michael Zhadkevich Catheter for prevention of stroke and method of use
US11433226B2 (en) 2015-04-10 2022-09-06 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US11471182B2 (en) * 2011-06-08 2022-10-18 Cvdevices, Llc Thrombectomy systems and devices and methods of using the same
US11534187B2 (en) * 2004-09-20 2022-12-27 P Tech, Llc Acoustic therapy device
WO2023280315A1 (en) * 2021-07-08 2023-01-12 张桂运 Endovascular plaque excision system and excision method
US11633571B2 (en) 2015-02-04 2023-04-25 Route 92 Medical, Inc. Rapid aspiration thrombectomy system and method
US11793529B2 (en) 2015-02-04 2023-10-24 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US11918226B2 (en) 2021-05-05 2024-03-05 Silk Road Medical, Inc. Method and apparatus for treating an arterial lesion

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958059B2 (en) 1996-05-20 2005-10-25 Medtronic Ave, Inc. Methods and apparatuses for drug delivery to an intravascular occlusion
US20050245894A1 (en) * 1996-05-20 2005-11-03 Medtronic Vascular, Inc. Methods and apparatuses for drug delivery to an intravascular occlusion
US6666874B2 (en) 1998-04-10 2003-12-23 Endicor Medical, Inc. Rotational atherectomy system with serrated cutting tip
US6482217B1 (en) 1998-04-10 2002-11-19 Endicor Medical, Inc. Neuro thrombectomy catheter
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
US6800075B2 (en) * 1999-12-10 2004-10-05 Sprite Solutions Method to inject and extract fluid at a treatment site to remove debris
US7494484B2 (en) * 1999-12-10 2009-02-24 Beck Robert C Method of removing particulate debris with an interventional device
US6443926B1 (en) 2000-02-01 2002-09-03 Harold D. Kletschka Embolic protection device having expandable trap
US7322957B2 (en) 2000-02-01 2008-01-29 Harold D. Kletschka Angioplasty device and method of making same
US8435225B2 (en) * 2000-06-02 2013-05-07 Fox Hollow Technologies, Inc. Embolization protection system for vascular procedures
AU2002231074A1 (en) 2000-12-20 2002-07-01 Fox Hollow Technologies, Inc. Debulking catheter
US6514214B2 (en) 2001-02-13 2003-02-04 Scimed Life Systems, Inc. Intravascular temperature sensor
US6706055B2 (en) * 2001-04-03 2004-03-16 Medtronic Ave Inc. Guidewire apparatus for temporary distal embolic protection
US6866677B2 (en) * 2001-04-03 2005-03-15 Medtronic Ave, Inc. Temporary intraluminal filter guidewire and methods of use
EP1420844A2 (en) * 2001-04-16 2004-05-26 Medtronic Percusurge, Inc. Aspiration catheters and method of use
US7604612B2 (en) * 2001-05-01 2009-10-20 St. Jude Medical, Cardiology Division, Inc. Emboli protection devices and related methods of use
US7422579B2 (en) * 2001-05-01 2008-09-09 St. Jude Medical Cardiology Divison, Inc. Emboli protection devices and related methods of use
US7374560B2 (en) * 2001-05-01 2008-05-20 St. Jude Medical, Cardiology Division, Inc. Emboli protection devices and related methods of use
US6929652B1 (en) * 2001-06-01 2005-08-16 Advanced Cardiovascular Systems, Inc. Delivery and recovery systems having steerability and rapid exchange operating modes for embolic protection systems
US6951570B2 (en) * 2001-07-02 2005-10-04 Rubicon Medical, Inc. Methods, systems, and devices for deploying a filter from a filter device
US6855136B2 (en) * 2002-04-03 2005-02-15 Gore Enterprise Holdings, Inc. Infusion catheter having an atraumatic tip
US7503904B2 (en) * 2002-04-25 2009-03-17 Cardiac Pacemakers, Inc. Dual balloon telescoping guiding catheter
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US9301829B2 (en) * 2003-07-30 2016-04-05 Boston Scientific Scimed, Inc. Embolic protection aspirator
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
EP1557128B1 (en) * 2004-01-23 2007-03-07 Cathenet Corporation Atherectomy head and atherectomy catheter using the same
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
US7686825B2 (en) 2004-03-25 2010-03-30 Hauser David L Vascular filter device
TW200624130A (en) * 2004-12-07 2006-07-16 Nipro Corp A thrombus suction catheter with excellent crossability
WO2006089243A2 (en) * 2005-02-16 2006-08-24 University Of Virginia Patent Foundation Blood flow bypass catheters and methods for the delivery of medium to the vasculature and body ducts
US7645290B2 (en) * 2005-05-05 2010-01-12 Lucas Paul R Multi-functional thrombectomy device
US8221348B2 (en) * 2005-07-07 2012-07-17 St. Jude Medical, Cardiology Division, Inc. Embolic protection device and methods of use
US8641729B2 (en) * 2005-07-13 2014-02-04 Creighton University Systems and techniques for minimally invasive gastrointestinal procedures
US8906040B2 (en) * 2005-07-13 2014-12-09 Creighton University Systems and techniques for minimally invasive gastrointestinal procedures
US8444598B2 (en) * 2005-08-29 2013-05-21 Medtronic Vascular, Inc. Intravascular therapeutic agent delivery
US20070106245A1 (en) * 2005-11-08 2007-05-10 Kerberos Proximal Solutions, Inc. Infusion guidewire
US7740609B2 (en) * 2006-03-03 2010-06-22 Boston Scientific Scimed, Inc. Balloon catheter
US20070244500A1 (en) * 2006-03-27 2007-10-18 422 Medical Laboratories Percutaneous introducer and associated balloon catheter
US20070250149A1 (en) * 2006-04-21 2007-10-25 Abbott Laboratories Stiffening Support Catheters and Methods for Using the Same
US8246574B2 (en) * 2006-04-21 2012-08-21 Abbott Laboratories Support catheter
US8206370B2 (en) * 2006-04-21 2012-06-26 Abbott Laboratories Dual lumen guidewire support catheter
US7993303B2 (en) * 2006-04-21 2011-08-09 Abbott Laboratories Stiffening support catheter and methods for using the same
US20080065014A1 (en) * 2006-04-21 2008-03-13 Abbott Laboratories Systems, Methods, and Devices to Facilitate Wire and Device Crossings of Obstructions in Body Lumens
US7927305B2 (en) * 2006-04-21 2011-04-19 Abbott Laboratories Systems, methods, and devices for injecting media contrast
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
WO2008035349A1 (en) * 2006-09-21 2008-03-27 Avraham Zakai Device and method for crossing a vascular occlusion
US7686783B2 (en) * 2007-03-30 2010-03-30 Boston Scientific Scimed, Inc. Perfusion and embolic protection
US7780630B2 (en) * 2007-03-30 2010-08-24 Boston Scientific Scimed, Inc. Perfusion device
US20080243170A1 (en) * 2007-03-30 2008-10-02 Boston Scientific Scimed, Inc. Embolic capturing devices and methods
US7850078B2 (en) * 2007-04-23 2010-12-14 Lear Corporation Remote control reactivation
US20090198172A1 (en) * 2008-02-05 2009-08-06 Garrison Michi E Interventional sheath with retention features
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US20100023034A1 (en) * 2008-06-19 2010-01-28 Coherex Medical, Inc. Clot retrieval method and device
WO2010019481A1 (en) 2008-08-11 2010-02-18 Conceptx Medical, Inc. Systems and methods for treating dyspnea, including via electrical afferent signal blocking
EP3275383A1 (en) 2008-10-13 2018-01-31 Covidien LP Devices and methods for manipulating a catheter shaft
US8622992B2 (en) * 2009-02-08 2014-01-07 Blaise Baxter Devices and methods for perfusion therapy
US9526863B2 (en) * 2009-02-08 2016-12-27 Neuronal Protection System, Llc Devices and methods for perfusion therapy
EP2395929A4 (en) * 2009-02-11 2014-02-26 Mark Mallaby Neurovascular microcatheter device, system and methods for use thereof
GB2469073A (en) 2009-03-31 2010-10-06 Barking Havering And Redbridge Balloon Assisted Occlusion of Aneurysms
KR101323553B1 (en) 2009-04-29 2013-10-29 코비디엔 엘피 Methods and devices for cutting and abrading tissue
EP2429423B1 (en) 2009-05-14 2015-11-11 Covidien LP Easily cleaned atherectomy catheters
US20110106135A1 (en) * 2009-10-29 2011-05-05 Medtronic Vascular, Inc. Indwelling Temporary IVC Filter System With Drug Delivery and Aspiration
WO2011056981A2 (en) 2009-11-04 2011-05-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
CA2781046C (en) 2009-12-02 2014-09-16 Tyco Healthcare Group Lp Methods and devices for cutting tissue
CA2783301C (en) 2009-12-11 2015-02-24 Tyco Healthcare Group Lp Material removal device having improved material capture efficiency and methods of use
CN102946815B (en) 2010-06-14 2015-07-15 科维蒂恩有限合伙公司 Material removal device
WO2012047308A1 (en) 2010-10-08 2012-04-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
KR101518147B1 (en) 2010-10-28 2015-05-06 코비디엔 엘피 Material removal device and method of use
CA2817213C (en) 2010-11-11 2016-06-14 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
EP2658605B1 (en) * 2010-12-28 2016-07-27 Cibiem, Inc. Endovascular carotid body ablation catheter for sympathetic rebalancing of patient
US8948848B2 (en) 2011-01-07 2015-02-03 Innovative Cardiovascular Solutions, Llc Angiography catheter
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
DE112013002175T5 (en) * 2012-04-24 2015-01-22 Cibiem, Inc. Endovascular catheters and procedures for ablation of the carotid body
US9402677B2 (en) 2012-06-01 2016-08-02 Cibiem, Inc. Methods and devices for cryogenic carotid body ablation
US9955946B2 (en) 2014-03-12 2018-05-01 Cibiem, Inc. Carotid body ablation with a transvenous ultrasound imaging and ablation catheter
US10342699B2 (en) 2012-08-03 2019-07-09 J.D. Franco & Co., Llc Systems and methods for treating eye diseases
CA2881016A1 (en) * 2012-08-03 2014-02-06 J.D. Franco & Company Devices and methods for treating occlusion of the ophthalmic artery
WO2017156333A1 (en) 2016-03-09 2017-09-14 J.D. Franco & Co. Systems and methods for treating eye diseases using retrograde blood flow
CN102871702B (en) * 2012-09-07 2014-12-10 中国人民解放军第三军医大学第三附属医院 Embolectomy and thrombolysis device for visceral arterial embolism
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
PT2897536T (en) 2012-09-24 2020-11-12 Inari Medical Inc Device and method for treating vascular occlusion
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
US9597110B2 (en) 2012-11-08 2017-03-21 Covidien Lp Tissue-removing catheter including operational control mechanism
US8784434B2 (en) 2012-11-20 2014-07-22 Inceptus Medical, Inc. Methods and apparatus for treating embolism
US20140214002A1 (en) * 2013-01-27 2014-07-31 Thermopeutix, Inc. Bifurcation catheter with variable length occlusion elements
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
EP3620203A1 (en) 2013-03-15 2020-03-11 Insera Therapeutics, Inc. Vascular treatment devices
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
US20140378873A1 (en) * 2013-06-24 2014-12-25 Ary S. Chernomorsky Methods, devices and systems for increasing the effectiveness of ultrasound and other tissue treatment modalities
US10238406B2 (en) 2013-10-21 2019-03-26 Inari Medical, Inc. Methods and apparatus for treating embolism
US9456843B2 (en) 2014-02-03 2016-10-04 Covidien Lp Tissue-removing catheter including angular displacement sensor
US9526519B2 (en) 2014-02-03 2016-12-27 Covidien Lp Tissue-removing catheter with improved angular tissue-removing positioning within body lumen
WO2015191646A1 (en) * 2014-06-09 2015-12-17 Inceptus Medical, Llc Retraction and aspiration device for treating embolism and associated systems and methods
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
EP3240507A4 (en) 2014-12-29 2018-12-05 Ocudyne LLC Apparatus and method for treating eye diseases
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
US9700332B2 (en) 2015-10-23 2017-07-11 Inari Medical, Inc. Intravascular treatment of vascular occlusion and associated devices, systems, and methods
US10342571B2 (en) 2015-10-23 2019-07-09 Inari Medical, Inc. Intravascular treatment of vascular occlusion and associated devices, systems, and methods
EP3389757A4 (en) 2015-12-18 2019-08-21 Inari Medical, Inc. Catheter shaft and associated devices, systems, and methods
CN108697423A (en) 2016-02-16 2018-10-23 伊瑟拉医疗公司 The part flow arrangement of suction unit and anchoring
US11877752B2 (en) * 2016-09-07 2024-01-23 Daniel Ezra Walzman Filterless aspiration, irrigating, macerating, rotating microcatheter and method of use
US11439492B2 (en) 2016-09-07 2022-09-13 Daniel Ezra Walzman Lasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
US10299824B2 (en) * 2016-09-07 2019-05-28 Daniel Ezra Walzman Rotating separator, irrigator microcatheter for thrombectomy
US11259820B2 (en) 2016-09-07 2022-03-01 Daniel Ezra Walzman Methods and devices to ameliorate vascular obstruction
US10314684B2 (en) * 2016-09-07 2019-06-11 Daniel Ezra Walzman Simultaneous rotating separator, irrigator microcatheter for thrombectomy
WO2018057854A1 (en) 2016-09-24 2018-03-29 J.D. Franco & Company Systems and methods for single puncture percutaneous reverse blood flow
AU2017370691A1 (en) 2016-12-08 2019-07-04 J.D. Franco & Co., Llc Methods and devices for treating an eye using a filter
US10098651B2 (en) 2017-01-10 2018-10-16 Inari Medical, Inc. Devices and methods for treating vascular occlusion
US11529130B2 (en) 2017-01-25 2022-12-20 J.D. Franco & Co., Llc Blood vessel access and closure devices and related methods of use
US10898212B2 (en) 2017-05-07 2021-01-26 J.D. Franco & Co., Llc Devices and methods for treating an artery
US11207131B2 (en) 2017-07-17 2021-12-28 Medtronic, Inc. Reverse irrigation for embolic mitigation
WO2019050765A1 (en) 2017-09-06 2019-03-14 Inari Medical, Inc. Hemostasis valves and methods of use
US10779929B2 (en) 2017-10-06 2020-09-22 J.D. Franco & Co., Llc Treating eye diseases by deploying a stent
CA3195810A1 (en) 2017-10-16 2022-04-21 Michael Bruce Horowitz Clot removal methods and devices with multiple independently controllable elements
US20220104839A1 (en) 2017-10-16 2022-04-07 Retriever Medical, Inc. Clot Removal Methods and Devices with Multiple Independently Controllable Elements
US20190110804A1 (en) 2017-10-16 2019-04-18 Michael Bruce Horowitz Catheter based retrieval device with proximal body having axial freedom of movement
US10398880B2 (en) 2017-11-02 2019-09-03 J.D. Franco & Co., Llc Medical systems, devices, and related methods
US10588656B2 (en) 2017-11-10 2020-03-17 Penumbra, Inc. Thrombectomy catheter
US10758254B2 (en) 2017-12-15 2020-09-01 J.D. Franco & Co., Llc Medical systems, devices, and related methods
US11154314B2 (en) 2018-01-26 2021-10-26 Inari Medical, Inc. Single insertion delivery system for treating embolism and associated systems and methods
US11478249B2 (en) 2018-02-23 2022-10-25 J.D. Franco & Co., Llc Ophthalmic artery therapy under reverse flow
CA3092870A1 (en) 2018-03-07 2019-09-12 Innovative Cardiovascular Solutions, Llc Embolic protection device
US20210315604A1 (en) * 2018-07-11 2021-10-14 Boards Of Regents Of The University Of Texas System Systems and methods for providing distal embolic protection
US10531883B1 (en) 2018-07-20 2020-01-14 Syntheon 2.0, LLC Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter
CN109173015A (en) * 2018-08-01 2019-01-11 中国医学科学院北京协和医院 Big cavities conduit pipe and its system
EP3836855A4 (en) 2018-08-13 2022-08-10 Inari Medical, Inc. System for treating embolism and associated devices and methods
US10792478B2 (en) 2018-12-31 2020-10-06 J.D. Franco & Co., Llc Intravascular devices, systems, and methods to address eye disorders
AU2020368528A1 (en) 2019-10-16 2022-04-21 Inari Medical, Inc. Systems, devices, and methods for treating vascular occlusions
RU2740242C1 (en) * 2020-06-29 2021-01-12 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Method for prediction of patient's cognitive functions after internal carotid artery stenting
US11471183B1 (en) 2021-02-18 2022-10-18 Boston Scientific Scimed, Inc. Thrombectomy methods
US20220257269A1 (en) 2021-02-18 2022-08-18 Boston Scientific Scimed, Inc. Thrombectomy apparatuses and methods

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3144868A (en) 1960-10-21 1964-08-18 Mario E Jascalevich Drainage and feeding cannulae
US4276874A (en) 1978-11-15 1981-07-07 Datascope Corp. Elongatable balloon catheter
US4511354A (en) 1980-05-07 1985-04-16 Medical Research Associates, Ltd. Hydrocarbon block copolymer with dispersed polysiloxane
US4456011A (en) 1980-12-22 1984-06-26 Irene Warnecke Balloon-catheter
DE3235974A1 (en) 1981-11-24 1983-06-01 Volkmar Dipl.-Ing. Merkel (FH), 8520 Erlangen DEVICE FOR REMOVAL OR FOR THE EXPANSION OF CONSTRAINTS IN BODY LIQUID LEADING VESSELS
US4636195A (en) 1982-04-02 1987-01-13 Harvey Wolinsky Method and apparatus for removing arterial constriction
US4445892A (en) 1982-05-06 1984-05-01 Laserscope, Inc. Dual balloon catheter device
US4468216A (en) 1982-05-20 1984-08-28 Rudolph Muto Irrigation suction catheter
US4714460A (en) 1983-07-29 1987-12-22 Reynaldo Calderon Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency
CA1237482A (en) 1984-03-09 1988-05-31 Frank B. Stiles Catheter for effecting removal of obstructions from a biological duct
US4705507A (en) 1984-05-02 1987-11-10 Boyles Paul W Arterial catheter means
US4926858A (en) 1984-05-30 1990-05-22 Devices For Vascular Intervention, Inc. Atherectomy device for severe occlusions
US4790813A (en) 1984-12-17 1988-12-13 Intravascular Surgical Instruments, Inc. Method and apparatus for surgically removing remote deposits
US4824436A (en) 1985-04-09 1989-04-25 Harvey Wolinsky Method for the prevention of restenosis
US4781677A (en) 1985-07-17 1988-11-01 Wilcox Gilbert M Method of treatment utilizing a double balloon nasobiliary occlusion catheter
US4696668A (en) 1985-07-17 1987-09-29 Wilcox Gilbert M Double balloon nasobiliary occlusion catheter for treating gallstones and method of using the same
US5449343A (en) 1985-07-30 1995-09-12 Advanced Cardiovascular Systems, Inc. Steerable dilatation catheter
US4790812A (en) 1985-11-15 1988-12-13 Hawkins Jr Irvin F Apparatus and method for removing a target object from a body passsageway
US4655746A (en) 1985-12-02 1987-04-07 Target Therapeutics Catheter device
US4867742A (en) 1986-06-06 1989-09-19 Reynaldo Calderon Retrograde perfusion
IT8629545V0 (en) 1986-06-12 1986-06-12 Fina Ernesto SET BALLOON URETERAL CATHETER BALLOON FOR EXTRACTION OF URETERAL STONES
US4748982A (en) 1987-01-06 1988-06-07 Advanced Cardiovascular Systems, Inc. Reinforced balloon dilatation catheter with slitted exchange sleeve and method
DE3804849A1 (en) 1987-02-19 1988-09-01 Cramer Bernhard M Priv Doz Dr Device for removing blood clots from vessels
US4832028A (en) 1987-02-27 1989-05-23 Patel Piyush V Catheter assembly and method of performing percutaneous transluminal coronary angioplasty
US5000743A (en) 1987-02-27 1991-03-19 Patel Piyush V Catheter assembly and method of performing percutaneous transluminal coronary angioplasty
EP0369012A4 (en) 1987-07-23 1990-12-27 Terumo Kabushiki Kaisha Catheter tube
US4964409A (en) 1989-05-11 1990-10-23 Advanced Cardiovascular Systems, Inc. Flexible hollow guiding member with means for fluid communication therethrough
US4921478A (en) 1988-02-23 1990-05-01 C. R. Bard, Inc. Cerebral balloon angioplasty system
US4838268A (en) 1988-03-07 1989-06-13 Scimed Life Systems, Inc. Non-over-the wire balloon catheter
US4998917A (en) 1988-05-26 1991-03-12 Advanced Cardiovascular Systems, Inc. High torque steerable dilatation catheter
US4950238A (en) 1988-07-07 1990-08-21 Clarence E. Sikes Hydro-rotary vascular catheter
JPH0255064A (en) 1988-08-03 1990-02-23 Toa O Skin removal for throm bus in blood vessel using catheter and throm bus removing system in blood vessel using catheter
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
CH676426A5 (en) * 1988-09-27 1991-01-31 Schneider Shiley Ag
US5035686A (en) 1989-01-27 1991-07-30 C. R. Bard, Inc. Catheter exchange system with detachable luer fitting
US4946466A (en) 1989-03-03 1990-08-07 Cordis Corporation Transluminal angioplasty apparatus
DE8910856U1 (en) 1989-09-12 1989-11-30 Schneider (Europe) Ag, Zuerich, Ch
US5195955A (en) 1989-11-14 1993-03-23 Don Michael T Anthony Device for removal of embolic debris
US5439446A (en) 1994-06-30 1995-08-08 Boston Scientific Corporation Stent and therapeutic delivery system
US5460610A (en) 1990-01-12 1995-10-24 Don Michael; T. Anthony Treatment of obstructions in body passages
US5135484A (en) 1990-05-09 1992-08-04 Pioneering Technologies, Inc. Method of removing plaque from vessels
US5395311A (en) 1990-05-14 1995-03-07 Andrews; Winston A. Atherectomy catheter
US5279546A (en) 1990-06-27 1994-01-18 Lake Region Manufacturing Company, Inc. Thrombolysis catheter system
IT9084979A1 (en) 1990-07-30 1992-01-31 Imad Sheiban PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTIC CATHETER WITH TWO BALLOONS AT ITS DISTAL END ONE OF SMALL DIAMETER (1, 5MM. FOLLOWED BY ANOTHER BALLOON OF GREATER DIAMETER VARIABLE FROM 2, 5 TO 4 MM THE BALLOON THE SMALL BALLOON
CA2104121C (en) 1991-04-24 1998-12-22 Blair D. Walker Exchangeable integrated-wire balloon catheter
US5167239A (en) 1991-05-30 1992-12-01 Endomedix Corporation Anchorable guidewire
US5221270A (en) 1991-06-28 1993-06-22 Cook Incorporated Soft tip guiding catheter
US5645533A (en) 1991-07-05 1997-07-08 Scimed Life Systems, Inc. Apparatus and method for performing an intravascular procedure and exchanging an intravascular device
US5458574A (en) 1994-03-16 1995-10-17 Heartport, Inc. System for performing a cardiac procedure
US5413558A (en) 1991-09-09 1995-05-09 New York University Selective aortic perfusion system for use during CPR
US5505702A (en) 1992-04-09 1996-04-09 Scimed Life Systems, Inc. Balloon catheter for dilatation and perfusion
US5458573A (en) 1992-05-01 1995-10-17 American Biomed, Inc. Everting toposcopic dilation catheter
US5250060A (en) 1992-06-26 1993-10-05 Carbo Paul L Angioplasty apparatus
US5415635A (en) 1992-07-21 1995-05-16 Advanced Cardiovascular Systems, Inc. Balloon assembly with separately inflatable sections
US5500180A (en) 1992-09-30 1996-03-19 C. R. Bard, Inc. Method of making a distensible dilatation balloon using a block copolymer
EP0669820B1 (en) 1992-11-18 1997-04-16 Spectrascience, Inc. Apparatus for diagnostic imaging
US5281200A (en) 1992-12-08 1994-01-25 Cordis Corporation Multiple component balloon catheter system and stenosis treatment procedure
US5256141A (en) 1992-12-22 1993-10-26 Nelson Gencheff Biological material deployment method and apparatus
US5320605A (en) 1993-01-22 1994-06-14 Harvinder Sahota Multi-wire multi-balloon catheter
US5403274A (en) 1993-03-15 1995-04-04 Cannon; Louis A. Perfusion catheter and method of use
US5322508A (en) 1993-04-08 1994-06-21 Cordis Corporation Guidewire fluid delivery system and method of use
US5342306A (en) 1993-05-26 1994-08-30 Don Michael T Anthony Adjustable catheter device
US5464394A (en) 1993-06-08 1995-11-07 American Biomed, Inc. Multilumen percutaneous angioscopy catheter
DE69432148T2 (en) * 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
US5599307A (en) 1993-07-26 1997-02-04 Loyola University Of Chicago Catheter and method for the prevention and/or treatment of stenotic processes of vessels and cavities
US5405322A (en) 1993-08-12 1995-04-11 Boston Scientific Corporation Method for treating aneurysms with a thermal source
US5380284A (en) 1993-08-13 1995-01-10 Don Michael; T. Anthony Obstruction dissolution catheter with variably expanding blocking balloons and method of use
US5462529A (en) 1993-09-29 1995-10-31 Technology Development Center Adjustable treatment chamber catheter
US5634897A (en) 1993-10-08 1997-06-03 Lake Region Manufacturing, Inc. Rheolytic occlusion removal catheter system and method
US5476450A (en) 1993-11-04 1995-12-19 Ruggio; Joseph M. Apparatus and method for aspirating intravascular, pulmonary and cardiac obstructions
US5397307A (en) 1993-12-07 1995-03-14 Schneider (Usa) Inc. Drug delivery PTCA catheter and method for drug delivery
US5415636A (en) 1994-04-13 1995-05-16 Schneider (Usa) Inc Dilation-drug delivery catheter
US5484412A (en) 1994-04-19 1996-01-16 Pierpont; Brien E. Angioplasty method and means for performing angioplasty
US5478309A (en) 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5505700A (en) 1994-06-14 1996-04-09 Cordis Corporation Electro-osmotic infusion catheter
EP0954244A1 (en) 1994-07-01 1999-11-10 SciMed Life Systems, Inc. Intravascular device utilizing fluid to extract occlusive material
US5514092A (en) 1994-08-08 1996-05-07 Schneider (Usa) Inc. Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration
DE69527644T2 (en) 1994-11-23 2003-04-03 Micro Interventional Systems I BALLOON CATHETER WITH HIGH TORQUE
US5833650A (en) 1995-06-05 1998-11-10 Percusurge, Inc. Catheter apparatus and method for treating occluded vessels
US5674198A (en) 1995-06-23 1997-10-07 Cordis Corporation Tandem balloon catheter
US5681336A (en) 1995-09-07 1997-10-28 Boston Scientific Corporation Therapeutic device for treating vien graft lesions
US5688234A (en) 1996-01-26 1997-11-18 Cardiometrics Inc. Apparatus and method for the treatment of thrombotic occlusions in vessels
US5823996A (en) 1996-02-29 1998-10-20 Cordis Corporation Infusion balloon catheter
US6022336A (en) 1996-05-20 2000-02-08 Percusurge, Inc. Catheter system for emboli containment
US6270477B1 (en) 1996-05-20 2001-08-07 Percusurge, Inc. Catheter for emboli containment
US5833644A (en) 1996-05-20 1998-11-10 Percusurge, Inc. Method for emboli containment
US5779721A (en) 1996-07-26 1998-07-14 Kensey Nash Corporation System and method of use for revascularizing stenotic bypass grafts and other blood vessels
US6162362A (en) 1996-10-08 2000-12-19 Phenomenex, Inc. Direct screw-on cartridge holder with self-adjustable connection
US5807330A (en) 1996-12-16 1998-09-15 University Of Southern California Angioplasty catheter
US6295989B1 (en) 1997-02-06 2001-10-02 Arteria Medical Science, Inc. ICA angioplasty with cerebral protection
AU6450198A (en) * 1997-03-06 1998-09-22 Percusurge, Inc. Catheter system for containing and removing vascular occlusions
CA2322876A1 (en) 1997-03-06 1998-09-11 Percusurge, Inc. Intravascular aspiration system
US5954745A (en) 1997-05-16 1999-09-21 Gertler; Jonathan Catheter-filter set having a compliant seal
US5941896A (en) 1997-09-08 1999-08-24 Montefiore Hospital And Medical Center Filter and method for trapping emboli during endovascular procedures

Cited By (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030199802A1 (en) * 1999-01-15 2003-10-23 Denise Barbut Methods for flow augmentation in patients with occlusive cerebrovascular disease
US6878140B2 (en) * 1999-01-15 2005-04-12 Coaxia, Inc. Methods for flow augmentation in patients with occlusive cerebrovascular disease
US6620148B1 (en) * 1999-08-04 2003-09-16 Scimed Life Systems, Inc. Filter flush system and methods of use
US8444665B2 (en) 1999-08-04 2013-05-21 Boston Scientific Scimed, Inc. Filter flush system and methods of use
US8152782B2 (en) 1999-12-22 2012-04-10 Boston Scientific Scimed, Inc. Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use
US7731683B2 (en) 1999-12-22 2010-06-08 Boston Scientific Scimed, Inc. Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use
US20100222736A1 (en) * 1999-12-22 2010-09-02 Boston Scientific Scimed, Inc. Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use
US20050020973A1 (en) * 2001-07-17 2005-01-27 Macmahon John M. Fluid exchange system for controlled and localized irrigation and aspiration
US7530976B2 (en) * 2001-07-17 2009-05-12 Fox Hollow Technologies, Inc. Fluid exchange system for controlled and localized irrigation and aspiration
US8562555B2 (en) 2001-07-17 2013-10-22 John M. MacMahon Fluid exchange system for controlled and localized irrigation and aspiration
US8721674B2 (en) * 2002-07-12 2014-05-13 Covidien Lp Catheter with occluding cuff
US7232452B2 (en) 2002-07-12 2007-06-19 Ev3 Inc. Device to create proximal stasis
US10136906B2 (en) 2002-07-12 2018-11-27 Covidien Lp Catheter with occluding cuff
US20110130784A1 (en) * 2002-07-12 2011-06-02 Ev3 Inc. Catheter with occluding cuff
US7887560B2 (en) * 2002-07-12 2011-02-15 Ev3 Inc. Catheter with occluding cuff
US20070038178A1 (en) * 2002-07-12 2007-02-15 Ev3 Inc. Catheter with occluding cuff
US7166120B2 (en) 2002-07-12 2007-01-23 Ev3 Inc. Catheter with occluding cuff
US20100191169A1 (en) * 2003-11-21 2010-07-29 Chang David W Method and apparatus for treating a carotid artery
US10722239B2 (en) 2003-11-21 2020-07-28 Silk Road Medical, Inc. Method and apparatus for treating an arterial lesion
US20150025616A1 (en) * 2003-11-21 2015-01-22 Silk Road Medical, Inc. Method And Apparatus For Treating A Carotid Artery
WO2005051206A1 (en) * 2003-11-21 2005-06-09 Vnus Medical Technologies, Inc. Method and apparatus for treating a carotid artery
US9526504B2 (en) 2003-11-21 2016-12-27 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US8870805B2 (en) 2003-11-21 2014-10-28 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US20100191170A1 (en) * 2003-11-21 2010-07-29 Chang David W Method and apparatus for treating a carotid artery
US9662118B2 (en) * 2003-11-21 2017-05-30 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
EP2260776A1 (en) * 2003-11-21 2010-12-15 Vnus Medical Technologies, Inc. Apparatus for treating the carotid artery
US11849954B2 (en) 2003-11-21 2023-12-26 Silk Road Medical, Inc. Method and apparatus for treating an arterial lesion
US10779835B2 (en) 2003-11-21 2020-09-22 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US8414516B2 (en) * 2003-11-21 2013-04-09 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US7998104B2 (en) 2003-11-21 2011-08-16 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US8002728B2 (en) 2003-11-21 2011-08-23 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US8343089B2 (en) * 2003-11-21 2013-01-01 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US10188399B2 (en) 2003-11-21 2019-01-29 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US20060129223A1 (en) * 2004-07-27 2006-06-15 University Of Southern California Percutaneously retrievable stent assembly with fluid draining capability
US8267917B2 (en) * 2004-07-27 2012-09-18 University Of Southern California Percutaneously retrievable stent assembly with fluid draining capability
US11534187B2 (en) * 2004-09-20 2022-12-27 P Tech, Llc Acoustic therapy device
US20230285039A1 (en) * 2004-09-20 2023-09-14 P Tech, Llc Acoustic therapy device
WO2006055967A2 (en) * 2004-11-19 2006-05-26 Lumen Biomedical, Inc. Extendable device on an aspiration catheter
WO2006055967A3 (en) * 2004-11-19 2008-01-17 Lumen Biomedical Inc Extendable device on an aspiration catheter
US20080086110A1 (en) * 2004-11-19 2008-04-10 Galdonik Jason A Extendable Device On An Aspiration Catheter
US8603132B2 (en) 2005-01-13 2013-12-10 Azam Anwar System and method for providing embolic protection
US8252016B2 (en) 2005-01-13 2012-08-28 Azam Anwar System and method for providing embolic protection
US20060200168A1 (en) * 2005-03-03 2006-09-07 Azam Anwar System and method for providing access in divergent directions in a vascular environment
US20070088379A1 (en) * 2005-10-17 2007-04-19 Jacob Schneiderman Minimally invasive a AAPT extirpation
US20070142819A1 (en) * 2005-12-20 2007-06-21 El-Nounou Fozan O Bifurcated catheter for agent delivery and method of agent delivery
US20100145356A1 (en) * 2006-02-08 2010-06-10 Vance Products, Inc., D/B/A Cook Urological Inc. Irrigating Catch and Removal Device
US20090222035A1 (en) * 2006-03-27 2009-09-03 Tel Hashomer Medical Research Infrastructure And S Intraluminal Mass Collector
US9533127B2 (en) * 2006-07-24 2017-01-03 Abbott Cardiovascular Systems Inc. Methods for inhibiting reperfusion injury
US20080017202A1 (en) * 2006-07-24 2008-01-24 Advanced Cardiovascular Systems, Inc. Methods for inhibiting reperfusion injury
US8480702B2 (en) 2007-01-11 2013-07-09 Covidien Lp Convertible embolic protection devices and methods of use
US20080172084A1 (en) * 2007-01-11 2008-07-17 Ev3 Inc. Convertible embolic protection devices and methods of use
US8157760B2 (en) 2007-07-18 2012-04-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10543307B2 (en) 2007-07-18 2020-01-28 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US8740834B2 (en) 2007-07-18 2014-06-03 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US8784355B2 (en) 2007-07-18 2014-07-22 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US11364332B2 (en) 2007-07-18 2022-06-21 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10952882B2 (en) 2007-07-18 2021-03-23 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9259215B2 (en) 2007-07-18 2016-02-16 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9789242B2 (en) 2007-07-18 2017-10-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10709832B2 (en) 2007-07-18 2020-07-14 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9011364B2 (en) 2007-07-18 2015-04-21 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10485917B2 (en) 2007-07-18 2019-11-26 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10426885B2 (en) 2007-07-18 2019-10-01 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10286139B2 (en) 2007-07-18 2019-05-14 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10085864B2 (en) 2007-07-18 2018-10-02 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9655755B2 (en) 2007-07-18 2017-05-23 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9833555B2 (en) 2007-07-18 2017-12-05 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9669191B2 (en) 2008-02-05 2017-06-06 Silk Road Medical, Inc. Interventional catheter system and methods
US10226598B2 (en) 2008-02-05 2019-03-12 Silk Road Medical, Inc. Interventional catheter system and methods
US11364369B2 (en) 2008-02-05 2022-06-21 Silk Road Medical, Inc. Interventional catheter system and methods
US20110112564A1 (en) * 2008-05-21 2011-05-12 Wolf Yehuda G Device And Method For Crossing Occlusions
US8162879B2 (en) 2008-09-22 2012-04-24 Tyco Healthcare Group Lp Double balloon catheter and methods for homogeneous drug delivery using the same
US20100082012A1 (en) * 2008-09-22 2010-04-01 Foxhollow Technologies, Inc. Double balloon catheter and methods for homogeneous drug delivery using the same
US8603064B2 (en) 2008-09-22 2013-12-10 Covidien Lp Double balloon catheter and methods for homogeneous drug delivery using the same
US11654222B2 (en) 2008-12-23 2023-05-23 Silk Road Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11103627B2 (en) 2008-12-23 2021-08-31 Silk Road Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10226563B2 (en) 2008-12-23 2019-03-12 Silk Road Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10828462B2 (en) * 2009-06-01 2020-11-10 Sanovas Intellectual Property, Llc Systems and methods for impairing smooth muscle tissue function
US20120143099A1 (en) * 2009-06-01 2012-06-07 Mayo Foundation For Medical Education And Research Systems and methods for impairing smooth muscle tissue function
US8545432B2 (en) 2009-06-03 2013-10-01 Silk Road Medical, Inc. System and methods for controlling retrograde carotid arterial blood flow
US9138527B2 (en) 2009-06-03 2015-09-22 Silk Road Medical, Inc. System and methods for controlling retrograde carotid arterial blood flow
US11471182B2 (en) * 2011-06-08 2022-10-18 Cvdevices, Llc Thrombectomy systems and devices and methods of using the same
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10327790B2 (en) 2011-08-05 2019-06-25 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10646239B2 (en) 2011-08-05 2020-05-12 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10722251B2 (en) 2011-08-05 2020-07-28 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11871944B2 (en) 2011-08-05 2024-01-16 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10743893B2 (en) 2011-08-05 2020-08-18 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US9119935B2 (en) * 2012-01-12 2015-09-01 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US20140288587A1 (en) * 2012-01-12 2014-09-25 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US9302083B2 (en) 2012-01-12 2016-04-05 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US11311365B2 (en) 2012-07-06 2022-04-26 Michael Zhadkevich Catheter for prevention of stroke and method of use
US11160957B2 (en) * 2012-07-17 2021-11-02 Michael Zhadkevich Carotid artery occluding apparatus with first, second and third occluding balloons
US10471241B2 (en) 2013-08-26 2019-11-12 Merit Medical Systems, Inc. Sheathless guide, rapid exchange dilator and associated methods
US9492637B2 (en) 2013-12-23 2016-11-15 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9561345B2 (en) 2013-12-23 2017-02-07 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10864351B2 (en) 2013-12-23 2020-12-15 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11534575B2 (en) 2013-12-23 2022-12-27 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10213582B2 (en) 2013-12-23 2019-02-26 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9861783B2 (en) 2013-12-23 2018-01-09 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US10569049B2 (en) 2013-12-23 2020-02-25 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US10384034B2 (en) 2013-12-23 2019-08-20 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US10471233B2 (en) 2013-12-23 2019-11-12 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11318282B2 (en) 2013-12-23 2022-05-03 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11291799B2 (en) 2013-12-23 2022-04-05 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US11027104B2 (en) 2014-09-04 2021-06-08 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9399118B2 (en) 2014-09-04 2016-07-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
US10039906B2 (en) 2014-09-04 2018-08-07 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9241699B1 (en) 2014-09-04 2016-01-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
US10864357B2 (en) 2014-09-04 2020-12-15 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9662480B2 (en) 2014-09-04 2017-05-30 Silk Road Medical, Inc. Methods and devices for transcarotid access
US11759613B2 (en) 2014-09-04 2023-09-19 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9126018B1 (en) 2014-09-04 2015-09-08 Silk Road Medical, Inc. Methods and devices for transcarotid access
US11793529B2 (en) 2015-02-04 2023-10-24 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US11806032B2 (en) 2015-02-04 2023-11-07 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US11633571B2 (en) 2015-02-04 2023-04-25 Route 92 Medical, Inc. Rapid aspiration thrombectomy system and method
US11433226B2 (en) 2015-04-10 2022-09-06 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US11129702B2 (en) 2018-05-09 2021-09-28 Boston Scientific Scimed, Inc. Pedal access embolic filtering sheath
US11607523B2 (en) 2018-05-17 2023-03-21 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US11229770B2 (en) 2018-05-17 2022-01-25 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
CN111000616A (en) * 2018-10-04 2020-04-14 尼尔拉维有限公司 Reverse blood flow blocking flushing device
US20210170148A1 (en) * 2019-09-25 2021-06-10 Thrombolex, Inc Balloon Basket Catheter Device
US11918226B2 (en) 2021-05-05 2024-03-05 Silk Road Medical, Inc. Method and apparatus for treating an arterial lesion
WO2023280315A1 (en) * 2021-07-08 2023-01-12 张桂运 Endovascular plaque excision system and excision method
US11925770B2 (en) 2023-04-07 2024-03-12 Route 92 Medical, Inc. Aspiration catheter systems and methods of use

Also Published As

Publication number Publication date
EP1164944A1 (en) 2002-01-02
DE60039594D1 (en) 2008-09-04
WO2000054673A1 (en) 2000-09-21
US20030023227A1 (en) 2003-01-30
US6605074B2 (en) 2003-08-12
US20040054347A1 (en) 2004-03-18
AU3751200A (en) 2000-10-04
EP1164944B1 (en) 2008-07-23
US6790204B2 (en) 2004-09-14

Similar Documents

Publication Publication Date Title
US6605074B2 (en) Method for containing and removing occlusions in the carotid arteries
US11185664B2 (en) Rapid aspiration thrombectomy system and method
US20060200191A1 (en) Method and apparatuses for treating an intravascular occlusion
US9681882B2 (en) Rapid aspiration thrombectomy system and method
US6398773B1 (en) Aspiration system and method
US6805692B2 (en) Aspiration method
WO1998038930A9 (en) Catheter system for containing and removing vascular occlusions
WO1998038930A1 (en) Catheter system for containing and removing vascular occlusions
US6849068B1 (en) Aspiration catheter

Legal Events

Date Code Title Description
AS Assignment

Owner name: PERCUSURGE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZADNO-AZIZI, GHOLAM-REZA;PATEL, MUKUND R.;MUNI, KETAN P.;AND OTHERS;REEL/FRAME:010002/0979

Effective date: 19990511

AS Assignment

Owner name: MEDTRONIC PERCUSURGE, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNORS:ZADNO-AZIZI, GHOLAM-REZA;PATEL, MUKUND R.;MUNI, KETAN P.;AND OTHERS;REEL/FRAME:012572/0792

Effective date: 19990511

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE